id	sid	tid	token	lemma	pos
bam-9518	1	1	effect	effect	NOUN
bam-9518	1	2	of	of	ADP
bam-9518	1	3	allicin	allicin	NOUN
bam-9518	1	4	(	(	PUNCT
bam-9518	1	5	l	l	NOUN
bam-9518	1	6	-	-	NOUN
bam-9518	1	7	cysteine	cysteine	NOUN
bam-9518	1	8	)	)	PUNCT
bam-9518	1	9	on	on	ADP
bam-9518	1	10	covid-19	covid-19	PROPN
bam-9518	1	11	eur	eur	PROPN
bam-9518	1	12	j	j	PROPN
bam-9518	1	13	transl	transl	PROPN
bam-9518	1	14	myol	myol	ADV
bam-9518	1	15	31	31	NUM
bam-9518	1	16	(	(	PUNCT
bam-9518	1	17	2	2	NUM
bam-9518	1	18	):	):	PUNCT
bam-9518	1	19	9518	9518	NUM
bam-9518	1	20	,	,	PUNCT
bam-9518	1	21	2021	2021	NUM
bam-9518	1	22	doi	doi	NOUN
bam-9518	1	23	:	:	PUNCT
bam-9518	1	24	10.4081	10.4081	NUM
bam-9518	1	25	/	/	SYM
bam-9518	1	26	ejtm.2021.9518	ejtm.2021.9518	ADJ
bam-9518	1	27	1	1	NUM
bam-9518	1	28	evaluate	evaluate	VERB
bam-9518	1	29	the	the	DET
bam-9518	1	30	therapeutic	therapeutic	ADJ
bam-9518	1	31	effect	effect	NOUN
bam-9518	1	32	of	of	ADP
bam-9518	1	33	allicin	allicin	NOUN
bam-9518	1	34	(	(	PUNCT
bam-9518	1	35	l	l	NOUN
bam-9518	1	36	-	-	NOUN
bam-9518	1	37	cysteine	cysteine	NOUN
bam-9518	1	38	)	)	PUNCT
bam-9518	1	39	on	on	ADP
bam-9518	1	40	clinical	clinical	ADJ
bam-9518	1	41	presentation	presentation	NOUN
bam-9518	1	42	and	and	CCONJ
bam-9518	1	43	prognosis	prognosis	NOUN
bam-9518	1	44	in	in	ADP
bam-9518	1	45	patients	patient	NOUN
bam-9518	1	46	with	with	ADP
bam-9518	1	47	covid-19	covid-19	PROPN
bam-9518	1	48	hosein	hosein	PROPN
bam-9518	1	49	yaghoubian	yaghoubian	NOUN
bam-9518	1	50	(	(	PUNCT
bam-9518	1	51	1	1	NUM
bam-9518	1	52	)	)	PUNCT
bam-9518	1	53	,	,	PUNCT
bam-9518	1	54	hossein	hossein	PROPN
bam-9518	1	55	niktale	niktale	PROPN
bam-9518	1	56	(	(	PUNCT
bam-9518	1	57	2	2	NUM
bam-9518	1	58	)	)	PUNCT
bam-9518	1	59	,	,	PUNCT
bam-9518	1	60	arash	arash	PROPN
bam-9518	1	61	peivandi	peivandi	PROPN
bam-9518	1	62	yazdi	yazdi	PROPN
bam-9518	1	63	(	(	PUNCT
bam-9518	1	64	3	3	NUM
bam-9518	1	65	)	)	PUNCT
bam-9518	1	66	,	,	PUNCT
bam-9518	1	67	vahideh	vahideh	NOUN
bam-9518	1	68	ghorani	ghorani	NOUN
bam-9518	1	69	(	(	PUNCT
bam-9518	1	70	4	4	NUM
bam-9518	1	71	)	)	PUNCT
bam-9518	1	72	,	,	PUNCT
bam-9518	1	73	masoud	masoud	PROPN
bam-9518	1	74	mahdavi	mahdavi	PROPN
bam-9518	1	75	rashed	rashed	PROPN
bam-9518	1	76	(	(	PUNCT
bam-9518	1	77	5	5	NUM
bam-9518	1	78	)	)	PUNCT
bam-9518	1	79	,	,	PUNCT
bam-9518	1	80	amir	amir	PROPN
bam-9518	1	81	masoud	masoud	PROPN
bam-9518	1	82	hashemian	hashemian	PROPN
bam-9518	1	83	(	(	PUNCT
bam-9518	1	84	6	6	NUM
bam-9518	1	85	)	)	PUNCT
bam-9518	1	86	(	(	PUNCT
bam-9518	1	87	1	1	X
bam-9518	1	88	)	)	PUNCT
bam-9518	1	89	department	department	NOUN
bam-9518	1	90	of	of	ADP
bam-9518	1	91	emergency	emergency	NOUN
bam-9518	1	92	medicine	medicine	NOUN
bam-9518	1	93	,	,	PUNCT
bam-9518	1	94	mashhad	mashhad	PROPN
bam-9518	1	95	university	university	PROPN
bam-9518	1	96	of	of	ADP
bam-9518	1	97	medical	medical	ADJ
bam-9518	1	98	sciences	sciences	PROPN
bam-9518	1	99	,	,	PUNCT
bam-9518	1	100	mashhad	mashhad	PROPN
bam-9518	1	101	,	,	PUNCT
bam-9518	1	102	iran	iran	PROPN
bam-9518	1	103	;	;	PUNCT
bam-9518	1	104	(	(	PUNCT
bam-9518	1	105	2	2	X
bam-9518	1	106	)	)	PUNCT
bam-9518	1	107	innovation	innovation	NOUN
bam-9518	1	108	,	,	PUNCT
bam-9518	1	109	technology	technology	NOUN
bam-9518	1	110	and	and	CCONJ
bam-9518	1	111	entrepreneurship	entrepreneurship	NOUN
bam-9518	1	112	,	,	PUNCT
bam-9518	1	113	molecule	molecule	NOUN
bam-9518	1	114	of	of	ADP
bam-9518	1	115	allicin	allicin	NOUN
bam-9518	1	116	(	(	PUNCT
bam-9518	1	117	l	l	NOUN
bam-9518	1	118	-	-	NOUN
bam-9518	1	119	cysteine	cysteine	NOUN
bam-9518	1	120	)	)	PUNCT
bam-9518	1	121	with	with	ADP
bam-9518	1	122	stabilized	stabilize	VERB
bam-9518	1	123	oxidation	oxidation	NOUN
bam-9518	1	124	capacity	capacity	NOUN
bam-9518	1	125	,	,	PUNCT
bam-9518	1	126	mashhad	mashhad	PROPN
bam-9518	1	127	,	,	PUNCT
bam-9518	1	128	iran	iran	PROPN
bam-9518	1	129	;	;	PUNCT
bam-9518	1	130	(	(	PUNCT
bam-9518	1	131	3	3	X
bam-9518	1	132	)	)	PUNCT
bam-9518	1	133	lung	lung	NOUN
bam-9518	1	134	diseases	disease	NOUN
bam-9518	1	135	research	research	NOUN
bam-9518	1	136	center	center	NOUN
bam-9518	1	137	,	,	PUNCT
bam-9518	1	138	mashhad	mashhad	PROPN
bam-9518	1	139	university	university	PROPN
bam-9518	1	140	of	of	ADP
bam-9518	1	141	medical	medical	ADJ
bam-9518	1	142	sciences	sciences	PROPN
bam-9518	1	143	,	,	PUNCT
bam-9518	1	144	mashhad	mashhad	PROPN
bam-9518	1	145	,	,	PUNCT
bam-9518	1	146	iran	iran	PROPN
bam-9518	1	147	;	;	PUNCT
bam-9518	1	148	(	(	PUNCT
bam-9518	1	149	4	4	X
bam-9518	1	150	)	)	PUNCT
bam-9518	1	151	clinical	clinical	ADJ
bam-9518	1	152	research	research	NOUN
bam-9518	1	153	unit	unit	NOUN
bam-9518	1	154	,	,	PUNCT
bam-9518	1	155	faculty	faculty	NOUN
bam-9518	1	156	of	of	ADP
bam-9518	1	157	medicine	medicine	NOUN
bam-9518	1	158	,	,	PUNCT
bam-9518	1	159	mashhad	mashhad	PROPN
bam-9518	1	160	university	university	PROPN
bam-9518	1	161	of	of	ADP
bam-9518	1	162	medical	medical	ADJ
bam-9518	1	163	sciences	sciences	PROPN
bam-9518	1	164	,	,	PUNCT
bam-9518	1	165	mashhad	mashhad	PROPN
bam-9518	1	166	,	,	PUNCT
bam-9518	1	167	iran	iran	PROPN
bam-9518	1	168	;	;	PUNCT
bam-9518	1	169	(	(	PUNCT
bam-9518	1	170	5	5	X
bam-9518	1	171	)	)	PUNCT
bam-9518	1	172	akbar	akbar	NOUN
bam-9518	1	173	children	child	NOUN
bam-9518	1	174	hospital	hospital	NOUN
bam-9518	1	175	,	,	PUNCT
bam-9518	1	176	mashhad	mashhad	PROPN
bam-9518	1	177	university	university	PROPN
bam-9518	1	178	of	of	ADP
bam-9518	1	179	medical	medical	ADJ
bam-9518	1	180	sciences	sciences	PROPN
bam-9518	1	181	,	,	PUNCT
bam-9518	1	182	mashhad	mashhad	PROPN
bam-9518	1	183	,	,	PUNCT
bam-9518	1	184	iran	iran	PROPN
bam-9518	1	185	;	;	PUNCT
bam-9518	1	186	(	(	PUNCT
bam-9518	1	187	6	6	X
bam-9518	1	188	)	)	PUNCT
bam-9518	1	189	department	department	NOUN
bam-9518	1	190	of	of	ADP
bam-9518	1	191	emergency	emergency	NOUN
bam-9518	1	192	medicine	medicine	NOUN
bam-9518	1	193	,	,	PUNCT
bam-9518	1	194	faculty	faculty	NOUN
bam-9518	1	195	of	of	ADP
bam-9518	1	196	medicine	medicine	NOUN
bam-9518	1	197	,	,	PUNCT
bam-9518	1	198	mashhad	mashhad	PROPN
bam-9518	1	199	university	university	PROPN
bam-9518	1	200	of	of	ADP
bam-9518	1	201	medical	medical	ADJ
bam-9518	1	202	sciences	sciences	PROPN
bam-9518	1	203	,	,	PUNCT
bam-9518	1	204	mashhad	mashhad	PROPN
bam-9518	1	205	,	,	PUNCT
bam-9518	1	206	iran	iran	PROPN
bam-9518	1	207	.	.	PUNCT
bam-9518	2	1	this	this	DET
bam-9518	2	2	article	article	NOUN
bam-9518	2	3	is	be	AUX
bam-9518	2	4	distributed	distribute	VERB
bam-9518	2	5	under	under	ADP
bam-9518	2	6	the	the	DET
bam-9518	2	7	terms	term	NOUN
bam-9518	2	8	of	of	ADP
bam-9518	2	9	the	the	DET
bam-9518	2	10	creative	creative	ADJ
bam-9518	2	11	commons	common	NOUN
bam-9518	2	12	attribution	attribution	NOUN
bam-9518	2	13	noncommercial	noncommercial	ADJ
bam-9518	2	14	license	license	NOUN
bam-9518	2	15	(	(	PUNCT
bam-9518	2	16	cc	cc	NOUN
bam-9518	2	17	by	by	ADP
bam-9518	2	18	-	-	PUNCT
bam-9518	2	19	nc	nc	PROPN
bam-9518	2	20	4.0	4.0	NUM
bam-9518	2	21	)	)	PUNCT
bam-9518	2	22	which	which	PRON
bam-9518	2	23	permits	permit	VERB
bam-9518	2	24	any	any	DET
bam-9518	2	25	noncommercial	noncommercial	ADJ
bam-9518	2	26	use	use	NOUN
bam-9518	2	27	,	,	PUNCT
bam-9518	2	28	distribution	distribution	NOUN
bam-9518	2	29	,	,	PUNCT
bam-9518	2	30	and	and	CCONJ
bam-9518	2	31	reproduction	reproduction	NOUN
bam-9518	2	32	in	in	ADP
bam-9518	2	33	any	any	DET
bam-9518	2	34	medium	medium	NOUN
bam-9518	2	35	,	,	PUNCT
bam-9518	2	36	provided	provide	VERB
bam-9518	2	37	the	the	DET
bam-9518	2	38	original	original	ADJ
bam-9518	2	39	author(s	author(s	NOUN
bam-9518	2	40	)	)	PUNCT
bam-9518	2	41	and	and	CCONJ
bam-9518	2	42	source	source	NOUN
bam-9518	2	43	are	be	AUX
bam-9518	2	44	credited	credit	VERB
bam-9518	2	45	.	.	PUNCT
bam-9518	3	1	abstract	abstract	ADV
bam-9518	3	2	the	the	DET
bam-9518	3	3	antiviral	antiviral	ADJ
bam-9518	3	4	effectiveness	effectiveness	NOUN
bam-9518	3	5	of	of	ADP
bam-9518	3	6	allicin	allicin	NOUN
bam-9518	3	7	(	(	PUNCT
bam-9518	3	8	l	l	NOUN
bam-9518	3	9	-	-	NOUN
bam-9518	3	10	cysteine	cysteine	NOUN
bam-9518	3	11	)	)	PUNCT
bam-9518	3	12	has	have	AUX
bam-9518	3	13	been	be	AUX
bam-9518	3	14	shown	show	VERB
bam-9518	3	15	by	by	ADP
bam-9518	3	16	numerous	numerous	ADJ
bam-9518	3	17	studies	study	NOUN
bam-9518	3	18	in	in	ADP
bam-9518	3	19	both	both	DET
bam-9518	3	20	levels	level	NOUN
bam-9518	3	21	of	of	ADP
bam-9518	3	22	clinical	clinical	ADJ
bam-9518	3	23	and	and	CCONJ
bam-9518	3	24	animals	animal	NOUN
bam-9518	3	25	.	.	PUNCT
bam-9518	4	1	the	the	DET
bam-9518	4	2	aim	aim	NOUN
bam-9518	4	3	of	of	ADP
bam-9518	4	4	this	this	DET
bam-9518	4	5	study	study	NOUN
bam-9518	4	6	was	be	AUX
bam-9518	4	7	to	to	PART
bam-9518	4	8	evaluate	evaluate	VERB
bam-9518	4	9	the	the	DET
bam-9518	4	10	therapeutic	therapeutic	ADJ
bam-9518	4	11	effect	effect	NOUN
bam-9518	4	12	of	of	ADP
bam-9518	4	13	allicin	allicin	NOUN
bam-9518	4	14	(	(	PUNCT
bam-9518	4	15	l	l	NOUN
bam-9518	4	16	-	-	NOUN
bam-9518	4	17	cysteine	cysteine	NOUN
bam-9518	4	18	)	)	PUNCT
bam-9518	4	19	on	on	ADP
bam-9518	4	20	clinical	clinical	ADJ
bam-9518	4	21	presentation	presentation	NOUN
bam-9518	4	22	and	and	CCONJ
bam-9518	4	23	prognosis	prognosis	NOUN
bam-9518	4	24	.	.	PUNCT
bam-9518	5	1	in	in	ADP
bam-9518	5	2	the	the	DET
bam-9518	5	3	current	current	ADJ
bam-9518	5	4	study	study	NOUN
bam-9518	5	5	,	,	PUNCT
bam-9518	5	6	66	66	NUM
bam-9518	5	7	patients	patient	NOUN
bam-9518	5	8	with	with	ADP
bam-9518	5	9	covid-19	covid-19	PROPN
bam-9518	5	10	based	base	VERB
bam-9518	5	11	on	on	ADP
bam-9518	5	12	clinical	clinical	ADJ
bam-9518	5	13	,	,	PUNCT
bam-9518	5	14	radiological	radiological	ADJ
bam-9518	5	15	presentations	presentation	NOUN
bam-9518	5	16	and	and	CCONJ
bam-9518	5	17	rt	rt	ADJ
bam-9518	5	18	-	-	PUNCT
bam-9518	5	19	pcr	pcr	ADJ
bam-9518	5	20	results	result	NOUN
bam-9518	5	21	,	,	PUNCT
bam-9518	5	22	were	be	AUX
bam-9518	5	23	enrolled	enrol	VERB
bam-9518	5	24	in	in	ADP
bam-9518	5	25	two	two	NUM
bam-9518	5	26	groups	group	NOUN
bam-9518	5	27	of	of	ADP
bam-9518	5	28	placebo	placebo	NOUN
bam-9518	5	29	and	and	CCONJ
bam-9518	5	30	allicin	allicin	NOUN
bam-9518	5	31	.	.	PUNCT
bam-9518	6	1	in	in	ADP
bam-9518	6	2	the	the	DET
bam-9518	6	3	both	both	DET
bam-9518	6	4	allicin	allicin	NOUN
bam-9518	6	5	(	(	PUNCT
bam-9518	6	6	l	l	NOUN
bam-9518	6	7	-	-	NOUN
bam-9518	6	8	cysteine	cysteine	ADJ
bam-9518	6	9	)	)	PUNCT
bam-9518	6	10	and	and	CCONJ
bam-9518	6	11	placebo	placebo	NOUN
bam-9518	6	12	groups	group	NOUN
bam-9518	6	13	(	(	PUNCT
bam-9518	6	14	n=33	n=33	NOUN
bam-9518	6	15	in	in	ADP
bam-9518	6	16	each	each	DET
bam-9518	6	17	group	group	NOUN
bam-9518	6	18	)	)	PUNCT
bam-9518	6	19	,	,	PUNCT
bam-9518	6	20	the	the	DET
bam-9518	6	21	capsules	capsule	NOUN
bam-9518	6	22	were	be	AUX
bam-9518	6	23	prescribed	prescribe	VERB
bam-9518	6	24	two	two	NUM
bam-9518	6	25	times	time	NOUN
bam-9518	6	26	a	a	DET
bam-9518	6	27	day	day	NOUN
bam-9518	6	28	for	for	ADP
bam-9518	6	29	two	two	NUM
bam-9518	6	30	weeks	week	NOUN
bam-9518	6	31	.	.	PUNCT
bam-9518	7	1	clinical	clinical	ADJ
bam-9518	7	2	signs	sign	NOUN
bam-9518	7	3	and	and	CCONJ
bam-9518	7	4	symptoms	symptom	NOUN
bam-9518	7	5	,	,	PUNCT
bam-9518	7	6	blood	blood	NOUN
bam-9518	7	7	parameters	parameter	NOUN
bam-9518	7	8	and	and	CCONJ
bam-9518	7	9	chest	chest	NOUN
bam-9518	7	10	ct	ct	PROPN
bam-9518	7	11	scan	scan	PROPN
bam-9518	7	12	were	be	AUX
bam-9518	7	13	evaluated	evaluate	VERB
bam-9518	7	14	before	before	ADP
bam-9518	7	15	and	and	CCONJ
bam-9518	7	16	two	two	NUM
bam-9518	7	17	weeks	week	NOUN
bam-9518	7	18	after	after	ADP
bam-9518	7	19	treatment	treatment	NOUN
bam-9518	7	20	.	.	PUNCT
bam-9518	8	1	the	the	DET
bam-9518	8	2	results	result	NOUN
bam-9518	8	3	showed	show	VERB
bam-9518	8	4	that	that	SCONJ
bam-9518	8	5	allicin	allicin	NOUN
bam-9518	8	6	(	(	PUNCT
bam-9518	8	7	l	l	NOUN
bam-9518	8	8	-	-	NOUN
bam-9518	8	9	cysteine	cysteine	NOUN
bam-9518	8	10	)	)	PUNCT
bam-9518	8	11	could	could	AUX
bam-9518	8	12	significantly	significantly	ADV
bam-9518	8	13	impact	impact	VERB
bam-9518	8	14	on	on	ADP
bam-9518	8	15	improvement	improvement	NOUN
bam-9518	8	16	of	of	ADP
bam-9518	8	17	signs	sign	NOUN
bam-9518	8	18	and	and	CCONJ
bam-9518	8	19	symptoms	symptom	NOUN
bam-9518	8	20	of	of	ADP
bam-9518	8	21	covid-19	covid-19	PROPN
bam-9518	8	22	after	after	ADP
bam-9518	8	23	two	two	NUM
bam-9518	8	24	weeks	week	NOUN
bam-9518	8	25	of	of	ADP
bam-9518	8	26	treatment	treatment	NOUN
bam-9518	8	27	in	in	ADP
bam-9518	8	28	comparison	comparison	NOUN
bam-9518	8	29	to	to	ADP
bam-9518	8	30	placebo	placebo	NOUN
bam-9518	8	31	.	.	PUNCT
bam-9518	9	1	allicin	allicin	NOUN
bam-9518	9	2	(	(	PUNCT
bam-9518	9	3	l	l	NOUN
bam-9518	9	4	-	-	NOUN
bam-9518	9	5	cysteine	cysteine	NOUN
bam-9518	9	6	)	)	PUNCT
bam-9518	9	7	not	not	PART
bam-9518	9	8	only	only	ADV
bam-9518	9	9	improve	improve	VERB
bam-9518	9	10	the	the	DET
bam-9518	9	11	clinical	clinical	ADJ
bam-9518	9	12	signs	sign	NOUN
bam-9518	9	13	,	,	PUNCT
bam-9518	9	14	but	but	CCONJ
bam-9518	9	15	also	also	ADV
bam-9518	9	16	ameliorate	ameliorate	VERB
bam-9518	9	17	the	the	DET
bam-9518	9	18	lab	lab	NOUN
bam-9518	9	19	and	and	CCONJ
bam-9518	9	20	radiological	radiological	ADJ
bam-9518	9	21	data	datum	NOUN
bam-9518	9	22	,	,	PUNCT
bam-9518	9	23	which	which	PRON
bam-9518	9	24	suggest	suggest	VERB
bam-9518	9	25	a	a	DET
bam-9518	9	26	therapeutic	therapeutic	ADJ
bam-9518	9	27	effect	effect	NOUN
bam-9518	9	28	for	for	ADP
bam-9518	9	29	this	this	DET
bam-9518	9	30	agent	agent	NOUN
bam-9518	9	31	in	in	ADP
bam-9518	9	32	covid-19	covid-19	PROPN
bam-9518	9	33	.	.	PUNCT
bam-9518	10	1	our	our	PRON
bam-9518	10	2	data	datum	NOUN
bam-9518	10	3	suggest	suggest	VERB
bam-9518	10	4	the	the	DET
bam-9518	10	5	therapeutic	therapeutic	ADJ
bam-9518	10	6	effect	effect	NOUN
bam-9518	10	7	of	of	ADP
bam-9518	10	8	allicin	allicin	NOUN
bam-9518	10	9	(	(	PUNCT
bam-9518	10	10	l	l	NOUN
bam-9518	10	11	-	-	NOUN
bam-9518	10	12	cysteine	cysteine	NOUN
bam-9518	10	13	)	)	PUNCT
bam-9518	10	14	on	on	ADP
bam-9518	10	15	covid-19	covid-19	PROPN
bam-9518	10	16	through	through	ADP
bam-9518	10	17	improvement	improvement	NOUN
bam-9518	10	18	of	of	ADP
bam-9518	10	19	clinical	clinical	ADJ
bam-9518	10	20	symptoms	symptom	NOUN
bam-9518	10	21	and	and	CCONJ
bam-9518	10	22	acceleration	acceleration	NOUN
bam-9518	10	23	of	of	ADP
bam-9518	10	24	the	the	DET
bam-9518	10	25	healing	healing	NOUN
bam-9518	10	26	process	process	NOUN
bam-9518	10	27	.	.	PUNCT
bam-9518	11	1	key	key	ADJ
bam-9518	11	2	words	word	NOUN
bam-9518	11	3	:	:	PUNCT
bam-9518	11	4	covid-19	covid-19	PROPN
bam-9518	11	5	;	;	PUNCT
bam-9518	11	6	allicin	allicin	NOUN
bam-9518	11	7	;	;	PUNCT
bam-9518	11	8	chest	chest	NOUN
bam-9518	11	9	ct	ct	PROPN
bam-9518	11	10	;	;	PUNCT
bam-9518	11	11	laboratory	laboratory	NOUN
bam-9518	11	12	findings	finding	NOUN
bam-9518	11	13	;	;	PUNCT
bam-9518	11	14	clinical	clinical	ADJ
bam-9518	11	15	trial	trial	NOUN
bam-9518	11	16	.	.	PUNCT
bam-9518	12	1	eur	eur	PROPN
bam-9518	12	2	j	j	PROPN
bam-9518	12	3	transl	transl	PROPN
bam-9518	12	4	myol	myol	ADV
bam-9518	12	5	31	31	NUM
bam-9518	12	6	(	(	PUNCT
bam-9518	12	7	2	2	NUM
bam-9518	12	8	):	):	PUNCT
bam-9518	12	9	9518	9518	NUM
bam-9518	12	10	,	,	PUNCT
bam-9518	12	11	2021	2021	NUM
bam-9518	12	12	doi	doi	NOUN
bam-9518	12	13	:	:	PUNCT
bam-9518	12	14	10.4081	10.4081	NUM
bam-9518	12	15	/	/	SYM
bam-9518	12	16	ejtm.2021.9518	ejtm.2021.9518	ADJ
bam-9518	12	17	two	two	NUM
bam-9518	12	18	identified	identify	VERB
bam-9518	12	19	zoonotic	zoonotic	ADJ
bam-9518	12	20	coronaviruses	coronaviruse	NOUN
bam-9518	12	21	,	,	PUNCT
bam-9518	12	22	severe	severe	ADJ
bam-9518	12	23	acute	acute	ADJ
bam-9518	12	24	respiratory	respiratory	ADJ
bam-9518	12	25	coronavirus	coronavirus	NOUN
bam-9518	12	26	syndrome	syndrome	NOUN
bam-9518	12	27	(	(	PUNCT
bam-9518	12	28	sars	sars	PROPN
bam-9518	12	29	-	-	PUNCT
bam-9518	12	30	cov	cov	NOUN
bam-9518	12	31	)	)	PUNCT
bam-9518	12	32	and	and	CCONJ
bam-9518	12	33	middle	middle	PROPN
bam-9518	12	34	east	east	PROPN
bam-9518	12	35	respiratory	respiratory	ADJ
bam-9518	12	36	coronavirus	coronavirus	NOUN
bam-9518	12	37	syndrome	syndrome	NOUN
bam-9518	12	38	(	(	PUNCT
bam-9518	12	39	merscov	merscov	PROPN
bam-9518	12	40	)	)	PUNCT
bam-9518	12	41	have	have	AUX
bam-9518	12	42	been	be	AUX
bam-9518	12	43	reported	report	VERB
bam-9518	12	44	to	to	PART
bam-9518	12	45	have	have	AUX
bam-9518	12	46	disturbed	disturb	VERB
bam-9518	12	47	the	the	DET
bam-9518	12	48	respiratory	respiratory	ADJ
bam-9518	12	49	tract	tract	NOUN
bam-9518	12	50	and	and	CCONJ
bam-9518	12	51	caused	cause	VERB
bam-9518	12	52	significant	significant	ADJ
bam-9518	12	53	outbreaks	outbreak	NOUN
bam-9518	12	54	in	in	ADP
bam-9518	12	55	two	two	NUM
bam-9518	12	56	past	past	ADJ
bam-9518	12	57	decades.1,2	decades.1,2	ADJ
bam-9518	12	58	severe	severe	ADJ
bam-9518	12	59	acute	acute	ADJ
bam-9518	12	60	respiratory	respiratory	ADJ
bam-9518	12	61	syndrome	syndrome	NOUN
bam-9518	12	62	coronavirus	coronavirus	NOUN
bam-9518	12	63	2	2	NUM
bam-9518	12	64	is	be	AUX
bam-9518	12	65	a	a	DET
bam-9518	12	66	recently	recently	ADV
bam-9518	12	67	identified	identify	VERB
bam-9518	12	68	coronavirus	coronavirus	NOUN
bam-9518	12	69	,	,	PUNCT
bam-9518	12	70	first	first	ADV
bam-9518	12	71	discovered	discover	VERB
bam-9518	12	72	in	in	ADP
bam-9518	12	73	wuhan	wuhan	PROPN
bam-9518	12	74	,	,	PUNCT
bam-9518	12	75	china	china	PROPN
bam-9518	12	76	,	,	PUNCT
bam-9518	12	77	in	in	ADP
bam-9518	12	78	december	december	PROPN
bam-9518	12	79	2019	2019	NUM
bam-9518	12	80	.	.	PUNCT
bam-9518	13	1	the	the	DET
bam-9518	13	2	disease	disease	NOUN
bam-9518	13	3	was	be	AUX
bam-9518	13	4	formally	formally	ADV
bam-9518	13	5	named	name	VERB
bam-9518	13	6	coronavirus	coronavirus	NOUN
bam-9518	13	7	disease	disease	NOUN
bam-9518	13	8	2019	2019	NUM
bam-9518	13	9	(	(	PUNCT
bam-9518	13	10	covid-19	covid-19	PROPN
bam-9518	13	11	)	)	PUNCT
bam-9518	13	12	on	on	ADP
bam-9518	13	13	11	11	NUM
bam-9518	13	14	february	february	PROPN
bam-9518	13	15	2020.3	2020.3	NUM
bam-9518	13	16	epidemiological	epidemiological	ADJ
bam-9518	13	17	results	result	NOUN
bam-9518	13	18	have	have	AUX
bam-9518	13	19	effectively	effectively	ADV
bam-9518	13	20	determined	determine	VERB
bam-9518	13	21	the	the	DET
bam-9518	13	22	path	path	NOUN
bam-9518	13	23	of	of	ADP
bam-9518	13	24	person	person	NOUN
bam-9518	13	25	-	-	PUNCT
bam-9518	13	26	toperson	toperson	NOUN
bam-9518	13	27	dissemination	dissemination	NOUN
bam-9518	13	28	in	in	ADP
bam-9518	13	29	covid-19	covid-19	PROPN
bam-9518	13	30	,	,	PUNCT
bam-9518	13	31	which	which	PRON
bam-9518	13	32	has	have	AUX
bam-9518	13	33	expanded	expand	VERB
bam-9518	13	34	exponentially	exponentially	ADV
bam-9518	13	35	and	and	CCONJ
bam-9518	13	36	has	have	AUX
bam-9518	13	37	become	become	VERB
bam-9518	13	38	a	a	DET
bam-9518	13	39	global	global	ADJ
bam-9518	13	40	public	public	ADJ
bam-9518	13	41	health	health	NOUN
bam-9518	13	42	issue.4,5	issue.4,5	NOUN
bam-9518	13	43	many	many	ADJ
bam-9518	13	44	patients	patient	NOUN
bam-9518	13	45	have	have	AUX
bam-9518	13	46	acquired	acquire	VERB
bam-9518	13	47	pneumonia	pneumonia	NOUN
bam-9518	13	48	,	,	PUNCT
bam-9518	13	49	which	which	PRON
bam-9518	13	50	can	can	AUX
bam-9518	13	51	worsen	worsen	VERB
bam-9518	13	52	quickly	quickly	ADV
bam-9518	13	53	as	as	ADP
bam-9518	13	54	a	a	DET
bam-9518	13	55	result	result	NOUN
bam-9518	13	56	of	of	ADP
bam-9518	13	57	respiratory	respiratory	ADJ
bam-9518	13	58	failure	failure	NOUN
bam-9518	13	59	.	.	PUNCT
bam-9518	14	1	elderly	elderly	ADJ
bam-9518	14	2	and	and	CCONJ
bam-9518	14	3	patients	patient	NOUN
bam-9518	14	4	with	with	ADP
bam-9518	14	5	poor	poor	ADJ
bam-9518	14	6	immune	immune	ADJ
bam-9518	14	7	function	function	NOUN
bam-9518	14	8	have	have	VERB
bam-9518	14	9	higher	high	ADJ
bam-9518	14	10	susceptibility	susceptibility	NOUN
bam-9518	14	11	and	and	CCONJ
bam-9518	14	12	mortality	mortality	NOUN
bam-9518	14	13	rates.6	rates.6	NOUN
bam-9518	14	14	-	-	PUNCT
bam-9518	14	15	8	8	NUM
bam-9518	14	16	it	it	PRON
bam-9518	14	17	has	have	AUX
bam-9518	14	18	been	be	AUX
bam-9518	14	19	well	well	ADV
bam-9518	14	20	documented	document	VERB
bam-9518	14	21	that	that	SCONJ
bam-9518	14	22	most	most	ADJ
bam-9518	14	23	patients	patient	NOUN
bam-9518	14	24	typically	typically	ADV
bam-9518	14	25	have	have	VERB
bam-9518	14	26	pneumonia	pneumonia	NOUN
bam-9518	14	27	with	with	ADP
bam-9518	14	28	irregular	irregular	ADJ
bam-9518	14	29	chest	chest	NOUN
bam-9518	14	30	computed	compute	VERB
bam-9518	14	31	tomography	tomography	NOUN
bam-9518	14	32	(	(	PUNCT
bam-9518	14	33	ct	ct	PROPN
bam-9518	14	34	)	)	PUNCT
bam-9518	14	35	scan	scan	ADJ
bam-9518	14	36	results	result	NOUN
bam-9518	14	37	.	.	PUNCT
bam-9518	15	1	popular	popular	ADJ
bam-9518	15	2	signs	sign	NOUN
bam-9518	15	3	at	at	ADP
bam-9518	15	4	onset	onset	NOUN
bam-9518	15	5	include	include	VERB
bam-9518	15	6	fever	fever	NOUN
bam-9518	15	7	,	,	PUNCT
bam-9518	15	8	cough	cough	NOUN
bam-9518	15	9	,	,	PUNCT
bam-9518	15	10	and	and	CCONJ
bam-9518	15	11	myalgia	myalgia	NOUN
bam-9518	15	12	or	or	CCONJ
bam-9518	15	13	tiredness.9	tiredness.9	PRON
bam-9518	15	14	a	a	DET
bam-9518	15	15	significant	significant	ADJ
bam-9518	15	16	number	number	NOUN
bam-9518	15	17	of	of	ADP
bam-9518	15	18	patients	patient	NOUN
bam-9518	15	19	suffered	suffer	VERB
bam-9518	15	20	serious	serious	ADJ
bam-9518	15	21	complications	complication	NOUN
bam-9518	15	22	,	,	PUNCT
bam-9518	15	23	including	include	VERB
bam-9518	15	24	acute	acute	ADJ
bam-9518	15	25	respiratory	respiratory	ADJ
bam-9518	15	26	distress	distress	NOUN
bam-9518	15	27	syndrome	syndrome	NOUN
bam-9518	15	28	(	(	PUNCT
bam-9518	15	29	ards	ard	NOUN
bam-9518	15	30	)	)	PUNCT
bam-9518	15	31	;	;	PUNCT
bam-9518	15	32	32	32	NUM
bam-9518	15	33	%	%	NOUN
bam-9518	15	34	of	of	ADP
bam-9518	15	35	patients	patient	NOUN
bam-9518	15	36	required	require	VERB
bam-9518	15	37	intensive	intensive	ADJ
bam-9518	15	38	care	care	NOUN
bam-9518	15	39	(	(	PUNCT
bam-9518	15	40	icu	icu	PROPN
bam-9518	15	41	)	)	PUNCT
bam-9518	15	42	admission	admission	NOUN
bam-9518	15	43	;	;	PUNCT
bam-9518	15	44	and	and	CCONJ
bam-9518	15	45	15	15	NUM
bam-9518	15	46	%	%	NOUN
bam-9518	15	47	died	die	VERB
bam-9518	15	48	.	.	PUNCT
bam-9518	16	1	according	accord	VERB
bam-9518	16	2	to	to	ADP
bam-9518	16	3	the	the	DET
bam-9518	16	4	latest	late	ADJ
bam-9518	16	5	studies	study	NOUN
bam-9518	16	6	,	,	PUNCT
bam-9518	16	7	the	the	DET
bam-9518	16	8	mortality	mortality	NOUN
bam-9518	16	9	rate	rate	NOUN
bam-9518	16	10	for	for	ADP
bam-9518	16	11	severe	severe	ADJ
bam-9518	16	12	cases	case	NOUN
bam-9518	16	13	was	be	AUX
bam-9518	16	14	60.5%.10	60.5%.10	NOUN
bam-9518	16	15	-	-	PUNCT
bam-9518	16	16	12	12	NUM
bam-9518	16	17	unfortunately	unfortunately	ADV
bam-9518	16	18	,	,	PUNCT
bam-9518	16	19	the	the	DET
bam-9518	16	20	pathogenesis	pathogenesis	NOUN
bam-9518	16	21	of	of	ADP
bam-9518	16	22	covid-19	covid-19	PROPN
bam-9518	16	23	is	be	AUX
bam-9518	16	24	uncertain	uncertain	ADJ
bam-9518	16	25	and	and	CCONJ
bam-9518	16	26	there	there	PRON
bam-9518	16	27	is	be	VERB
bam-9518	16	28	no	no	DET
bam-9518	16	29	appropriate	appropriate	ADJ
bam-9518	16	30	treatment	treatment	NOUN
bam-9518	16	31	.	.	PUNCT
bam-9518	17	1	allicin	allicin	NOUN
bam-9518	17	2	,	,	PUNCT
bam-9518	17	3	a	a	DET
bam-9518	17	4	bioactive	bioactive	ADJ
bam-9518	17	5	ingredient	ingredient	NOUN
bam-9518	17	6	of	of	ADP
bam-9518	17	7	garlic	garlic	NOUN
bam-9518	17	8	,	,	PUNCT
bam-9518	17	9	has	have	AUX
bam-9518	17	10	been	be	AUX
bam-9518	17	11	reported	report	VERB
bam-9518	17	12	to	to	PART
bam-9518	17	13	possess	possess	VERB
bam-9518	17	14	antiviral	antiviral	ADJ
bam-9518	17	15	activity	activity	NOUN
bam-9518	17	16	in	in	ADP
bam-9518	17	17	vivo	vivo	NOUN
bam-9518	17	18	in	in	ADP
bam-9518	17	19	the	the	DET
bam-9518	17	20	case	case	NOUN
bam-9518	17	21	of	of	ADP
bam-9518	17	22	common	common	ADJ
bam-9518	17	23	cold	cold	NOUN
bam-9518	17	24	,	,	PUNCT
bam-9518	17	25	and	and	CCONJ
bam-9518	17	26	it	it	PRON
bam-9518	17	27	could	could	AUX
bam-9518	17	28	reduce	reduce	VERB
bam-9518	17	29	the	the	DET
bam-9518	17	30	growth	growth	NOUN
bam-9518	17	31	of	of	ADP
bam-9518	17	32	influenza	influenza	NOUN
bam-9518	17	33	virus	virus	NOUN
bam-9518	17	34	and	and	CCONJ
bam-9518	17	35	h1n1	h1n1	NOUN
bam-9518	17	36	in	in	ADP
bam-9518	17	37	vitro.13,14	vitro.13,14	ADV
bam-9518	17	38	many	many	ADJ
bam-9518	17	39	reports	report	NOUN
bam-9518	17	40	have	have	AUX
bam-9518	17	41	shown	show	VERB
bam-9518	17	42	phytochemicals	phytochemical	NOUN
bam-9518	17	43	as	as	ADP
bam-9518	17	44	inhibitors	inhibitor	NOUN
bam-9518	17	45	of	of	ADP
bam-9518	17	46	key	key	ADJ
bam-9518	17	47	protease	protease	NOUN
bam-9518	17	48	in	in	ADP
bam-9518	17	49	coronavirus	coronavirus	NOUN
bam-9518	17	50	by	by	ADP
bam-9518	17	51	using	use	VERB
bam-9518	17	52	molecular	molecular	ADJ
bam-9518	17	53	modeling	modeling	NOUN
bam-9518	17	54	approaches.15	approaches.15	PROPN
bam-9518	17	55	in	in	ADP
bam-9518	17	56	this	this	DET
bam-9518	17	57	regard	regard	NOUN
bam-9518	17	58	,	,	PUNCT
bam-9518	17	59	the	the	DET
bam-9518	17	60	effectiveness	effectiveness	NOUN
bam-9518	17	61	of	of	ADP
bam-9518	17	62	allicin	allicin	NOUN
bam-9518	17	63	(	(	PUNCT
bam-9518	17	64	l	l	NOUN
bam-9518	17	65	-	-	NOUN
bam-9518	17	66	cysteine	cysteine	NOUN
bam-9518	17	67	)	)	PUNCT
bam-9518	17	68	on	on	ADP
bam-9518	17	69	covid-19	covid-19	PROPN
bam-9518	17	70	has	have	AUX
bam-9518	17	71	been	be	AUX
bam-9518	17	72	reported	report	VERB
bam-9518	17	73	recently	recently	ADV
bam-9518	17	74	in	in	ADP
bam-9518	17	75	vitro.16	vitro.16	PROPN
bam-9518	17	76	however	however	ADV
bam-9518	17	77	,	,	PUNCT
bam-9518	17	78	no	no	DET
bam-9518	17	79	clinical	clinical	ADJ
bam-9518	17	80	effectiveness	effectiveness	NOUN
bam-9518	17	81	study	study	NOUN
bam-9518	17	82	has	have	AUX
bam-9518	17	83	reported	report	VERB
bam-9518	17	84	.	.	PUNCT
bam-9518	18	1	so	so	ADV
bam-9518	18	2	,	,	PUNCT
bam-9518	18	3	we	we	PRON
bam-9518	18	4	aimed	aim	VERB
bam-9518	18	5	to	to	PART
bam-9518	18	6	use	use	VERB
bam-9518	18	7	the	the	DET
bam-9518	18	8	allicin	allicin	NOUN
bam-9518	18	9	(	(	PUNCT
bam-9518	18	10	l	l	NOUN
bam-9518	18	11	-	-	NOUN
bam-9518	18	12	cysteine	cysteine	NOUN
bam-9518	18	13	)	)	PUNCT
bam-9518	18	14	to	to	PART
bam-9518	18	15	evaluate	evaluate	VERB
bam-9518	18	16	the	the	DET
bam-9518	18	17	therapeutic	therapeutic	ADJ
bam-9518	18	18	effect	effect	NOUN
bam-9518	18	19	of	of	ADP
bam-9518	18	20	this	this	DET
bam-9518	18	21	agent	agent	NOUN
bam-9518	18	22	on	on	ADP
bam-9518	18	23	clinical	clinical	ADJ
bam-9518	18	24	presentation	presentation	NOUN
bam-9518	18	25	and	and	CCONJ
bam-9518	18	26	prognosis	prognosis	NOUN
bam-9518	18	27	.	.	PUNCT
bam-9518	19	1	effect	effect	NOUN
bam-9518	19	2	of	of	ADP
bam-9518	19	3	allicin	allicin	NOUN
bam-9518	19	4	(	(	PUNCT
bam-9518	19	5	l	l	NOUN
bam-9518	19	6	-	-	NOUN
bam-9518	19	7	cysteine	cysteine	NOUN
bam-9518	19	8	)	)	PUNCT
bam-9518	19	9	on	on	ADP
bam-9518	19	10	covid-19	covid-19	PROPN
bam-9518	19	11	eur	eur	PROPN
bam-9518	19	12	j	j	PROPN
bam-9518	19	13	transl	transl	PROPN
bam-9518	19	14	myol	myol	ADV
bam-9518	19	15	31	31	NUM
bam-9518	19	16	(	(	PUNCT
bam-9518	19	17	2	2	NUM
bam-9518	19	18	):	):	PUNCT
bam-9518	19	19	9518	9518	NUM
bam-9518	19	20	,	,	PUNCT
bam-9518	19	21	2021	2021	NUM
bam-9518	19	22	doi	doi	NOUN
bam-9518	19	23	:	:	PUNCT
bam-9518	19	24	10.4081	10.4081	NUM
bam-9518	19	25	/	/	SYM
bam-9518	19	26	ejtm.2021.9518	ejtm.2021.9518	ADJ
bam-9518	19	27	2	2	NUM
bam-9518	19	28	materials	material	NOUN
bam-9518	19	29	and	and	CCONJ
bam-9518	19	30	methods	method	NOUN
bam-9518	19	31	research	research	NOUN
bam-9518	19	32	design	design	NOUN
bam-9518	19	33	in	in	ADP
bam-9518	19	34	this	this	DET
bam-9518	19	35	randomized	randomize	VERB
bam-9518	19	36	double	double	ADJ
bam-9518	19	37	-	-	PUNCT
bam-9518	19	38	blinded	blind	VERB
bam-9518	19	39	clinical	clinical	ADJ
bam-9518	19	40	trial	trial	NOUN
bam-9518	19	41	,	,	PUNCT
bam-9518	19	42	83	83	NUM
bam-9518	19	43	patients	patient	NOUN
bam-9518	19	44	were	be	AUX
bam-9518	19	45	enrolled	enrol	VERB
bam-9518	19	46	with	with	ADP
bam-9518	19	47	covid-19	covid-19	PROPN
bam-9518	19	48	according	accord	VERB
bam-9518	19	49	to	to	ADP
bam-9518	19	50	the	the	DET
bam-9518	19	51	diagnosis	diagnosis	NOUN
bam-9518	19	52	by	by	ADP
bam-9518	19	53	the	the	DET
bam-9518	19	54	emergency	emergency	NOUN
bam-9518	19	55	medicine	medicine	NOUN
bam-9518	19	56	specialist	specialist	NOUN
bam-9518	19	57	and	and	CCONJ
bam-9518	19	58	the	the	DET
bam-9518	19	59	approval	approval	NOUN
bam-9518	19	60	of	of	ADP
bam-9518	19	61	the	the	DET
bam-9518	19	62	infectious	infectious	ADJ
bam-9518	19	63	disease	disease	NOUN
bam-9518	19	64	specialist	specialist	NOUN
bam-9518	19	65	and	and	CCONJ
bam-9518	19	66	based	base	VERB
bam-9518	19	67	on	on	ADP
bam-9518	19	68	rt	rt	ADJ
bam-9518	19	69	-	-	PUNCT
bam-9518	19	70	pcr	pcr	ADJ
bam-9518	19	71	results	result	NOUN
bam-9518	19	72	,	,	PUNCT
bam-9518	19	73	referred	refer	VERB
bam-9518	19	74	to	to	ADP
bam-9518	19	75	emergency	emergency	PROPN
bam-9518	19	76	department	department	PROPN
bam-9518	19	77	of	of	ADP
bam-9518	19	78	imam	imam	PROPN
bam-9518	19	79	reza	reza	PROPN
bam-9518	19	80	hospital	hospital	PROPN
bam-9518	19	81	,	,	PUNCT
bam-9518	19	82	mashhad	mashhad	PROPN
bam-9518	19	83	.	.	PUNCT
bam-9518	20	1	patients	patient	NOUN
bam-9518	20	2	were	be	AUX
bam-9518	20	3	selected	select	VERB
bam-9518	20	4	based	base	VERB
bam-9518	20	5	on	on	ADP
bam-9518	20	6	following	follow	VERB
bam-9518	20	7	inclusion	inclusion	NOUN
bam-9518	20	8	and	and	CCONJ
bam-9518	20	9	exclusion	exclusion	NOUN
bam-9518	20	10	criteria	criterion	NOUN
bam-9518	20	11	:	:	PUNCT
bam-9518	20	12	1	1	X
bam-9518	20	13	.	.	X
bam-9518	20	14	inclusion	inclusion	NOUN
bam-9518	20	15	criteria	criterion	NOUN
bam-9518	20	16	:	:	PUNCT
bam-9518	21	1	patients	patient	NOUN
bam-9518	21	2	diagnosed	diagnose	VERB
bam-9518	21	3	with	with	ADP
bam-9518	21	4	covid19	covid19	NOUN
bam-9518	21	5	based	base	VERB
bam-9518	21	6	on	on	ADP
bam-9518	21	7	the	the	DET
bam-9518	21	8	patients	patient	NOUN
bam-9518	21	9	’	'	PUNCT
bam-9518	21	10	clinical	clinical	ADJ
bam-9518	21	11	,	,	PUNCT
bam-9518	21	12	radiological	radiological	ADJ
bam-9518	21	13	findings	finding	NOUN
bam-9518	21	14	and	and	CCONJ
bam-9518	21	15	rt	rt	ADJ
bam-9518	21	16	-	-	PUNCT
bam-9518	21	17	pcr	pcr	ADJ
bam-9518	21	18	results	result	NOUN
bam-9518	21	19	;	;	PUNCT
bam-9518	21	20	age	age	NOUN
bam-9518	21	21	between	between	ADP
bam-9518	21	22	18	18	NUM
bam-9518	21	23	-	-	SYM
bam-9518	21	24	70	70	NUM
bam-9518	21	25	years	year	NOUN
bam-9518	21	26	;	;	PUNCT
bam-9518	21	27	absence	absence	NOUN
bam-9518	21	28	of	of	ADP
bam-9518	21	29	pregnancy	pregnancy	NOUN
bam-9518	21	30	or	or	CCONJ
bam-9518	21	31	lactation	lactation	NOUN
bam-9518	21	32	;	;	PUNCT
bam-9518	21	33	2	2	X
bam-9518	21	34	.	.	X
bam-9518	21	35	exclusion	exclusion	NOUN
bam-9518	21	36	criteria	criterion	NOUN
bam-9518	21	37	:	:	PUNCT
bam-9518	21	38	history	history	NOUN
bam-9518	21	39	of	of	ADP
bam-9518	21	40	allergies	allergy	NOUN
bam-9518	21	41	to	to	ADP
bam-9518	21	42	allicin	allicin	NOUN
bam-9518	21	43	,	,	PUNCT
bam-9518	21	44	garlic	garlic	NOUN
bam-9518	21	45	or	or	CCONJ
bam-9518	21	46	onions	onion	NOUN
bam-9518	21	47	;	;	PUNCT
bam-9518	21	48	patient	patient	ADJ
bam-9518	21	49	with	with	ADP
bam-9518	21	50	a	a	DET
bam-9518	21	51	history	history	NOUN
bam-9518	21	52	of	of	ADP
bam-9518	21	53	hypotension	hypotension	NOUN
bam-9518	21	54	or	or	CCONJ
bam-9518	21	55	gastrointestinal	gastrointestinal	ADJ
bam-9518	21	56	bleeding	bleeding	NOUN
bam-9518	21	57	;	;	PUNCT
bam-9518	21	58	low	low	ADJ
bam-9518	21	59	blood	blood	NOUN
bam-9518	21	60	pressure	pressure	NOUN
bam-9518	21	61	at	at	ADP
bam-9518	21	62	the	the	DET
bam-9518	21	63	beginning	beginning	NOUN
bam-9518	21	64	of	of	ADP
bam-9518	21	65	the	the	DET
bam-9518	21	66	study	study	NOUN
bam-9518	21	67	;	;	PUNCT
bam-9518	21	68	immunodeficient	immunodeficient	NOUN
bam-9518	21	69	patients	patient	NOUN
bam-9518	21	70	;	;	PUNCT
bam-9518	21	71	chemotherapy	chemotherapy	NOUN
bam-9518	21	72	;	;	PUNCT
bam-9518	21	73	organ	organ	NOUN
bam-9518	21	74	and	and	CCONJ
bam-9518	21	75	bone	bone	NOUN
bam-9518	21	76	marrow	marrow	NOUN
bam-9518	21	77	transplantation	transplantation	NOUN
bam-9518	21	78	,	,	PUNCT
bam-9518	21	79	and	and	CCONJ
bam-9518	21	80	patients	patient	NOUN
bam-9518	21	81	with	with	ADP
bam-9518	21	82	autoimmune	autoimmune	ADJ
bam-9518	21	83	diseases	disease	NOUN
bam-9518	21	84	;	;	PUNCT
bam-9518	21	85	patient	patient	ADJ
bam-9518	21	86	who	who	PRON
bam-9518	21	87	require	require	VERB
bam-9518	21	88	ventilation	ventilation	NOUN
bam-9518	21	89	in	in	ADP
bam-9518	21	90	this	this	DET
bam-9518	21	91	study	study	NOUN
bam-9518	21	92	,	,	PUNCT
bam-9518	21	93	83	83	NUM
bam-9518	21	94	patients	patient	NOUN
bam-9518	21	95	were	be	AUX
bam-9518	21	96	randomly	randomly	ADV
bam-9518	21	97	and	and	CCONJ
bam-9518	21	98	equally	equally	ADV
bam-9518	21	99	allocated	allocate	VERB
bam-9518	21	100	to	to	ADP
bam-9518	21	101	allicin	allicin	NOUN
bam-9518	21	102	(	(	PUNCT
bam-9518	21	103	l	l	NOUN
bam-9518	21	104	-	-	NOUN
bam-9518	21	105	cysteine	cysteine	NOUN
bam-9518	21	106	)	)	PUNCT
bam-9518	21	107	(	(	PUNCT
bam-9518	21	108	90	90	NUM
bam-9518	21	109	mg	mg	NUM
bam-9518	21	110	/	/	SYM
bam-9518	21	111	kg	kg	NOUN
bam-9518	21	112	)	)	PUNCT
bam-9518	21	113	or	or	CCONJ
bam-9518	21	114	placebo	placebo	NOUN
bam-9518	21	115	groups	group	NOUN
bam-9518	21	116	.	.	PUNCT
bam-9518	22	1	however	however	ADV
bam-9518	22	2	,	,	PUNCT
bam-9518	22	3	66	66	NUM
bam-9518	22	4	patients	patient	NOUN
bam-9518	22	5	completed	complete	VERB
bam-9518	22	6	the	the	DET
bam-9518	22	7	treatment	treatment	NOUN
bam-9518	22	8	period	period	NOUN
bam-9518	22	9	.	.	PUNCT
bam-9518	23	1	in	in	ADP
bam-9518	23	2	the	the	DET
bam-9518	23	3	allicin	allicin	NOUN
bam-9518	23	4	(	(	PUNCT
bam-9518	23	5	l	l	NOUN
bam-9518	23	6	-	-	NOUN
bam-9518	23	7	cysteine	cysteine	ADJ
bam-9518	23	8	)	)	PUNCT
bam-9518	23	9	and	and	CCONJ
bam-9518	23	10	placebo	placebo	NOUN
bam-9518	23	11	groups	group	NOUN
bam-9518	23	12	(	(	PUNCT
bam-9518	23	13	n=33	n=33	NOUN
bam-9518	23	14	in	in	ADP
bam-9518	23	15	each	each	DET
bam-9518	23	16	group	group	NOUN
bam-9518	23	17	)	)	PUNCT
bam-9518	23	18	,	,	PUNCT
bam-9518	23	19	the	the	DET
bam-9518	23	20	capsules	capsule	NOUN
bam-9518	23	21	were	be	AUX
bam-9518	23	22	prescribed	prescribe	VERB
bam-9518	23	23	three	three	NUM
bam-9518	23	24	times	time	NOUN
bam-9518	23	25	a	a	DET
bam-9518	23	26	day	day	NOUN
bam-9518	23	27	for	for	ADP
bam-9518	23	28	two	two	NUM
bam-9518	23	29	weeks	week	NOUN
bam-9518	23	30	(	(	PUNCT
bam-9518	23	31	every	every	DET
bam-9518	23	32	8	8	NUM
bam-9518	23	33	hours	hour	NOUN
bam-9518	23	34	)	)	PUNCT
bam-9518	23	35	.	.	PUNCT
bam-9518	24	1	the	the	DET
bam-9518	24	2	molecule	molecule	NOUN
bam-9518	24	3	of	of	ADP
bam-9518	24	4	allicin	allicin	NOUN
bam-9518	24	5	(	(	PUNCT
bam-9518	24	6	lcysteine	lcysteine	NOUN
bam-9518	24	7	)	)	PUNCT
bam-9518	24	8	with	with	ADP
bam-9518	24	9	stable	stable	ADJ
bam-9518	24	10	oxidation	oxidation	NOUN
bam-9518	24	11	capacity	capacity	NOUN
bam-9518	24	12	by	by	ADP
bam-9518	24	13	a	a	DET
bam-9518	24	14	new	new	ADJ
bam-9518	24	15	allotropic	allotropic	NOUN
bam-9518	24	16	process	process	NOUN
bam-9518	24	17	is	be	AUX
bam-9518	24	18	one	one	NUM
bam-9518	24	19	of	of	ADP
bam-9518	24	20	the	the	DET
bam-9518	24	21	active	active	ADJ
bam-9518	24	22	ingredients	ingredient	NOUN
bam-9518	24	23	in	in	ADP
bam-9518	24	24	organosulfur	organosulfur	NOUN
bam-9518	24	25	as	as	ADP
bam-9518	24	26	the	the	DET
bam-9518	24	27	main	main	ADJ
bam-9518	24	28	composition	composition	NOUN
bam-9518	24	29	of	of	ADP
bam-9518	24	30	this	this	DET
bam-9518	24	31	supplement	supplement	NOUN
bam-9518	24	32	.	.	PUNCT
bam-9518	25	1	in	in	ADP
bam-9518	25	2	order	order	NOUN
bam-9518	25	3	to	to	ADP
bam-9518	25	4	blinding	blind	VERB
bam-9518	25	5	the	the	DET
bam-9518	25	6	results	result	NOUN
bam-9518	25	7	,	,	PUNCT
bam-9518	25	8	allicin	allicin	NOUN
bam-9518	25	9	(	(	PUNCT
bam-9518	25	10	l	l	NOUN
bam-9518	25	11	-	-	NOUN
bam-9518	25	12	cysteine	cysteine	ADJ
bam-9518	25	13	)	)	PUNCT
bam-9518	25	14	and	and	CCONJ
bam-9518	25	15	placebo	placebo	NOUN
bam-9518	25	16	capsules	capsule	NOUN
bam-9518	25	17	with	with	ADP
bam-9518	25	18	similar	similar	ADJ
bam-9518	25	19	appearance	appearance	NOUN
bam-9518	25	20	were	be	AUX
bam-9518	25	21	prepared	prepare	VERB
bam-9518	25	22	and	and	CCONJ
bam-9518	25	23	given	give	VERB
bam-9518	25	24	to	to	ADP
bam-9518	25	25	the	the	DET
bam-9518	25	26	patients	patient	NOUN
bam-9518	25	27	by	by	ADP
bam-9518	25	28	a	a	DET
bam-9518	25	29	nurse	nurse	NOUN
bam-9518	25	30	or	or	CCONJ
bam-9518	25	31	a	a	DET
bam-9518	25	32	physician	physician	NOUN
bam-9518	25	33	.	.	PUNCT
bam-9518	26	1	it	it	PRON
bam-9518	26	2	should	should	AUX
bam-9518	26	3	be	be	AUX
bam-9518	26	4	noted	note	VERB
bam-9518	26	5	that	that	SCONJ
bam-9518	26	6	both	both	DET
bam-9518	26	7	groups	group	NOUN
bam-9518	26	8	were	be	AUX
bam-9518	26	9	treated	treat	VERB
bam-9518	26	10	with	with	ADP
bam-9518	26	11	routine	routine	ADJ
bam-9518	26	12	treatment	treatment	NOUN
bam-9518	26	13	of	of	ADP
bam-9518	26	14	covid-19	covid-19	PROPN
bam-9518	26	15	based	base	VERB
bam-9518	26	16	on	on	ADP
bam-9518	26	17	the	the	DET
bam-9518	26	18	latest	late	ADJ
bam-9518	26	19	regional	regional	ADJ
bam-9518	26	20	guidelines	guideline	NOUN
bam-9518	26	21	.	.	PUNCT
bam-9518	27	1	patients	patient	NOUN
bam-9518	27	2	in	in	ADP
bam-9518	27	3	allicin	allicin	NOUN
bam-9518	27	4	(	(	PUNCT
bam-9518	27	5	l	l	NOUN
bam-9518	27	6	-	-	NOUN
bam-9518	27	7	cysteine	cysteine	ADJ
bam-9518	27	8	)	)	PUNCT
bam-9518	27	9	group	group	NOUN
bam-9518	27	10	were	be	AUX
bam-9518	27	11	treated	treat	VERB
bam-9518	27	12	with	with	ADP
bam-9518	27	13	routine	routine	ADJ
bam-9518	27	14	treatment	treatment	NOUN
bam-9518	27	15	plus	plus	CCONJ
bam-9518	27	16	allicin	allicin	NOUN
bam-9518	27	17	(	(	PUNCT
bam-9518	27	18	lcysteine	lcysteine	NOUN
bam-9518	27	19	)	)	PUNCT
bam-9518	27	20	90	90	NUM
bam-9518	27	21	mg	mg	NUM
bam-9518	27	22	/	/	SYM
bam-9518	27	23	kg	kg	PROPN
bam-9518	27	24	,	,	PUNCT
bam-9518	27	25	and	and	CCONJ
bam-9518	27	26	placebo	placebo	NOUN
bam-9518	27	27	groups	group	NOUN
bam-9518	27	28	were	be	AUX
bam-9518	27	29	treated	treat	VERB
bam-9518	27	30	with	with	ADP
bam-9518	27	31	routine	routine	ADJ
bam-9518	27	32	treatment	treatment	NOUN
bam-9518	27	33	plus	plus	CCONJ
bam-9518	27	34	placebo	placebo	NOUN
bam-9518	27	35	capsules	capsule	NOUN
bam-9518	27	36	.	.	PUNCT
bam-9518	28	1	evaluation	evaluation	NOUN
bam-9518	28	2	of	of	ADP
bam-9518	28	3	clinical	clinical	ADJ
bam-9518	28	4	symptoms	symptom	NOUN
bam-9518	28	5	and	and	CCONJ
bam-9518	28	6	vital	vital	ADJ
bam-9518	28	7	signs	sign	NOUN
bam-9518	28	8	(	(	PUNCT
bam-9518	28	9	cough	cough	NOUN
bam-9518	28	10	,	,	PUNCT
bam-9518	28	11	dyspnea	dyspnea	NOUN
bam-9518	28	12	,	,	PUNCT
bam-9518	28	13	myalgia	myalgia	NOUN
bam-9518	28	14	,	,	PUNCT
bam-9518	28	15	anosmia	anosmia	NOUN
bam-9518	28	16	,	,	PUNCT
bam-9518	28	17	chill	chill	NOUN
bam-9518	28	18	,	,	PUNCT
bam-9518	28	19	consciousness	consciousness	NOUN
bam-9518	28	20	,	,	PUNCT
bam-9518	28	21	diarrhea	diarrhea	PROPN
bam-9518	28	22	,	,	PUNCT
bam-9518	28	23	headache	headache	NOUN
bam-9518	28	24	,	,	PUNCT
bam-9518	28	25	nasal	nasal	PROPN
bam-9518	28	26	congestion	congestion	NOUN
bam-9518	28	27	,	,	PUNCT
bam-9518	28	28	nausea	nausea	NOUN
bam-9518	28	29	and	and	CCONJ
bam-9518	28	30	vomiting	vomiting	NOUN
bam-9518	28	31	,	,	PUNCT
bam-9518	28	32	sore	sore	ADJ
bam-9518	28	33	throat	throat	NOUN
bam-9518	28	34	,	,	PUNCT
bam-9518	28	35	weakness	weakness	NOUN
bam-9518	28	36	,	,	PUNCT
bam-9518	28	37	taste	taste	NOUN
bam-9518	28	38	disorder	disorder	NOUN
bam-9518	28	39	,	,	PUNCT
bam-9518	28	40	respiratory	respiratory	ADJ
bam-9518	28	41	rate	rate	NOUN
bam-9518	28	42	,	,	PUNCT
bam-9518	28	43	pulse	pulse	NOUN
bam-9518	28	44	rate	rate	NOUN
bam-9518	28	45	,	,	PUNCT
bam-9518	28	46	temperature	temperature	NOUN
bam-9518	28	47	,	,	PUNCT
bam-9518	28	48	o2	o2	ADJ
bam-9518	28	49	saturation	saturation	NOUN
bam-9518	28	50	)	)	PUNCT
bam-9518	28	51	,	,	PUNCT
bam-9518	28	52	blood	blood	NOUN
bam-9518	28	53	parameters	parameter	NOUN
bam-9518	28	54	(	(	PUNCT
bam-9518	28	55	total	total	ADJ
bam-9518	28	56	and	and	CCONJ
bam-9518	28	57	differential	differential	ADJ
bam-9518	28	58	white	white	ADJ
bam-9518	28	59	blood	blood	NOUN
bam-9518	28	60	cells	cell	NOUN
bam-9518	28	61	,	,	PUNCT
bam-9518	28	62	red	red	ADJ
bam-9518	28	63	blood	blood	NOUN
bam-9518	28	64	cells	cell	NOUN
bam-9518	28	65	,	,	PUNCT
bam-9518	28	66	hemoglobin	hemoglobin	NOUN
bam-9518	28	67	,	,	PUNCT
bam-9518	28	68	platelet	platelet	NOUN
bam-9518	28	69	,	,	PUNCT
bam-9518	28	70	c	c	NOUN
bam-9518	28	71	-	-	ADJ
bam-9518	28	72	reactive	reactive	ADJ
bam-9518	28	73	protein	protein	NOUN
bam-9518	28	74	)	)	PUNCT
bam-9518	28	75	and	and	CCONJ
bam-9518	28	76	chest	chest	NOUN
bam-9518	28	77	ct	ct	PROPN
bam-9518	28	78	scan	scan	PROPN
bam-9518	28	79	were	be	AUX
bam-9518	28	80	performed	perform	VERB
bam-9518	28	81	pretreatment	pretreatment	NOUN
bam-9518	28	82	and	and	CCONJ
bam-9518	28	83	two	two	NUM
bam-9518	28	84	weeks	week	NOUN
bam-9518	28	85	after	after	ADP
bam-9518	28	86	treatment	treatment	NOUN
bam-9518	28	87	.	.	PUNCT
bam-9518	29	1	this	this	DET
bam-9518	29	2	study	study	NOUN
bam-9518	29	3	was	be	AUX
bam-9518	29	4	performed	perform	VERB
bam-9518	29	5	in	in	ADP
bam-9518	29	6	accordance	accordance	NOUN
bam-9518	29	7	with	with	ADP
bam-9518	29	8	the	the	DET
bam-9518	29	9	principles	principle	NOUN
bam-9518	29	10	of	of	ADP
bam-9518	29	11	the	the	DET
bam-9518	29	12	declaration	declaration	NOUN
bam-9518	29	13	of	of	ADP
bam-9518	29	14	helsinki	helsinki	PROPN
bam-9518	29	15	and	and	CCONJ
bam-9518	29	16	was	be	AUX
bam-9518	29	17	approved	approve	VERB
bam-9518	29	18	by	by	ADP
bam-9518	29	19	mashhad	mashhad	PROPN
bam-9518	29	20	university	university	PROPN
bam-9518	29	21	of	of	ADP
bam-9518	29	22	medical	medical	PROPN
bam-9518	29	23	sciences	sciences	PROPN
bam-9518	29	24	(	(	PUNCT
bam-9518	29	25	code	code	NOUN
bam-9518	29	26	#	#	NOUN
bam-9518	29	27	ir.mums.rec.1399.289iran	ir.mums.rec.1399.289iran	NUM
bam-9518	29	28	)	)	PUNCT
bam-9518	29	29	.	.	PUNCT
bam-9518	30	1	written	write	VERB
bam-9518	30	2	informed	informed	ADJ
bam-9518	30	3	consent	consent	NOUN
bam-9518	30	4	was	be	AUX
bam-9518	30	5	obtained	obtain	VERB
bam-9518	30	6	from	from	ADP
bam-9518	30	7	all	all	DET
bam-9518	30	8	patients	patient	NOUN
bam-9518	30	9	.	.	PUNCT
bam-9518	31	1	statistical	statistical	ADJ
bam-9518	31	2	analysis	analysis	NOUN
bam-9518	31	3	the	the	DET
bam-9518	31	4	data	datum	NOUN
bam-9518	31	5	was	be	AUX
bam-9518	31	6	described	describe	VERB
bam-9518	31	7	by	by	ADP
bam-9518	31	8	frequency	frequency	NOUN
bam-9518	31	9	[	[	X
bam-9518	31	10	percentage	percentage	NOUN
bam-9518	31	11	(	(	PUNCT
bam-9518	31	12	%	%	NOUN
bam-9518	31	13	)	)	PUNCT
bam-9518	31	14	]	]	PUNCT
bam-9518	31	15	or	or	CCONJ
bam-9518	31	16	mean±s.d	mean±s.d	PROPN
bam-9518	31	17	.	.	PUNCT
bam-9518	32	1	comparisons	comparison	NOUN
bam-9518	32	2	within	within	ADP
bam-9518	32	3	each	each	DET
bam-9518	32	4	group	group	NOUN
bam-9518	32	5	were	be	AUX
bam-9518	32	6	performed	perform	VERB
bam-9518	32	7	using	use	VERB
bam-9518	32	8	mcnemar	mcnemar	NOUN
bam-9518	32	9	and	and	CCONJ
bam-9518	32	10	wilcoxon	wilcoxon	ADJ
bam-9518	32	11	tests	test	NOUN
bam-9518	32	12	and	and	CCONJ
bam-9518	32	13	the	the	DET
bam-9518	32	14	comparison	comparison	NOUN
bam-9518	32	15	between	between	ADP
bam-9518	32	16	the	the	DET
bam-9518	32	17	two	two	NUM
bam-9518	32	18	groups	group	NOUN
bam-9518	32	19	was	be	AUX
bam-9518	32	20	tested	test	VERB
bam-9518	32	21	by	by	ADP
bam-9518	32	22	mann	mann	PROPN
bam-9518	32	23	–	–	PUNCT
bam-9518	32	24	whitney	whitney	NOUN
bam-9518	32	25	u	u	PROPN
bam-9518	32	26	test	test	NOUN
bam-9518	32	27	and	and	CCONJ
bam-9518	32	28	κ2	κ2	PROPN
bam-9518	32	29	test	test	VERB
bam-9518	32	30	.	.	PUNCT
bam-9518	33	1	all	all	DET
bam-9518	33	2	statistical	statistical	ADJ
bam-9518	33	3	analysis	analysis	NOUN
bam-9518	33	4	was	be	AUX
bam-9518	33	5	implemented	implement	VERB
bam-9518	33	6	in	in	ADP
bam-9518	33	7	spss	spss	PROPN
bam-9518	33	8	25.0	25.0	NUM
bam-9518	33	9	,	,	PUNCT
bam-9518	33	10	p	p	NOUN
bam-9518	33	11	values	value	NOUN
bam-9518	33	12	<	<	NOUN
bam-9518	33	13	0.05	0.05	NUM
bam-9518	33	14	were	be	AUX
bam-9518	33	15	considered	consider	VERB
bam-9518	33	16	statistically	statistically	ADV
bam-9518	33	17	significant	significant	ADJ
bam-9518	33	18	.	.	PUNCT
bam-9518	34	1	results	result	NOUN
bam-9518	34	2	in	in	ADP
bam-9518	34	3	this	this	DET
bam-9518	34	4	study	study	NOUN
bam-9518	34	5	,	,	PUNCT
bam-9518	34	6	33	33	NUM
bam-9518	34	7	patients	patient	NOUN
bam-9518	34	8	in	in	ADP
bam-9518	34	9	placebo	placebo	NOUN
bam-9518	34	10	group	group	NOUN
bam-9518	34	11	(	(	PUNCT
bam-9518	34	12	66.7	66.7	NUM
bam-9518	34	13	%	%	NOUN
bam-9518	34	14	men	man	NOUN
bam-9518	34	15	and	and	CCONJ
bam-9518	34	16	33.3	33.3	NUM
bam-9518	34	17	%	%	NOUN
bam-9518	34	18	women	woman	NOUN
bam-9518	34	19	)	)	PUNCT
bam-9518	34	20	and	and	CCONJ
bam-9518	34	21	33	33	NUM
bam-9518	34	22	patients	patient	NOUN
bam-9518	34	23	in	in	ADP
bam-9518	34	24	allicin	allicin	NOUN
bam-9518	34	25	(	(	PUNCT
bam-9518	34	26	l	l	NOUN
bam-9518	34	27	-	-	ADJ
bam-9518	34	28	cysteine	cysteine	ADJ
bam-9518	34	29	)	)	PUNCT
bam-9518	34	30	group	group	NOUN
bam-9518	34	31	(	(	PUNCT
bam-9518	34	32	72.7	72.7	NUM
bam-9518	34	33	%	%	NOUN
bam-9518	34	34	men	man	NOUN
bam-9518	34	35	and	and	CCONJ
bam-9518	34	36	27.3	27.3	NUM
bam-9518	34	37	%	%	NOUN
bam-9518	34	38	women	woman	NOUN
bam-9518	34	39	)	)	PUNCT
bam-9518	34	40	were	be	AUX
bam-9518	34	41	included	include	VERB
bam-9518	34	42	.	.	PUNCT
bam-9518	35	1	the	the	DET
bam-9518	35	2	average	average	ADJ
bam-9518	35	3	age	age	NOUN
bam-9518	35	4	of	of	ADP
bam-9518	35	5	patients	patient	NOUN
bam-9518	35	6	in	in	ADP
bam-9518	35	7	placebo	placebo	NOUN
bam-9518	35	8	and	and	CCONJ
bam-9518	35	9	allicin	allicin	NOUN
bam-9518	35	10	(	(	PUNCT
bam-9518	35	11	lcysteine	lcysteine	ADJ
bam-9518	35	12	)	)	PUNCT
bam-9518	35	13	groups	group	NOUN
bam-9518	35	14	was	be	AUX
bam-9518	35	15	(	(	PUNCT
bam-9518	35	16	52.9±5.0	52.9±5.0	NUM
bam-9518	35	17	)	)	PUNCT
bam-9518	35	18	and	and	CCONJ
bam-9518	35	19	(	(	PUNCT
bam-9518	35	20	51.4±5.1	51.4±5.1	NUM
bam-9518	35	21	)	)	PUNCT
bam-9518	35	22	years	year	NOUN
bam-9518	35	23	,	,	PUNCT
bam-9518	35	24	respectively	respectively	ADV
bam-9518	35	25	.	.	PUNCT
bam-9518	36	1	there	there	PRON
bam-9518	36	2	were	be	VERB
bam-9518	36	3	no	no	DET
bam-9518	36	4	differences	difference	NOUN
bam-9518	36	5	in	in	ADP
bam-9518	36	6	these	these	DET
bam-9518	36	7	values	value	NOUN
bam-9518	36	8	between	between	ADP
bam-9518	36	9	groups	group	NOUN
bam-9518	36	10	.	.	PUNCT
bam-9518	37	1	demographic	demographic	ADJ
bam-9518	37	2	characteristics	characteristic	NOUN
bam-9518	37	3	of	of	ADP
bam-9518	37	4	the	the	DET
bam-9518	37	5	subjects	subject	NOUN
bam-9518	37	6	are	be	AUX
bam-9518	37	7	displayed	display	VERB
bam-9518	37	8	in	in	ADP
bam-9518	37	9	table	table	NOUN
bam-9518	37	10	1	1	NUM
bam-9518	37	11	.	.	PUNCT
bam-9518	38	1	the	the	DET
bam-9518	38	2	most	most	ADV
bam-9518	38	3	common	common	ADJ
bam-9518	38	4	symptom	symptom	NOUN
bam-9518	38	5	in	in	ADP
bam-9518	38	6	both	both	DET
bam-9518	38	7	placebo	placebo	NOUN
bam-9518	38	8	and	and	CCONJ
bam-9518	38	9	allicin	allicin	NOUN
bam-9518	38	10	(	(	PUNCT
bam-9518	38	11	l	l	NOUN
bam-9518	38	12	-	-	NOUN
bam-9518	38	13	cysteine	cysteine	ADJ
bam-9518	38	14	)	)	PUNCT
bam-9518	38	15	groups	group	NOUN
bam-9518	38	16	was	be	AUX
bam-9518	38	17	dyspnea	dyspnea	VERB
bam-9518	38	18	(	(	PUNCT
bam-9518	38	19	77.8	77.8	NUM
bam-9518	38	20	%	%	NOUN
bam-9518	38	21	and	and	CCONJ
bam-9518	38	22	75.8	75.8	NUM
bam-9518	38	23	%	%	NOUN
bam-9518	38	24	,	,	PUNCT
bam-9518	38	25	respectively	respectively	ADV
bam-9518	38	26	)	)	PUNCT
bam-9518	38	27	;	;	PUNCT
bam-9518	38	28	and	and	CCONJ
bam-9518	38	29	the	the	DET
bam-9518	38	30	most	most	ADV
bam-9518	38	31	uncommon	uncommon	ADJ
bam-9518	38	32	symptom	symptom	NOUN
bam-9518	38	33	was	be	AUX
bam-9518	38	34	diarrhea	diarrhea	NOUN
bam-9518	38	35	in	in	ADP
bam-9518	38	36	both	both	DET
bam-9518	38	37	groups	group	NOUN
bam-9518	38	38	(	(	PUNCT
bam-9518	38	39	3	3	NUM
bam-9518	38	40	%	%	NOUN
bam-9518	38	41	in	in	ADP
bam-9518	38	42	both	both	DET
bam-9518	38	43	groups	group	NOUN
bam-9518	38	44	)	)	PUNCT
bam-9518	38	45	.	.	PUNCT
bam-9518	39	1	at	at	ADP
bam-9518	39	2	the	the	DET
bam-9518	39	3	beginning	beginning	NOUN
bam-9518	39	4	of	of	ADP
bam-9518	39	5	study	study	NOUN
bam-9518	39	6	,	,	PUNCT
bam-9518	39	7	there	there	PRON
bam-9518	39	8	was	be	VERB
bam-9518	39	9	no	no	DET
bam-9518	39	10	significant	significant	ADJ
bam-9518	39	11	changes	change	NOUN
bam-9518	39	12	in	in	ADP
bam-9518	39	13	clinical	clinical	ADJ
bam-9518	39	14	symptoms	symptom	NOUN
bam-9518	39	15	between	between	ADP
bam-9518	39	16	two	two	NUM
bam-9518	39	17	groups	group	NOUN
bam-9518	39	18	.	.	PUNCT
bam-9518	40	1	however	however	ADV
bam-9518	40	2	,	,	PUNCT
bam-9518	40	3	frequency	frequency	NOUN
bam-9518	40	4	of	of	ADP
bam-9518	40	5	anosmia	anosmia	NOUN
bam-9518	40	6	and	and	CCONJ
bam-9518	40	7	nasal	nasal	NOUN
bam-9518	40	8	congestion	congestion	NOUN
bam-9518	40	9	in	in	ADP
bam-9518	40	10	allicin	allicin	NOUN
bam-9518	40	11	(	(	PUNCT
bam-9518	40	12	lcysteine	lcysteine	PROPN
bam-9518	40	13	)	)	PUNCT
bam-9518	40	14	group	group	NOUN
bam-9518	40	15	were	be	AUX
bam-9518	40	16	significantly	significantly	ADV
bam-9518	40	17	higher	high	ADJ
bam-9518	40	18	than	than	ADP
bam-9518	40	19	placebo	placebo	NOUN
bam-9518	40	20	group	group	NOUN
bam-9518	40	21	(	(	PUNCT
bam-9518	40	22	p=0.031	p=0.031	NOUN
bam-9518	40	23	and	and	CCONJ
bam-9518	40	24	p=0.009	p=0.009	NOUN
bam-9518	40	25	,	,	PUNCT
bam-9518	40	26	respectively	respectively	ADV
bam-9518	40	27	)	)	PUNCT
bam-9518	40	28	.	.	PUNCT
bam-9518	41	1	at	at	ADP
bam-9518	41	2	the	the	DET
bam-9518	41	3	end	end	NOUN
bam-9518	41	4	of	of	ADP
bam-9518	41	5	the	the	DET
bam-9518	41	6	study	study	NOUN
bam-9518	41	7	,	,	PUNCT
bam-9518	41	8	allicin	allicin	NOUN
bam-9518	41	9	(	(	PUNCT
bam-9518	41	10	l	l	NOUN
bam-9518	41	11	-	-	NOUN
bam-9518	41	12	cysteine	cysteine	NOUN
bam-9518	41	13	)	)	PUNCT
bam-9518	41	14	led	lead	VERB
bam-9518	41	15	to	to	ADP
bam-9518	41	16	a	a	DET
bam-9518	41	17	significant	significant	ADJ
bam-9518	41	18	decrease	decrease	NOUN
bam-9518	41	19	of	of	ADP
bam-9518	41	20	cough	cough	NOUN
bam-9518	41	21	,	,	PUNCT
bam-9518	41	22	dyspnea	dyspnea	NOUN
bam-9518	41	23	and	and	CCONJ
bam-9518	41	24	myalgia	myalgia	NOUN
bam-9518	41	25	in	in	ADP
bam-9518	41	26	treated	treat	VERB
bam-9518	41	27	patients	patient	NOUN
bam-9518	41	28	compared	compare	VERB
bam-9518	41	29	to	to	ADP
bam-9518	41	30	placebo	placebo	NOUN
bam-9518	41	31	group	group	NOUN
bam-9518	41	32	(	(	PUNCT
bam-9518	41	33	p<0.05	p<0.05	NOUN
bam-9518	41	34	to	to	ADP
bam-9518	41	35	p<0.01	p<0.01	PROPN
bam-9518	41	36	)	)	PUNCT
bam-9518	41	37	,	,	PUNCT
bam-9518	41	38	table	table	NOUN
bam-9518	41	39	1	1	NUM
bam-9518	41	40	.	.	PUNCT
bam-9518	41	41	demographic	demographic	ADJ
bam-9518	41	42	characteristics	characteristic	NOUN
bam-9518	41	43	of	of	ADP
bam-9518	41	44	patients	patient	NOUN
bam-9518	41	45	.	.	PUNCT
bam-9518	42	1	p	p	X
bam-9518	42	2	-	-	PUNCT
bam-9518	42	3	value	value	NOUN
bam-9518	42	4	groups	group	NOUN
bam-9518	42	5	variables	variable	VERB
bam-9518	42	6	allicin	allicin	NOUN
bam-9518	42	7	placebo	placebo	NOUN
bam-9518	42	8	0.618	0.618	NUM
bam-9518	42	9	*	*	SYM
bam-9518	42	10	72.2	72.2	NUM
bam-9518	42	11	%	%	NOUN
bam-9518	42	12	66.7	66.7	NUM
bam-9518	42	13	%	%	NOUN
bam-9518	42	14	male	male	ADJ
bam-9518	42	15	sex	sex	NOUN
bam-9518	42	16	(	(	PUNCT
bam-9518	42	17	%	%	NOUN
bam-9518	42	18	)	)	PUNCT
bam-9518	42	19	27.3	27.3	NUM
bam-9518	42	20	%	%	NOUN
bam-9518	42	21	33.3	33.3	NUM
bam-9518	42	22	%	%	NOUN
bam-9518	42	23	female	female	NOUN
bam-9518	42	24	0.903	0.903	NUM
bam-9518	42	25	*	*	PUNCT
bam-9518	42	26	*	*	PUNCT
bam-9518	42	27	38.97±8.37	38.97±8.37	NUM
bam-9518	42	28	39.2±8.40	39.2±8.40	NUM
bam-9518	42	29	age	age	NOUN
bam-9518	42	30	(	(	PUNCT
bam-9518	42	31	mean	mean	PROPN
bam-9518	42	32	±	±	NUM
bam-9518	42	33	sd	sd	NOUN
bam-9518	42	34	)	)	PUNCT
bam-9518	42	35	*	*	PUNCT
bam-9518	43	1	chi	chi	ADJ
bam-9518	43	2	-	-	PUNCT
bam-9518	43	3	square	square	ADJ
bam-9518	43	4	test	test	NOUN
bam-9518	43	5	*	*	PUNCT
bam-9518	43	6	*	*	PUNCT
bam-9518	43	7	t	t	NOUN
bam-9518	43	8	-	-	PUNCT
bam-9518	43	9	independent	independent	ADJ
bam-9518	43	10	sample	sample	NOUN
bam-9518	43	11	test	test	NOUN
bam-9518	43	12	effect	effect	NOUN
bam-9518	43	13	of	of	ADP
bam-9518	43	14	allicin	allicin	NOUN
bam-9518	43	15	(	(	PUNCT
bam-9518	43	16	l	l	NOUN
bam-9518	43	17	-	-	NOUN
bam-9518	43	18	cysteine	cysteine	NOUN
bam-9518	43	19	)	)	PUNCT
bam-9518	43	20	on	on	ADP
bam-9518	43	21	covid-19	covid-19	PROPN
bam-9518	43	22	eur	eur	PROPN
bam-9518	43	23	j	j	PROPN
bam-9518	43	24	transl	transl	PROPN
bam-9518	43	25	myol	myol	ADV
bam-9518	43	26	31	31	NUM
bam-9518	43	27	(	(	PUNCT
bam-9518	43	28	2	2	NUM
bam-9518	43	29	):	):	PUNCT
bam-9518	43	30	9518	9518	NUM
bam-9518	43	31	,	,	PUNCT
bam-9518	43	32	2021	2021	NUM
bam-9518	43	33	doi	doi	NOUN
bam-9518	43	34	:	:	PUNCT
bam-9518	43	35	10.4081	10.4081	NUM
bam-9518	43	36	/	/	SYM
bam-9518	43	37	ejtm.2021.9518	ejtm.2021.9518	ADJ
bam-9518	43	38	3	3	NUM
bam-9518	43	39	(	(	PUNCT
bam-9518	43	40	table	table	NOUN
bam-9518	43	41	2	2	NUM
bam-9518	43	42	)	)	PUNCT
bam-9518	43	43	.	.	PUNCT
bam-9518	44	1	significant	significant	ADJ
bam-9518	44	2	statistical	statistical	ADJ
bam-9518	44	3	different	different	ADJ
bam-9518	44	4	did	do	AUX
bam-9518	44	5	not	not	PART
bam-9518	44	6	show	show	VERB
bam-9518	44	7	in	in	ADP
bam-9518	44	8	blood	blood	NOUN
bam-9518	44	9	parameters	parameter	NOUN
bam-9518	44	10	between	between	ADP
bam-9518	44	11	groups	group	NOUN
bam-9518	44	12	in	in	ADP
bam-9518	44	13	both	both	DET
bam-9518	44	14	preand	preand	NOUN
bam-9518	44	15	posttreatment	posttreatment	NOUN
bam-9518	44	16	(	(	PUNCT
bam-9518	44	17	table	table	NOUN
bam-9518	44	18	2	2	NUM
bam-9518	44	19	)	)	PUNCT
bam-9518	44	20	.	.	PUNCT
bam-9518	45	1	in	in	ADP
bam-9518	45	2	this	this	DET
bam-9518	45	3	study	study	NOUN
bam-9518	45	4	,	,	PUNCT
bam-9518	45	5	the	the	DET
bam-9518	45	6	results	result	NOUN
bam-9518	45	7	of	of	ADP
bam-9518	45	8	chest	chest	NOUN
bam-9518	45	9	ct	ct	PROPN
bam-9518	45	10	scan	scan	PROPN
bam-9518	45	11	categorized	categorize	VERB
bam-9518	45	12	to	to	ADP
bam-9518	45	13	four	four	NUM
bam-9518	45	14	levels	level	NOUN
bam-9518	45	15	including	include	VERB
bam-9518	45	16	normal	normal	ADJ
bam-9518	45	17	,	,	PUNCT
bam-9518	45	18	mild	mild	ADJ
bam-9518	45	19	,	,	PUNCT
bam-9518	45	20	moderate	moderate	ADJ
bam-9518	45	21	,	,	PUNCT
bam-9518	45	22	and	and	CCONJ
bam-9518	45	23	severe	severe	ADJ
bam-9518	45	24	based	base	VERB
bam-9518	45	25	on	on	ADP
bam-9518	45	26	the	the	DET
bam-9518	45	27	lung	lung	NOUN
bam-9518	45	28	involvement	involvement	NOUN
bam-9518	45	29	in	in	ADP
bam-9518	45	30	chest	chest	NOUN
bam-9518	45	31	ct	ct	NUM
bam-9518	45	32	scan	scan	PROPN
bam-9518	45	33	.	.	PUNCT
bam-9518	46	1	before	before	ADP
bam-9518	46	2	treatment	treatment	NOUN
bam-9518	46	3	,	,	PUNCT
bam-9518	46	4	the	the	DET
bam-9518	46	5	number	number	NOUN
bam-9518	46	6	of	of	ADP
bam-9518	46	7	patients	patient	NOUN
bam-9518	46	8	with	with	ADP
bam-9518	46	9	normal	normal	ADJ
bam-9518	46	10	and	and	CCONJ
bam-9518	46	11	mild	mild	ADJ
bam-9518	46	12	chest	chest	NOUN
bam-9518	46	13	ct	ct	NUM
bam-9518	46	14	scan	scan	PROPN
bam-9518	46	15	were	be	AUX
bam-9518	46	16	significantly	significantly	ADV
bam-9518	46	17	different	different	ADJ
bam-9518	46	18	between	between	ADP
bam-9518	46	19	two	two	NUM
bam-9518	46	20	groups	group	NOUN
bam-9518	46	21	(	(	PUNCT
bam-9518	46	22	p	p	X
bam-9518	46	23	<	<	X
bam-9518	46	24	0.05	0.05	NUM
bam-9518	46	25	to	to	ADP
bam-9518	46	26	p	p	NOUN
bam-9518	46	27	<	<	X
bam-9518	46	28	0.001	0.001	NUM
bam-9518	46	29	)	)	PUNCT
bam-9518	46	30	.	.	PUNCT
bam-9518	47	1	however	however	ADV
bam-9518	47	2	,	,	PUNCT
bam-9518	47	3	there	there	PRON
bam-9518	47	4	was	be	VERB
bam-9518	47	5	a	a	DET
bam-9518	47	6	significant	significant	ADJ
bam-9518	47	7	increase	increase	NOUN
bam-9518	47	8	rate	rate	NOUN
bam-9518	47	9	of	of	ADP
bam-9518	47	10	normal	normal	ADJ
bam-9518	47	11	chest	chest	NOUN
bam-9518	47	12	ct	ct	NUM
bam-9518	47	13	scan	scan	NOUN
bam-9518	47	14	in	in	ADP
bam-9518	47	15	allicin	allicin	NOUN
bam-9518	47	16	(	(	PUNCT
bam-9518	47	17	l	l	NOUN
bam-9518	47	18	-	-	ADJ
bam-9518	47	19	cysteine	cysteine	ADJ
bam-9518	47	20	)	)	PUNCT
bam-9518	47	21	group	group	NOUN
bam-9518	47	22	compared	compare	VERB
bam-9518	47	23	to	to	ADP
bam-9518	47	24	placebo	placebo	NOUN
bam-9518	47	25	group	group	NOUN
bam-9518	47	26	after	after	ADP
bam-9518	47	27	two	two	NUM
bam-9518	47	28	weeks	week	NOUN
bam-9518	47	29	of	of	ADP
bam-9518	47	30	treatment	treatment	NOUN
bam-9518	47	31	(	(	PUNCT
bam-9518	47	32	p	p	X
bam-9518	47	33	<	<	X
bam-9518	47	34	0.001	0.001	NUM
bam-9518	47	35	,	,	PUNCT
bam-9518	47	36	table	table	NOUN
bam-9518	47	37	2	2	NUM
bam-9518	47	38	)	)	PUNCT
bam-9518	47	39	.	.	PUNCT
bam-9518	48	1	in	in	ADP
bam-9518	48	2	addition	addition	NOUN
bam-9518	48	3	,	,	PUNCT
bam-9518	48	4	figure	figure	NOUN
bam-9518	48	5	1	1	NUM
bam-9518	48	6	illustrated	illustrate	VERB
bam-9518	48	7	the	the	DET
bam-9518	48	8	chest	chest	NOUN
bam-9518	48	9	ct	ct	PROPN
bam-9518	48	10	scan	scan	PROPN
bam-9518	48	11	study	study	NOUN
bam-9518	48	12	in	in	ADP
bam-9518	48	13	some	some	DET
bam-9518	48	14	patients	patient	NOUN
bam-9518	48	15	before	before	ADP
bam-9518	48	16	and	and	CCONJ
bam-9518	48	17	after	after	ADP
bam-9518	48	18	treatment	treatment	NOUN
bam-9518	48	19	.	.	PUNCT
bam-9518	49	1	the	the	DET
bam-9518	49	2	results	result	NOUN
bam-9518	49	3	showed	show	VERB
bam-9518	49	4	the	the	DET
bam-9518	49	5	significant	significant	ADJ
bam-9518	49	6	improvements	improvement	NOUN
bam-9518	49	7	of	of	ADP
bam-9518	49	8	lung	lung	NOUN
bam-9518	49	9	based	base	VERB
bam-9518	49	10	on	on	ADP
bam-9518	49	11	lesions	lesion	NOUN
bam-9518	49	12	distribution	distribution	NOUN
bam-9518	49	13	and	and	CCONJ
bam-9518	49	14	involvement	involvement	NOUN
bam-9518	49	15	of	of	ADP
bam-9518	49	16	various	various	ADJ
bam-9518	49	17	regions	region	NOUN
bam-9518	49	18	of	of	ADP
bam-9518	49	19	lungs	lung	NOUN
bam-9518	49	20	as	as	ADV
bam-9518	49	21	well	well	ADV
bam-9518	49	22	as	as	ADP
bam-9518	49	23	ct	ct	NUM
bam-9518	49	24	score	score	NOUN
bam-9518	49	25	.	.	PUNCT
bam-9518	50	1	comparison	comparison	NOUN
bam-9518	50	2	of	of	ADP
bam-9518	50	3	the	the	DET
bam-9518	50	4	measured	measured	ADJ
bam-9518	50	5	parameters	parameter	NOUN
bam-9518	50	6	before	before	ADP
bam-9518	50	7	and	and	CCONJ
bam-9518	50	8	after	after	SCONJ
bam-9518	50	9	the	the	DET
bam-9518	50	10	intervention	intervention	NOUN
bam-9518	50	11	showed	show	VERB
bam-9518	50	12	that	that	SCONJ
bam-9518	50	13	in	in	ADP
bam-9518	50	14	placebo	placebo	NOUN
bam-9518	50	15	group	group	NOUN
bam-9518	50	16	,	,	PUNCT
bam-9518	50	17	all	all	DET
bam-9518	50	18	parameters	parameter	NOUN
bam-9518	50	19	(	(	PUNCT
bam-9518	50	20	except	except	SCONJ
bam-9518	50	21	cough	cough	NOUN
bam-9518	50	22	,	,	PUNCT
bam-9518	50	23	myalgia	myalgia	NOUN
bam-9518	50	24	,	,	PUNCT
bam-9518	50	25	chill	chill	NOUN
bam-9518	50	26	,	,	PUNCT
bam-9518	50	27	nausea	nausea	NOUN
bam-9518	50	28	and	and	CCONJ
bam-9518	50	29	vomiting	vomiting	NOUN
bam-9518	50	30	,	,	PUNCT
bam-9518	50	31	sore	sore	ADJ
bam-9518	50	32	throat	throat	NOUN
bam-9518	50	33	,	,	PUNCT
bam-9518	50	34	weakness	weakness	NOUN
bam-9518	50	35	,	,	PUNCT
bam-9518	50	36	and	and	CCONJ
bam-9518	50	37	taste	taste	NOUN
bam-9518	50	38	disorder	disorder	NOUN
bam-9518	50	39	,	,	PUNCT
bam-9518	50	40	as	as	ADV
bam-9518	50	41	well	well	ADV
bam-9518	50	42	as	as	ADP
bam-9518	50	43	chest	chest	NOUN
bam-9518	50	44	ct	ct	PROPN
bam-9518	50	45	)	)	PUNCT
bam-9518	50	46	were	be	AUX
bam-9518	50	47	not	not	PART
bam-9518	50	48	significantly	significantly	ADV
bam-9518	50	49	changed	change	VERB
bam-9518	50	50	after	after	ADP
bam-9518	50	51	two	two	NUM
bam-9518	50	52	weeks	week	NOUN
bam-9518	50	53	treatment	treatment	NOUN
bam-9518	50	54	compared	compare	VERB
bam-9518	50	55	to	to	PART
bam-9518	50	56	baseline	baseline	VERB
bam-9518	50	57	values	value	NOUN
bam-9518	50	58	.	.	PUNCT
bam-9518	51	1	however	however	ADV
bam-9518	51	2	,	,	PUNCT
bam-9518	51	3	lots	lot	NOUN
bam-9518	51	4	of	of	ADP
bam-9518	51	5	symptoms	symptom	NOUN
bam-9518	51	6	except	except	SCONJ
bam-9518	51	7	diarrhea	diarrhea	NOUN
bam-9518	51	8	and	and	CCONJ
bam-9518	51	9	blood	blood	NOUN
bam-9518	51	10	parameters	parameter	NOUN
bam-9518	51	11	as	as	ADV
bam-9518	51	12	well	well	ADV
bam-9518	51	13	as	as	ADP
bam-9518	51	14	chest	chest	NOUN
bam-9518	51	15	ct	ct	PROPN
bam-9518	51	16	scan	scan	PROPN
bam-9518	51	17	were	be	AUX
bam-9518	51	18	improved	improve	VERB
bam-9518	51	19	after	after	ADP
bam-9518	51	20	treatment	treatment	NOUN
bam-9518	51	21	compared	compare	VERB
bam-9518	51	22	to	to	ADP
bam-9518	51	23	before	before	ADP
bam-9518	51	24	treatment	treatment	NOUN
bam-9518	51	25	in	in	ADP
bam-9518	51	26	the	the	DET
bam-9518	51	27	allicin	allicin	NOUN
bam-9518	51	28	(	(	PUNCT
bam-9518	51	29	l	l	NOUN
bam-9518	51	30	-	-	ADJ
bam-9518	51	31	cysteine	cysteine	ADJ
bam-9518	51	32	)	)	PUNCT
bam-9518	51	33	group	group	NOUN
bam-9518	51	34	(	(	PUNCT
bam-9518	51	35	p	p	X
bam-9518	51	36	<	<	X
bam-9518	51	37	0.05	0.05	NUM
bam-9518	51	38	for	for	ADP
bam-9518	51	39	all	all	DET
bam-9518	51	40	cases	case	NOUN
bam-9518	51	41	)	)	PUNCT
bam-9518	51	42	(	(	PUNCT
bam-9518	51	43	see	see	VERB
bam-9518	51	44	table	table	NOUN
bam-9518	51	45	1	1	NUM
bam-9518	51	46	)	)	PUNCT
bam-9518	51	47	.	.	PUNCT
bam-9518	52	1	discussion	discussion	NOUN
bam-9518	52	2	in	in	ADP
bam-9518	52	3	this	this	DET
bam-9518	52	4	study	study	NOUN
bam-9518	52	5	,	,	PUNCT
bam-9518	52	6	we	we	PRON
bam-9518	52	7	showed	show	VERB
bam-9518	52	8	that	that	SCONJ
bam-9518	52	9	allicin	allicin	NOUN
bam-9518	52	10	(	(	PUNCT
bam-9518	52	11	l	l	NOUN
bam-9518	52	12	-	-	NOUN
bam-9518	52	13	cysteine	cysteine	NOUN
bam-9518	52	14	)	)	PUNCT
bam-9518	52	15	could	could	AUX
bam-9518	52	16	significantly	significantly	ADV
bam-9518	52	17	improve	improve	VERB
bam-9518	52	18	clinical	clinical	ADJ
bam-9518	52	19	symptoms	symptom	NOUN
bam-9518	52	20	of	of	ADP
bam-9518	52	21	covid-19	covid-19	PROPN
bam-9518	52	22	after	after	ADP
bam-9518	52	23	two	two	NUM
bam-9518	52	24	weeks	week	NOUN
bam-9518	52	25	of	of	ADP
bam-9518	52	26	treatment	treatment	NOUN
bam-9518	52	27	in	in	ADP
bam-9518	52	28	comparison	comparison	NOUN
bam-9518	52	29	to	to	ADP
bam-9518	52	30	placebo	placebo	NOUN
bam-9518	52	31	.	.	PUNCT
bam-9518	53	1	allicin	allicin	NOUN
bam-9518	53	2	(	(	PUNCT
bam-9518	53	3	l	l	NOUN
bam-9518	53	4	-	-	NOUN
bam-9518	53	5	cysteine	cysteine	NOUN
bam-9518	53	6	)	)	PUNCT
bam-9518	53	7	not	not	PART
bam-9518	53	8	only	only	ADV
bam-9518	53	9	improve	improve	VERB
bam-9518	53	10	the	the	DET
bam-9518	53	11	clinical	clinical	ADJ
bam-9518	53	12	signs	sign	NOUN
bam-9518	53	13	,	,	PUNCT
bam-9518	53	14	table	table	NOUN
bam-9518	53	15	2	2	NUM
bam-9518	53	16	.	.	PUNCT
bam-9518	53	17	measured	measure	VERB
bam-9518	53	18	parameters	parameter	NOUN
bam-9518	53	19	pre	pre	ADJ
bam-9518	53	20	-	-	NOUN
bam-9518	53	21	treatment	treatment	ADJ
bam-9518	53	22	(	(	PUNCT
bam-9518	53	23	day	day	NOUN
bam-9518	53	24	0	0	NUM
bam-9518	53	25	)	)	PUNCT
bam-9518	53	26	and	and	CCONJ
bam-9518	53	27	post	post	ADJ
bam-9518	53	28	-	-	ADJ
bam-9518	53	29	treatment	treatment	ADJ
bam-9518	53	30	(	(	PUNCT
bam-9518	53	31	day	day	NOUN
bam-9518	53	32	14	14	NUM
bam-9518	53	33	)	)	PUNCT
bam-9518	53	34	.	.	PUNCT
bam-9518	54	1	pre	pre	ADJ
bam-9518	54	2	-	-	ADJ
bam-9518	54	3	treatment	treatment	ADJ
bam-9518	54	4	post	post	ADJ
bam-9518	54	5	-	-	ADJ
bam-9518	54	6	tratment	tratment	ADJ
bam-9518	54	7	variables	variable	NOUN
bam-9518	54	8	placebo	placebo	NOUN
bam-9518	54	9	allicin	allicin	NOUN
bam-9518	54	10	p	p	NOUN
bam-9518	54	11	-	-	PUNCT
bam-9518	54	12	value	value	NOUN
bam-9518	54	13	*	*	NOUN
bam-9518	54	14	*	*	NOUN
bam-9518	54	15	placebo	placebo	NOUN
bam-9518	54	16	allicin	allicin	NOUN
bam-9518	54	17	(	(	PUNCT
bam-9518	54	18	l	l	NOUN
bam-9518	54	19	-	-	NOUN
bam-9518	54	20	cysteine	cysteine	ADJ
bam-9518	54	21	)	)	PUNCT
bam-9518	54	22	p	p	NOUN
bam-9518	54	23	-	-	PUNCT
bam-9518	54	24	value	value	NOUN
bam-9518	54	25	*	*	NOUN
bam-9518	54	26	*	*	NOUN
bam-9518	54	27	pvalue	pvalue	NOUN
bam-9518	54	28	#	#	NOUN
bam-9518	54	29	p	p	NOUN
bam-9518	54	30	value	value	NOUN
bam-9518	54	31	#	#	NOUN
bam-9518	54	32	#	#	NOUN
bam-9518	54	33	symptoms	symptom	NOUN
bam-9518	54	34	cough	cough	VERB
bam-9518	54	35	75.7	75.7	NUM
bam-9518	54	36	%	%	NOUN
bam-9518	54	37	72.7	72.7	NUM
bam-9518	54	38	%	%	NOUN
bam-9518	54	39	0.916	0.916	NUM
bam-9518	54	40	37.9	37.9	NUM
bam-9518	54	41	%	%	NOUN
bam-9518	54	42	12.5	12.5	NUM
bam-9518	54	43	%	%	NOUN
bam-9518	54	44	0.004	0.004	NUM
bam-9518	54	45	*	*	NOUN
bam-9518	54	46	p<0.05	p<0.05	NOUN
bam-9518	54	47	p<0.05	p<0.05	NOUN
bam-9518	54	48	dyspnea	dyspnea	VERB
bam-9518	54	49	77.8	77.8	NUM
bam-9518	54	50	%	%	NOUN
bam-9518	54	51	75.8	75.8	NUM
bam-9518	54	52	%	%	NOUN
bam-9518	54	53	0.961	0.961	NUM
bam-9518	54	54	69	69	NUM
bam-9518	54	55	%	%	NOUN
bam-9518	54	56	40.6	40.6	NUM
bam-9518	54	57	%	%	NOUN
bam-9518	54	58	0.014	0.014	NUM
bam-9518	54	59	*	*	PUNCT
bam-9518	54	60	ns	ns	NUM
bam-9518	54	61	p<0.05	p<0.05	NOUN
bam-9518	54	62	myalgia	myalgia	NOUN
bam-9518	54	63	66.7	66.7	NUM
bam-9518	54	64	%	%	NOUN
bam-9518	54	65	48.5	48.5	NUM
bam-9518	54	66	%	%	NOUN
bam-9518	54	67	0.578	0.578	NUM
bam-9518	54	68	31	31	NUM
bam-9518	54	69	%	%	NOUN
bam-9518	54	70	12.5	12.5	NUM
bam-9518	54	71	%	%	NOUN
bam-9518	54	72	0.009	0.009	NUM
bam-9518	54	73	*	*	NOUN
bam-9518	54	74	p<0.05	p<0.05	NOUN
bam-9518	54	75	p<0.05	p<0.05	NOUN
bam-9518	54	76	anosmia	anosmia	NOUN
bam-9518	54	77	18.2	18.2	NUM
bam-9518	54	78	%	%	NOUN
bam-9518	54	79	36.4	36.4	NUM
bam-9518	54	80	%	%	NOUN
bam-9518	54	81	0.031	0.031	NUM
bam-9518	54	82	*	*	NUM
bam-9518	54	83	10.3	10.3	NUM
bam-9518	54	84	%	%	NOUN
bam-9518	54	85	9.4	9.4	NUM
bam-9518	54	86	%	%	NOUN
bam-9518	54	87	0.863	0.863	NUM
bam-9518	54	88	ns	ns	NOUN
bam-9518	54	89	p	p	X
bam-9518	54	90	<	<	X
bam-9518	54	91	0.05	0.05	NUM
bam-9518	54	92	chill	chill	NOUN
bam-9518	54	93	48.5	48.5	NUM
bam-9518	54	94	%	%	NOUN
bam-9518	54	95	45.5	45.5	NUM
bam-9518	54	96	%	%	NOUN
bam-9518	54	97	0.956	0.956	NUM
bam-9518	54	98	0	0	NUM
bam-9518	54	99	%	%	NOUN
bam-9518	54	100	3.1	3.1	NUM
bam-9518	54	101	%	%	NOUN
bam-9518	54	102	0.131	0.131	NUM
bam-9518	54	103	p<0.05	p<0.05	NOUN
bam-9518	54	104	p	p	NOUN
bam-9518	54	105	<	<	NOUN
bam-9518	54	106	0.05	0.05	NUM
bam-9518	54	107	consciousness	consciousness	NOUN
bam-9518	54	108	97.0	97.0	NUM
bam-9518	54	109	%	%	NOUN
bam-9518	54	110	84.9	84.9	NUM
bam-9518	54	111	%	%	NOUN
bam-9518	54	112	0.883	0.883	NUM
bam-9518	54	113	97	97	NUM
bam-9518	54	114	%	%	NOUN
bam-9518	54	115	100	100	NUM
bam-9518	54	116	%	%	NOUN
bam-9518	54	117	0.782	0.782	NUM
bam-9518	54	118	ns	ns	NOUN
bam-9518	54	119	p	p	X
bam-9518	54	120	<	<	NOUN
bam-9518	54	121	0.05	0.05	NUM
bam-9518	54	122	diarrhea	diarrhea	NOUN
bam-9518	54	123	3	3	NUM
bam-9518	54	124	%	%	NOUN
bam-9518	54	125	3	3	NUM
bam-9518	54	126	%	%	NOUN
bam-9518	54	127	0.999	0.999	NUM
bam-9518	54	128	0	0	NUM
bam-9518	54	129	%	%	NOUN
bam-9518	54	130	0	0	NUM
bam-9518	54	131	%	%	NOUN
bam-9518	54	132	0.999	0.999	NUM
bam-9518	54	133	ns	ns	NUM
bam-9518	54	134	ns	ns	NUM
bam-9518	54	135	headache	headache	NOUN
bam-9518	54	136	36.4	36.4	NUM
bam-9518	54	137	%	%	NOUN
bam-9518	54	138	39.4	39.4	NUM
bam-9518	54	139	%	%	NOUN
bam-9518	54	140	0.977	0.977	NUM
bam-9518	54	141	27.6	27.6	NUM
bam-9518	54	142	%	%	NOUN
bam-9518	54	143	21.9	21.9	NUM
bam-9518	54	144	%	%	NOUN
bam-9518	54	145	0.601	0.601	NUM
bam-9518	54	146	ns	ns	NOUN
bam-9518	55	1	p	p	X
bam-9518	55	2	<	<	PROPN
bam-9518	55	3	0.05	0.05	NUM
bam-9518	55	4	nasal	nasal	NOUN
bam-9518	55	5	congest	cong	ADJ
bam-9518	55	6	ion	ion	NOUN
bam-9518	55	7	3	3	NUM
bam-9518	55	8	%	%	NOUN
bam-9518	55	9	15.2	15.2	NUM
bam-9518	55	10	%	%	NOUN
bam-9518	55	11	0.009	0.009	NUM
bam-9518	55	12	*	*	SYM
bam-9518	55	13	0	0	NUM
bam-9518	55	14	%	%	NOUN
bam-9518	55	15	0	0	NUM
bam-9518	55	16	%	%	NOUN
bam-9518	55	17	0.999	0.999	NUM
bam-9518	55	18	ns	ns	NOUN
bam-9518	56	1	p	p	X
bam-9518	56	2	<	<	X
bam-9518	56	3	0.05	0.05	NUM
bam-9518	56	4	nausea	nausea	NOUN
bam-9518	56	5	and	and	CCONJ
bam-9518	56	6	vomiting	vomit	VERB
bam-9518	56	7	15.2	15.2	NUM
bam-9518	56	8	%	%	NOUN
bam-9518	56	9	15.2	15.2	NUM
bam-9518	56	10	%	%	NOUN
bam-9518	56	11	0.999	0.999	NUM
bam-9518	56	12	0	0	NUM
bam-9518	56	13	%	%	NOUN
bam-9518	56	14	0	0	NUM
bam-9518	56	15	%	%	NOUN
bam-9518	56	16	0.999	0.999	NUM
bam-9518	56	17	p<0.05	p<0.05	NOUN
bam-9518	56	18	p	p	NOUN
bam-9518	56	19	<	<	NOUN
bam-9518	56	20	0.05	0.05	NUM
bam-9518	56	21	sore	sore	ADJ
bam-9518	56	22	throat	throat	NOUN
bam-9518	56	23	12.1	12.1	NUM
bam-9518	56	24	%	%	NOUN
bam-9518	56	25	18.2	18.2	NUM
bam-9518	56	26	%	%	NOUN
bam-9518	56	27	0.781	0.781	NUM
bam-9518	56	28	0	0	NUM
bam-9518	56	29	%	%	NOUN
bam-9518	56	30	3.1	3.1	NUM
bam-9518	56	31	%	%	NOUN
bam-9518	56	32	0.131	0.131	NUM
bam-9518	56	33	p<0.05	p<0.05	NOUN
bam-9518	57	1	p	p	NOUN
bam-9518	57	2	<	<	NOUN
bam-9518	57	3	0.05	0.05	NUM
bam-9518	57	4	weakness	weakness	NOUN
bam-9518	57	5	66.7	66.7	NUM
bam-9518	57	6	%	%	NOUN
bam-9518	57	7	60.7	60.7	NUM
bam-9518	57	8	%	%	NOUN
bam-9518	57	9	0.846	0.846	NUM
bam-9518	57	10	51.7	51.7	NUM
bam-9518	57	11	%	%	NOUN
bam-9518	57	12	50	50	NUM
bam-9518	57	13	%	%	NOUN
bam-9518	57	14	0.868	0.868	NUM
bam-9518	57	15	p<0.05	p<0.05	NOUN
bam-9518	57	16	p	p	NOUN
bam-9518	57	17	<	<	NOUN
bam-9518	57	18	0.05	0.05	NUM
bam-9518	57	19	taste	taste	NOUN
bam-9518	57	20	disorder	disorder	NOUN
bam-9518	57	21	12.1	12.1	NUM
bam-9518	57	22	%	%	NOUN
bam-9518	57	23	27.3	27.3	NUM
bam-9518	57	24	%	%	NOUN
bam-9518	57	25	0.086	0.086	NUM
bam-9518	57	26	6.9	6.9	NUM
bam-9518	57	27	%	%	NOUN
bam-9518	57	28	3.1	3.1	NUM
bam-9518	57	29	%	%	NOUN
bam-9518	57	30	0.655	0.655	NUM
bam-9518	57	31	p<0.05	p<0.05	NOUN
bam-9518	57	32	p<0.05	p<0.05	NOUN
bam-9518	57	33	respiratory	respiratory	ADJ
bam-9518	57	34	rate	rate	NOUN
bam-9518	57	35	21.1±2.2	21.1±2.2	NUM
bam-9518	57	36	24.8±2.8	24.8±2.8	NUM
bam-9518	57	37	0.593	0.593	NUM
bam-9518	57	38	22.4±1.1	22.4±1.1	NUM
bam-9518	57	39	19.5±1.3	19.5±1.3	NUM
bam-9518	57	40	0.671	0.671	NUM
bam-9518	57	41	ns	ns	ADJ
bam-9518	57	42	p<0.05	p<0.05	NOUN
bam-9518	57	43	pulse	pulse	NOUN
bam-9518	57	44	rate	rate	NOUN
bam-9518	57	45	97.4±3.6	97.4±3.6	NUM
bam-9518	57	46	91.1±4.2	91.1±4.2	NUM
bam-9518	57	47	0.773	0.773	NUM
bam-9518	57	48	90.9±2.3	90.9±2.3	NUM
bam-9518	57	49	82.8±5.9	82.8±5.9	NUM
bam-9518	57	50	0.694	0.694	NUM
bam-9518	57	51	ns	ns	ADJ
bam-9518	57	52	p<0.05	p<0.05	NOUN
bam-9518	57	53	temperature	temperature	NOUN
bam-9518	57	54	37.3±2.2	37.3±2.2	NUM
bam-9518	57	55	37.4±0.2	37.4±0.2	NUM
bam-9518	57	56	0.977	0.977	NUM
bam-9518	57	57	36.9±0.7	36.9±0.7	NUM
bam-9518	57	58	36.1±1.2	36.1±1.2	NUM
bam-9518	57	59	0.893	0.893	NUM
bam-9518	57	60	ns	ns	NUM
bam-9518	57	61	p<0.05	p<0.05	NOUN
bam-9518	57	62	o2saturation	o2saturation	NOUN
bam-9518	57	63	90.3±1.9	90.3±1.9	NUM
bam-9518	57	64	89.4±2.2	89.4±2.2	NUM
bam-9518	57	65	0.891	0.891	NUM
bam-9518	57	66	93.3±1.2	93.3±1.2	NUM
bam-9518	57	67	93.0±5.9	93.0±5.9	NUM
bam-9518	57	68	0.991	0.991	NUM
bam-9518	57	69	ns	ns	NUM
bam-9518	57	70	p<0.05	p<0.05	NOUN
bam-9518	57	71	laboratory	laboratory	NOUN
bam-9518	57	72	test	test	NOUN
bam-9518	57	73	white	white	ADJ
bam-9518	57	74	blood	blood	NOUN
bam-9518	57	75	cell	cell	NOUN
bam-9518	57	76	5.5±0.7	5.5±0.7	NUM
bam-9518	58	1	6.5±0.9	6.5±0.9	NUM
bam-9518	58	2	0.167	0.167	NUM
bam-9518	58	3	6.8±1.2	6.8±1.2	NUM
bam-9518	58	4	5.4±0.8	5.4±0.8	NUM
bam-9518	58	5	0.098	0.098	NUM
bam-9518	58	6	ns	ns	ADJ
bam-9518	58	7	p<0.05	p<0.05	NOUN
bam-9518	58	8	lymphocyte	lymphocyte	ADJ
bam-9518	58	9	22.5±3.7	22.5±3.7	NOUN
bam-9518	58	10	23.5±4.3	23.5±4.3	NUM
bam-9518	58	11	0.873	0.873	NUM
bam-9518	58	12	23.5±5.9	23.5±5.9	NUM
bam-9518	58	13	28.3±4.5	28.3±4.5	NUM
bam-9518	58	14	0.706	0.706	NUM
bam-9518	58	15	ns	ns	ADJ
bam-9518	58	16	p<0.05	p<0.05	NOUN
bam-9518	58	17	eosinophil	eosinophil	ADJ
bam-9518	58	18	2.7±0.7	2.7±0.7	NUM
bam-9518	58	19	3.5±1.0	3.5±1.0	NUM
bam-9518	58	20	0.515	0.515	NUM
bam-9518	58	21	2.9±0.3	2.9±0.3	NUM
bam-9518	58	22	3.6±0.4	3.6±0.4	NUM
bam-9518	58	23	0.228	0.228	NUM
bam-9518	58	24	ns	ns	NUM
bam-9518	58	25	ns	ns	NUM
bam-9518	58	26	pmn	pmn	PROPN
bam-9518	58	27	69.2±4.6	69.2±4.6	NUM
bam-9518	58	28	71.8±4.8	71.8±4.8	NUM
bam-9518	58	29	0.760	0.760	NUM
bam-9518	58	30	69.9±6.6	69.9±6.6	NUM
bam-9518	58	31	60.7±5.8	60.7±5.8	NUM
bam-9518	58	32	0.461	0.461	NUM
bam-9518	58	33	ns	ns	ADJ
bam-9518	58	34	p<0.05	p<0.05	NOUN
bam-9518	58	35	platelet	platelet	NOUN
bam-9518	58	36	202.5±28.5	202.5±28.5	NUM
bam-9518	58	37	209.9±33.7	209.9±33.7	NOUN
bam-9518	58	38	0.892	0.892	NUM
bam-9518	58	39	252±39	252±39	NUM
bam-9518	58	40	298±48	298±48	NUM
bam-9518	58	41	0.071	0.071	NUM
bam-9518	58	42	ns	ns	NUM
bam-9518	58	43	p<0.05	p<0.05	NOUN
bam-9518	58	44	red	red	ADJ
bam-9518	58	45	blood	blood	NOUN
bam-9518	58	46	cell	cell	NOUN
bam-9518	58	47	4.8±0.2	4.8±0.2	NUM
bam-9518	58	48	4.8±0.3	4.8±0.3	NUM
bam-9518	58	49	0.997	0.997	NUM
bam-9518	58	50	4.7±0.2	4.7±0.2	NUM
bam-9518	59	1	4.8±0.2	4.8±0.2	NUM
bam-9518	59	2	0.990	0.990	NUM
bam-9518	59	3	ns	ns	NUM
bam-9518	59	4	ns	ns	PROPN
bam-9518	59	5	hemoglobin	hemoglobin	NOUN
bam-9518	59	6	13.8±0.7	13.8±0.7	NUM
bam-9518	59	7	13.4±0.6	13.4±0.6	NUM
bam-9518	59	8	0.909	0.909	NUM
bam-9518	59	9	13.6±0.6	13.6±0.6	NUM
bam-9518	59	10	14.8±0.7	14.8±0.7	NUM
bam-9518	59	11	0.338	0.338	NUM
bam-9518	59	12	ns	ns	PROPN
bam-9518	59	13	p<0.05	p<0.05	NOUN
bam-9518	59	14	chest	chest	NOUN
bam-9518	59	15	ct	ct	NUM
bam-9518	59	16	scan	scan	NOUN
bam-9518	59	17	(	(	PUNCT
bam-9518	59	18	n=52	n=52	NOUN
bam-9518	59	19	)	)	PUNCT
bam-9518	59	20	n=26	n=26	VERB
bam-9518	59	21	n=26	n=26	NUM
bam-9518	59	22	n=26	n=26	NUM
bam-9518	59	23	n=26	n=26	NUM
bam-9518	59	24	n=26	n=26	NOUN
bam-9518	59	25	n=26	n=26	NOUN
bam-9518	59	26	sever	sever	VERB
bam-9518	59	27	diffuse	diffuse	NOUN
bam-9518	59	28	24.6	24.6	NUM
bam-9518	59	29	%	%	NOUN
bam-9518	59	30	27.7	27.7	NUM
bam-9518	59	31	%	%	NOUN
bam-9518	59	32	0.563	0.563	NUM
bam-9518	59	33	18.9	18.9	NUM
bam-9518	59	34	%	%	NOUN
bam-9518	59	35	12.2	12.2	NUM
bam-9518	59	36	%	%	NOUN
bam-9518	59	37	0.378	0.378	NUM
bam-9518	59	38	p<0.05	p<0.05	NOUN
bam-9518	59	39	p<0.05	p<0.05	NOUN
bam-9518	59	40	moderate	moderate	ADJ
bam-9518	59	41	28.6	28.6	NUM
bam-9518	59	42	%	%	NOUN
bam-9518	59	43	31.9	31.9	NUM
bam-9518	59	44	%	%	NOUN
bam-9518	59	45	0.772	0.772	NUM
bam-9518	59	46	36.9	36.9	NUM
bam-9518	59	47	%	%	NOUN
bam-9518	59	48	41.0	41.0	NUM
bam-9518	59	49	%	%	NOUN
bam-9518	59	50	0.457	0.457	NUM
bam-9518	59	51	p<0.05	p<0.05	NOUN
bam-9518	59	52	ns	ns	NUM
bam-9518	59	53	mild	mild	ADJ
bam-9518	59	54	diffuse	diffuse	NOUN
bam-9518	59	55	46.8	46.8	NUM
bam-9518	59	56	%	%	NOUN
bam-9518	59	57	24.3	24.3	NUM
bam-9518	59	58	%	%	NOUN
bam-9518	59	59	0.027	0.027	NUM
bam-9518	59	60	*	*	NOUN
bam-9518	59	61	41.2	41.2	NUM
bam-9518	59	62	%	%	NOUN
bam-9518	59	63	39.9	39.9	NUM
bam-9518	59	64	%	%	NOUN
bam-9518	59	65	0.733	0.733	NUM
bam-9518	59	66	ns	ns	ADJ
bam-9518	59	67	p<0.05	p<0.05	NOUN
bam-9518	59	68	normal	normal	ADJ
bam-9518	59	69	0	0	NUM
bam-9518	59	70	%	%	NOUN
bam-9518	59	71	16.1	16.1	NUM
bam-9518	59	72	%	%	NOUN
bam-9518	59	73	0.000	0.000	NUM
bam-9518	59	74	*	*	PUNCT
bam-9518	59	75	3	3	NUM
bam-9518	59	76	%	%	NOUN
bam-9518	59	77	26.9	26.9	NUM
bam-9518	59	78	%	%	NOUN
bam-9518	59	79	0.000	0.000	NUM
bam-9518	59	80	*	*	PUNCT
bam-9518	59	81	p<0.05	p<0.05	NOUN
bam-9518	59	82	p<0.05	p<0.05	NOUN
bam-9518	59	83	_	_	PUNCT
bam-9518	60	1	_	_	PUNCT
bam-9518	61	1	_	_	PUNCT
bam-9518	62	1	_	_	PUNCT
bam-9518	63	1	_	_	PUNCT
bam-9518	64	1	_	_	PUNCT
bam-9518	65	1	_	_	PUNCT
bam-9518	66	1	_	_	PUNCT
bam-9518	67	1	_	_	PUNCT
bam-9518	68	1	_	_	PUNCT
bam-9518	69	1	_	_	PUNCT
bam-9518	70	1	_	_	PUNCT
bam-9518	71	1	_	_	PUNCT
bam-9518	72	1	_	_	PUNCT
bam-9518	73	1	_	_	PUNCT
bam-9518	74	1	_	_	PUNCT
bam-9518	75	1	_	_	PUNCT
bam-9518	76	1	_	_	PUNCT
bam-9518	77	1	_	_	PUNCT
bam-9518	78	1	_	_	PUNCT
bam-9518	79	1	_	_	PUNCT
bam-9518	80	1	_	_	PUNCT
bam-9518	81	1	_	_	PUNCT
bam-9518	82	1	_	_	PUNCT
bam-9518	83	1	_	_	PUNCT
bam-9518	84	1	_	_	PUNCT
bam-9518	85	1	_	_	PUNCT
bam-9518	86	1	_	_	PUNCT
bam-9518	87	1	_	_	PUNCT
bam-9518	88	1	_	_	PUNCT
bam-9518	89	1	_	_	PUNCT
bam-9518	90	1	_	_	PUNCT
bam-9518	91	1	_	_	PUNCT
bam-9518	92	1	_	_	PUNCT
bam-9518	93	1	_	_	PUNCT
bam-9518	94	1	_	_	PUNCT
bam-9518	95	1	_	_	PUNCT
bam-9518	96	1	_	_	PUNCT
bam-9518	97	1	_	_	PUNCT
bam-9518	98	1	_	_	PUNCT
bam-9518	99	1	_	_	PUNCT
bam-9518	100	1	_	_	PUNCT
bam-9518	101	1	_	_	PUNCT
bam-9518	102	1	_	_	PUNCT
bam-9518	103	1	_	_	PUNCT
bam-9518	104	1	_	_	PUNCT
bam-9518	105	1	_	_	PUNCT
bam-9518	106	1	_	_	PUNCT
bam-9518	107	1	_	_	PUNCT
bam-9518	108	1	_	_	PUNCT
bam-9518	109	1	_	_	PUNCT
bam-9518	110	1	_	_	PUNCT
bam-9518	111	1	_	_	PUNCT
bam-9518	112	1	_	_	PUNCT
bam-9518	113	1	_	_	PUNCT
bam-9518	114	1	_	_	PUNCT
bam-9518	115	1	_	_	PUNCT
bam-9518	116	1	_	_	PUNCT
bam-9518	117	1	_	_	PUNCT
bam-9518	118	1	_	_	PUNCT
bam-9518	119	1	_	_	PUNCT
bam-9518	120	1	_	_	PUNCT
bam-9518	121	1	_	_	PUNCT
bam-9518	122	1	_	_	PUNCT
bam-9518	123	1	_	_	PUNCT
bam-9518	124	1	_	_	PUNCT
bam-9518	125	1	_	_	PUNCT
bam-9518	126	1	_	_	PUNCT
bam-9518	127	1	_	_	PUNCT
bam-9518	128	1	_	_	PUNCT
bam-9518	129	1	_	_	PUNCT
bam-9518	130	1	_	_	PUNCT
bam-9518	131	1	_	_	PUNCT
bam-9518	132	1	_	_	PUNCT
bam-9518	133	1	_	_	PUNCT
bam-9518	134	1	_	_	PUNCT
bam-9518	135	1	_	_	PUNCT
bam-9518	136	1	_	_	PUNCT
bam-9518	137	1	_	_	PUNCT
bam-9518	138	1	_	_	PUNCT
bam-9518	139	1	_	_	PUNCT
bam-9518	140	1	_	_	PUNCT
bam-9518	141	1	_	_	PUNCT
bam-9518	142	1	_	_	PUNCT
bam-9518	143	1	_	_	PUNCT
bam-9518	144	1	_	_	PUNCT
bam-9518	145	1	_	_	PUNCT
bam-9518	146	1	_	_	PUNCT
bam-9518	147	1	_	_	PUNCT
bam-9518	148	1	_	_	PUNCT
bam-9518	149	1	_	_	PUNCT
bam-9518	150	1	_	_	PUNCT
bam-9518	151	1	pmn	pmn	ADJ
bam-9518	151	2	:	:	PUNCT
bam-9518	151	3	polymorphonuclear	polymorphonuclear	NOUN
bam-9518	151	4	leukocytes	leukocyte	NOUN
bam-9518	151	5	;	;	PUNCT
bam-9518	151	6	ns	ns	NUM
bam-9518	151	7	:	:	PUNCT
bam-9518	151	8	non	non	ADJ
bam-9518	151	9	-	-	ADJ
bam-9518	151	10	significant	significant	ADJ
bam-9518	151	11	.	.	PUNCT
bam-9518	152	1	*	*	PUNCT
bam-9518	152	2	,	,	PUNCT
bam-9518	152	3	comparison	comparison	NOUN
bam-9518	152	4	between	between	ADP
bam-9518	152	5	allicin	allicin	NOUN
bam-9518	152	6	(	(	PUNCT
bam-9518	152	7	l	l	NOUN
bam-9518	152	8	-	-	NOUN
bam-9518	152	9	cysteine	cysteine	ADJ
bam-9518	152	10	)	)	PUNCT
bam-9518	152	11	and	and	CCONJ
bam-9518	152	12	placebo	placebo	NOUN
bam-9518	152	13	groups	group	NOUN
bam-9518	152	14	in	in	ADP
bam-9518	152	15	pre	pre	ADJ
bam-9518	152	16	-	-	NOUN
bam-9518	152	17	treatment	treatment	NOUN
bam-9518	152	18	,	,	PUNCT
bam-9518	152	19	by	by	ADP
bam-9518	152	20	chi	chi	ADJ
bam-9518	152	21	-	-	PUNCT
bam-9518	152	22	square	square	ADJ
bam-9518	152	23	and	and	CCONJ
bam-9518	152	24	mann	mann	PROPN
bam-9518	152	25	-	-	PUNCT
bam-9518	152	26	whitney	whitney	PROPN
bam-9518	152	27	u	u	NOUN
bam-9518	152	28	tests	test	VERB
bam-9518	152	29	.	.	PUNCT
bam-9518	153	1	*	*	PUNCT
bam-9518	153	2	*	*	PUNCT
bam-9518	153	3	,	,	PUNCT
bam-9518	153	4	comparison	comparison	NOUN
bam-9518	153	5	between	between	ADP
bam-9518	153	6	allicin	allicin	NOUN
bam-9518	153	7	(	(	PUNCT
bam-9518	153	8	l	l	NOUN
bam-9518	153	9	-	-	NOUN
bam-9518	153	10	cysteine	cysteine	ADJ
bam-9518	153	11	)	)	PUNCT
bam-9518	153	12	and	and	CCONJ
bam-9518	153	13	placebo	placebo	NOUN
bam-9518	153	14	groups	group	NOUN
bam-9518	153	15	in	in	ADP
bam-9518	153	16	post	post	ADJ
bam-9518	153	17	-	-	NOUN
bam-9518	153	18	treatment	treatment	NOUN
bam-9518	153	19	,	,	PUNCT
bam-9518	153	20	by	by	ADP
bam-9518	153	21	chi	chi	ADJ
bam-9518	153	22	-	-	PUNCT
bam-9518	153	23	square	square	ADJ
bam-9518	153	24	and	and	CCONJ
bam-9518	153	25	mann	mann	PROPN
bam-9518	153	26	-	-	PUNCT
bam-9518	153	27	whitney	whitney	PROPN
bam-9518	153	28	u	u	NOUN
bam-9518	153	29	tests	test	VERB
bam-9518	153	30	.	.	PUNCT
bam-9518	154	1	#	#	X
bam-9518	154	2	,	,	PUNCT
bam-9518	154	3	comparison	comparison	NOUN
bam-9518	154	4	between	between	ADP
bam-9518	154	5	data	datum	NOUN
bam-9518	154	6	of	of	ADP
bam-9518	154	7	preand	preand	NOUN
bam-9518	154	8	post	post	ADJ
bam-9518	154	9	-	-	NOUN
bam-9518	154	10	treatment	treatment	NOUN
bam-9518	154	11	in	in	ADP
bam-9518	154	12	in	in	ADP
bam-9518	154	13	placebo	placebo	NOUN
bam-9518	154	14	group	group	NOUN
bam-9518	154	15	,	,	PUNCT
bam-9518	154	16	by	by	ADP
bam-9518	154	17	mcnemar	mcnemar	NOUN
bam-9518	154	18	and	and	CCONJ
bam-9518	154	19	wilcoxon	wilcoxon	PROPN
bam-9518	154	20	signed	sign	VERB
bam-9518	154	21	rank	rank	NOUN
bam-9518	154	22	tests	test	NOUN
bam-9518	154	23	.	.	PUNCT
bam-9518	155	1	#	#	X
bam-9518	155	2	,	,	PUNCT
bam-9518	155	3	,	,	PUNCT
bam-9518	155	4	comparison	comparison	NOUN
bam-9518	155	5	between	between	ADP
bam-9518	155	6	data	datum	NOUN
bam-9518	155	7	of	of	ADP
bam-9518	155	8	preand	preand	NOUN
bam-9518	155	9	post	post	ADJ
bam-9518	155	10	-	-	NOUN
bam-9518	155	11	treatment	treatment	NOUN
bam-9518	155	12	in	in	ADP
bam-9518	155	13	allicin	allicin	NOUN
bam-9518	155	14	(	(	PUNCT
bam-9518	155	15	lcysteine	lcysteine	ADJ
bam-9518	155	16	)	)	PUNCT
bam-9518	155	17	group	group	NOUN
bam-9518	155	18	,	,	PUNCT
bam-9518	155	19	by	by	ADP
bam-9518	155	20	mcnemar	mcnemar	NOUN
bam-9518	155	21	and	and	CCONJ
bam-9518	155	22	wilcoxon	wilcoxon	PROPN
bam-9518	155	23	signed	sign	VERB
bam-9518	155	24	rank	rank	NOUN
bam-9518	155	25	tests	test	NOUN
bam-9518	155	26	.	.	PUNCT
bam-9518	156	1	effect	effect	NOUN
bam-9518	156	2	of	of	ADP
bam-9518	156	3	allicin	allicin	NOUN
bam-9518	156	4	(	(	PUNCT
bam-9518	156	5	l	l	NOUN
bam-9518	156	6	-	-	NOUN
bam-9518	156	7	cysteine	cysteine	NOUN
bam-9518	156	8	)	)	PUNCT
bam-9518	156	9	on	on	ADP
bam-9518	156	10	covid-19	covid-19	PROPN
bam-9518	156	11	eur	eur	PROPN
bam-9518	156	12	j	j	PROPN
bam-9518	156	13	transl	transl	PROPN
bam-9518	156	14	myol	myol	ADV
bam-9518	156	15	31	31	NUM
bam-9518	156	16	(	(	PUNCT
bam-9518	156	17	2	2	NUM
bam-9518	156	18	):	):	PUNCT
bam-9518	156	19	9518	9518	NUM
bam-9518	156	20	,	,	PUNCT
bam-9518	156	21	2021	2021	NUM
bam-9518	156	22	doi	doi	NOUN
bam-9518	156	23	:	:	PUNCT
bam-9518	156	24	10.4081	10.4081	NUM
bam-9518	156	25	/	/	SYM
bam-9518	156	26	ejtm.2021.9518	ejtm.2021.9518	ADJ
bam-9518	156	27	4	4	NUM
bam-9518	156	28	but	but	CCONJ
bam-9518	156	29	also	also	ADV
bam-9518	156	30	ameliorate	ameliorate	VERB
bam-9518	156	31	the	the	DET
bam-9518	156	32	lab	lab	NOUN
bam-9518	156	33	and	and	CCONJ
bam-9518	156	34	radiological	radiological	ADJ
bam-9518	156	35	data	datum	NOUN
bam-9518	156	36	,	,	PUNCT
bam-9518	156	37	which	which	PRON
bam-9518	156	38	suggest	suggest	VERB
bam-9518	156	39	a	a	DET
bam-9518	156	40	therapeutic	therapeutic	ADJ
bam-9518	156	41	effect	effect	NOUN
bam-9518	156	42	for	for	ADP
bam-9518	156	43	this	this	DET
bam-9518	156	44	agent	agent	NOUN
bam-9518	156	45	in	in	ADP
bam-9518	156	46	covid-19	covid-19	PROPN
bam-9518	156	47	.	.	PUNCT
bam-9518	157	1	plants	plant	NOUN
bam-9518	157	2	and	and	CCONJ
bam-9518	157	3	their	their	PRON
bam-9518	157	4	extracts	extract	NOUN
bam-9518	157	5	have	have	AUX
bam-9518	157	6	been	be	AUX
bam-9518	157	7	used	use	VERB
bam-9518	157	8	to	to	PART
bam-9518	157	9	treat	treat	VERB
bam-9518	157	10	human	human	ADJ
bam-9518	157	11	diseases	disease	NOUN
bam-9518	157	12	since	since	SCONJ
bam-9518	157	13	ancient	ancient	ADJ
bam-9518	157	14	times.17	times.17	NOUN
bam-9518	157	15	previous	previous	ADJ
bam-9518	157	16	experiments	experiment	NOUN
bam-9518	157	17	have	have	AUX
bam-9518	157	18	shown	show	VERB
bam-9518	157	19	that	that	SCONJ
bam-9518	157	20	phytochemicals	phytochemical	NOUN
bam-9518	157	21	are	be	AUX
bam-9518	157	22	good	good	ADJ
bam-9518	157	23	therapeutic	therapeutic	ADJ
bam-9518	157	24	agents	agent	NOUN
bam-9518	157	25	for	for	ADP
bam-9518	157	26	the	the	DET
bam-9518	157	27	treatment	treatment	NOUN
bam-9518	157	28	of	of	ADP
bam-9518	157	29	various	various	ADJ
bam-9518	157	30	diseases	disease	NOUN
bam-9518	157	31	,	,	PUNCT
bam-9518	157	32	including	include	VERB
bam-9518	157	33	viral	viral	ADJ
bam-9518	157	34	pathogens	pathogen	NOUN
bam-9518	157	35	,	,	PUNCT
bam-9518	157	36	either	either	CCONJ
bam-9518	157	37	by	by	ADP
bam-9518	157	38	blocking	block	VERB
bam-9518	157	39	the	the	DET
bam-9518	157	40	virus	virus	NOUN
bam-9518	157	41	from	from	ADP
bam-9518	157	42	penetrating	penetrate	VERB
bam-9518	157	43	host	host	NOUN
bam-9518	157	44	cells	cell	NOUN
bam-9518	157	45	or	or	CCONJ
bam-9518	157	46	by	by	ADP
bam-9518	157	47	attacking	attack	VERB
bam-9518	157	48	viral	viral	ADJ
bam-9518	157	49	proteins	protein	NOUN
bam-9518	157	50	in	in	ADP
bam-9518	157	51	host	host	NOUN
bam-9518	157	52	cells.18	cells.18	VERB
bam-9518	157	53	inhibition	inhibition	NOUN
bam-9518	157	54	of	of	ADP
bam-9518	157	55	proteolytic	proteolytic	ADJ
bam-9518	157	56	action	action	NOUN
bam-9518	157	57	of	of	ADP
bam-9518	157	58	viral	viral	ADJ
bam-9518	157	59	proteases	protease	NOUN
bam-9518	157	60	has	have	AUX
bam-9518	157	61	been	be	AUX
bam-9518	157	62	studied	study	VERB
bam-9518	157	63	in	in	ADP
bam-9518	157	64	the	the	DET
bam-9518	157	65	production	production	NOUN
bam-9518	157	66	of	of	ADP
bam-9518	157	67	various	various	ADJ
bam-9518	157	68	antiviral	antiviral	ADJ
bam-9518	157	69	drugs	drug	NOUN
bam-9518	157	70	such	such	ADJ
bam-9518	157	71	as	as	ADP
bam-9518	157	72	atazanavir	atazanavir	PROPN
bam-9518	157	73	,	,	PUNCT
bam-9518	157	74	lopinavir	lopinavir	PROPN
bam-9518	157	75	,	,	PUNCT
bam-9518	157	76	nelfinavir	nelfinavir	PROPN
bam-9518	157	77	,	,	PUNCT
bam-9518	157	78	ritonavir	ritonavir	PROPN
bam-9518	157	79	and	and	CCONJ
bam-9518	157	80	saquinavir.19	saquinavir.19	NOUN
bam-9518	157	81	protease	protease	NOUN
bam-9518	157	82	inhibitory	inhibitory	ADJ
bam-9518	157	83	potentials	potential	NOUN
bam-9518	157	84	have	have	AUX
bam-9518	157	85	been	be	AUX
bam-9518	157	86	found	find	VERB
bam-9518	157	87	to	to	PART
bam-9518	157	88	exist	exist	VERB
bam-9518	157	89	in	in	ADP
bam-9518	157	90	the	the	DET
bam-9518	157	91	extracts	extract	NOUN
bam-9518	157	92	of	of	ADP
bam-9518	157	93	cloves	clove	NOUN
bam-9518	157	94	a.	a.	NOUN
bam-9518	157	95	sativum	sativum	PROPN
bam-9518	157	96	and	and	CCONJ
bam-9518	157	97	rhizomes	rhizome	NOUN
bam-9518	157	98	of	of	ADP
bam-9518	157	99	c.	c.	NOUN
bam-9518	157	100	longa	longa	NOUN
bam-9518	157	101	,	,	PUNCT
bam-9518	157	102	and	and	CCONJ
bam-9518	157	103	z.	z.	PROPN
bam-9518	157	104	officinale.20	officinale.20	PROPN
bam-9518	157	105	allicin	allicin	NOUN
bam-9518	157	106	,	,	PUNCT
bam-9518	157	107	curcumin	curcumin	NOUN
bam-9518	157	108	and	and	CCONJ
bam-9518	157	109	gingerol	gingerol	NOUN
bam-9518	157	110	have	have	AUX
bam-9518	157	111	been	be	AUX
bam-9518	157	112	listed	list	VERB
bam-9518	157	113	by	by	ADP
bam-9518	157	114	the	the	DET
bam-9518	157	115	phytochemical	phytochemical	ADJ
bam-9518	157	116	and	and	CCONJ
bam-9518	157	117	ethnobotanical	ethnobotanical	ADJ
bam-9518	157	118	databases	database	NOUN
bam-9518	157	119	as	as	ADP
bam-9518	157	120	the	the	DET
bam-9518	157	121	key	key	ADJ
bam-9518	157	122	phytochemicals	phytochemical	NOUN
bam-9518	157	123	in	in	ADP
bam-9518	157	124	cloves	clove	NOUN
bam-9518	157	125	a.	a.	NOUN
bam-9518	157	126	sativum	sativum	PROPN
bam-9518	157	127	and	and	CCONJ
bam-9518	157	128	rhizomes	rhizome	NOUN
bam-9518	157	129	of	of	ADP
bam-9518	157	130	c.	c.	NOUN
bam-9518	157	131	longa	longa	NOUN
bam-9518	157	132	,	,	PUNCT
bam-9518	157	133	and	and	CCONJ
bam-9518	157	134	z.	z.	PROPN
bam-9518	157	135	officinale.20	officinale.20	PROPN
bam-9518	157	136	compounds	compound	NOUN
bam-9518	157	137	have	have	AUX
bam-9518	157	138	been	be	AUX
bam-9518	157	139	retrieved	retrieve	VERB
bam-9518	157	140	from	from	ADP
bam-9518	157	141	the	the	DET
bam-9518	157	142	pubchem	pubchem	NOUN
bam-9518	157	143	database	database	NOUN
bam-9518	157	144	in	in	ADP
bam-9518	157	145	ligand	ligand	NOUN
bam-9518	157	146	file	file	NOUN
bam-9518	157	147	format	format	NOUN
bam-9518	157	148	(	(	PUNCT
bam-9518	157	149	sdf	sdf	NOUN
bam-9518	157	150	)	)	PUNCT
bam-9518	157	151	.	.	PUNCT
bam-9518	158	1	plants	plant	NOUN
bam-9518	158	2	have	have	AUX
bam-9518	158	3	been	be	AUX
bam-9518	158	4	known	know	VERB
bam-9518	158	5	as	as	ADP
bam-9518	158	6	a	a	DET
bam-9518	158	7	good	good	ADJ
bam-9518	158	8	source	source	NOUN
bam-9518	158	9	of	of	ADP
bam-9518	158	10	protease	protease	NOUN
bam-9518	158	11	inhibitors.21	inhibitors.21	NOUN
bam-9518	158	12	however	however	ADV
bam-9518	158	13	,	,	PUNCT
bam-9518	158	14	in	in	ADP
bam-9518	158	15	addition	addition	NOUN
bam-9518	158	16	to	to	ADP
bam-9518	158	17	their	their	PRON
bam-9518	158	18	antiviral	antiviral	ADJ
bam-9518	158	19	potential	potential	NOUN
bam-9518	158	20	,	,	PUNCT
bam-9518	158	21	a	a	DET
bam-9518	158	22	detailed	detailed	ADJ
bam-9518	158	23	examination	examination	NOUN
bam-9518	158	24	of	of	ADP
bam-9518	158	25	the	the	DET
bam-9518	158	26	pharmacokinetics	pharmacokinetic	NOUN
bam-9518	158	27	and	and	CCONJ
bam-9518	158	28	bioavailability	bioavailability	NOUN
bam-9518	158	29	of	of	ADP
bam-9518	158	30	the	the	DET
bam-9518	158	31	described	describe	VERB
bam-9518	158	32	compounds	compound	NOUN
bam-9518	158	33	was	be	AUX
bam-9518	158	34	required	require	VERB
bam-9518	158	35	to	to	PART
bam-9518	158	36	ensure	ensure	VERB
bam-9518	158	37	protection	protection	NOUN
bam-9518	158	38	.	.	PUNCT
bam-9518	159	1	recent	recent	ADJ
bam-9518	159	2	reports	report	NOUN
bam-9518	159	3	have	have	AUX
bam-9518	159	4	suggested	suggest	VERB
bam-9518	159	5	that	that	SCONJ
bam-9518	159	6	these	these	DET
bam-9518	159	7	phytocompounds	phytocompound	NOUN
bam-9518	159	8	could	could	AUX
bam-9518	159	9	be	be	AUX
bam-9518	159	10	valuable	valuable	ADJ
bam-9518	159	11	for	for	ADP
bam-9518	159	12	the	the	DET
bam-9518	159	13	development	development	NOUN
bam-9518	159	14	of	of	ADP
bam-9518	159	15	drugs	drug	NOUN
bam-9518	159	16	useful	useful	ADJ
bam-9518	159	17	for	for	ADP
bam-9518	159	18	the	the	DET
bam-9518	159	19	prevention	prevention	NOUN
bam-9518	159	20	of	of	ADP
bam-9518	159	21	coronavirus	coronavirus	NOUN
bam-9518	159	22	entry	entry	NOUN
bam-9518	159	23	and	and	CCONJ
bam-9518	159	24	replication.21	replication.21	VERB
bam-9518	159	25	although	although	SCONJ
bam-9518	159	26	,	,	PUNCT
bam-9518	159	27	the	the	DET
bam-9518	159	28	effectiveness	effectiveness	NOUN
bam-9518	159	29	of	of	ADP
bam-9518	159	30	allicin	allicin	NOUN
bam-9518	159	31	(	(	PUNCT
bam-9518	159	32	l	l	NOUN
bam-9518	159	33	-	-	NOUN
bam-9518	159	34	cysteine	cysteine	NOUN
bam-9518	159	35	)	)	PUNCT
bam-9518	159	36	has	have	AUX
bam-9518	159	37	been	be	AUX
bam-9518	159	38	evaluated	evaluate	VERB
bam-9518	159	39	in	in	ADP
bam-9518	159	40	vitro	vitro	X
bam-9518	159	41	,	,	PUNCT
bam-9518	159	42	no	no	DET
bam-9518	159	43	clinical	clinical	ADJ
bam-9518	159	44	study	study	NOUN
bam-9518	159	45	has	have	AUX
bam-9518	159	46	been	be	AUX
bam-9518	159	47	conducted	conduct	VERB
bam-9518	159	48	to	to	PART
bam-9518	159	49	evaluate	evaluate	VERB
bam-9518	159	50	this	this	DET
bam-9518	159	51	issue	issue	NOUN
bam-9518	159	52	.	.	PUNCT
bam-9518	160	1	in	in	ADP
bam-9518	160	2	this	this	DET
bam-9518	160	3	regard	regard	NOUN
bam-9518	160	4	,	,	PUNCT
bam-9518	160	5	this	this	DET
bam-9518	160	6	study	study	NOUN
bam-9518	160	7	is	be	AUX
bam-9518	160	8	the	the	DET
bam-9518	160	9	first	first	ADJ
bam-9518	160	10	to	to	PART
bam-9518	160	11	evaluate	evaluate	VERB
bam-9518	160	12	the	the	DET
bam-9518	160	13	effectiveness	effectiveness	NOUN
bam-9518	160	14	of	of	ADP
bam-9518	160	15	this	this	DET
bam-9518	160	16	drug	drug	NOUN
bam-9518	160	17	on	on	ADP
bam-9518	160	18	covid-19	covid-19	PROPN
bam-9518	160	19	.	.	PUNCT
bam-9518	161	1	in	in	ADP
bam-9518	161	2	the	the	DET
bam-9518	161	3	current	current	ADJ
bam-9518	161	4	study	study	NOUN
bam-9518	161	5	,	,	PUNCT
bam-9518	161	6	we	we	PRON
bam-9518	161	7	observed	observe	VERB
bam-9518	161	8	that	that	SCONJ
bam-9518	161	9	allicin	allicin	NOUN
bam-9518	161	10	(	(	PUNCT
bam-9518	161	11	l	l	NOUN
bam-9518	161	12	-	-	NOUN
bam-9518	161	13	cysteine	cysteine	NOUN
bam-9518	161	14	)	)	PUNCT
bam-9518	161	15	was	be	AUX
bam-9518	161	16	effective	effective	ADJ
bam-9518	161	17	in	in	ADP
bam-9518	161	18	improvement	improvement	NOUN
bam-9518	161	19	of	of	ADP
bam-9518	161	20	both	both	CCONJ
bam-9518	161	21	clinical	clinical	ADJ
bam-9518	161	22	and	and	CCONJ
bam-9518	161	23	laboratory	laboratory	NOUN
bam-9518	161	24	parameters	parameter	NOUN
bam-9518	161	25	in	in	ADP
bam-9518	161	26	patients	patient	NOUN
bam-9518	161	27	with	with	ADP
bam-9518	161	28	covid-19	covid-19	PROPN
bam-9518	161	29	.	.	PUNCT
bam-9518	162	1	the	the	DET
bam-9518	162	2	results	result	NOUN
bam-9518	162	3	indicated	indicate	VERB
bam-9518	162	4	that	that	SCONJ
bam-9518	162	5	allicin	allicin	NOUN
bam-9518	162	6	(	(	PUNCT
bam-9518	162	7	l	l	NOUN
bam-9518	162	8	-	-	NOUN
bam-9518	162	9	cysteine	cysteine	NOUN
bam-9518	162	10	)	)	PUNCT
bam-9518	162	11	could	could	AUX
bam-9518	162	12	improve	improve	VERB
bam-9518	162	13	the	the	DET
bam-9518	162	14	chest	chest	NOUN
bam-9518	162	15	involvement	involvement	NOUN
bam-9518	162	16	based	base	VERB
bam-9518	162	17	on	on	ADP
bam-9518	162	18	the	the	DET
bam-9518	162	19	radiological	radiological	ADJ
bam-9518	162	20	findings	finding	NOUN
bam-9518	162	21	.	.	PUNCT
bam-9518	163	1	although	although	SCONJ
bam-9518	163	2	,	,	PUNCT
bam-9518	163	3	some	some	DET
bam-9518	163	4	signs	sign	NOUN
bam-9518	163	5	and	and	CCONJ
bam-9518	163	6	symptoms	symptom	NOUN
bam-9518	163	7	might	might	AUX
bam-9518	163	8	be	be	AUX
bam-9518	163	9	reified	reify	VERB
bam-9518	163	10	during	during	ADP
bam-9518	163	11	the	the	DET
bam-9518	163	12	two	two	NUM
bam-9518	163	13	weeks	week	NOUN
bam-9518	163	14	,	,	PUNCT
bam-9518	163	15	but	but	CCONJ
bam-9518	163	16	allicin	allicin	NOUN
bam-9518	163	17	(	(	PUNCT
bam-9518	163	18	l	l	NOUN
bam-9518	163	19	-	-	NOUN
bam-9518	163	20	cysteine	cysteine	NOUN
bam-9518	163	21	)	)	PUNCT
bam-9518	163	22	could	could	AUX
bam-9518	163	23	accelerate	accelerate	VERB
bam-9518	163	24	this	this	DET
bam-9518	163	25	process	process	NOUN
bam-9518	163	26	.	.	PUNCT
bam-9518	164	1	in	in	ADP
bam-9518	164	2	addition	addition	NOUN
bam-9518	164	3	,	,	PUNCT
bam-9518	164	4	since	since	SCONJ
bam-9518	164	5	the	the	DET
bam-9518	164	6	toxicity	toxicity	NOUN
bam-9518	164	7	and	and	CCONJ
bam-9518	164	8	hyperallergic	hyperallergic	ADJ
bam-9518	164	9	reaction	reaction	NOUN
bam-9518	164	10	to	to	ADP
bam-9518	164	11	allicin	allicin	NOUN
bam-9518	164	12	(	(	PUNCT
bam-9518	164	13	l	l	NOUN
bam-9518	164	14	-	-	NOUN
bam-9518	164	15	cysteine	cysteine	NOUN
bam-9518	164	16	)	)	PUNCT
bam-9518	164	17	have	have	AUX
bam-9518	164	18	not	not	PART
bam-9518	164	19	been	be	AUX
bam-9518	164	20	reported	report	VERB
bam-9518	164	21	yet	yet	ADV
bam-9518	164	22	,	,	PUNCT
bam-9518	164	23	this	this	DET
bam-9518	164	24	drug	drug	NOUN
bam-9518	164	25	might	might	AUX
bam-9518	164	26	be	be	AUX
bam-9518	164	27	a	a	DET
bam-9518	164	28	novel	novel	ADJ
bam-9518	164	29	treatment	treatment	NOUN
bam-9518	164	30	in	in	ADP
bam-9518	164	31	clinical	clinical	ADJ
bam-9518	164	32	settings	setting	NOUN
bam-9518	164	33	.	.	PUNCT
bam-9518	165	1	fig	fig	NOUN
bam-9518	165	2	1	1	NUM
bam-9518	165	3	.	.	PUNCT
bam-9518	166	1	the	the	DET
bam-9518	166	2	results	result	NOUN
bam-9518	166	3	of	of	ADP
bam-9518	166	4	chest	chest	NOUN
bam-9518	166	5	ct	ct	NUM
bam-9518	166	6	scan	scan	VERB
bam-9518	166	7	before	before	ADV
bam-9518	166	8	(	(	PUNCT
bam-9518	166	9	a1	a1	NOUN
bam-9518	166	10	and	and	CCONJ
bam-9518	166	11	b1	b1	NOUN
bam-9518	166	12	)	)	PUNCT
bam-9518	166	13	in	in	ADP
bam-9518	166	14	comparison	comparison	NOUN
bam-9518	166	15	to	to	ADP
bam-9518	166	16	after	after	ADP
bam-9518	166	17	treatment	treatment	NOUN
bam-9518	166	18	(	(	PUNCT
bam-9518	166	19	a2	a2	PROPN
bam-9518	166	20	and	and	CCONJ
bam-9518	166	21	b2	b2	NOUN
bam-9518	166	22	)	)	PUNCT
bam-9518	166	23	with	with	ADP
bam-9518	166	24	allicin	allicin	NOUN
bam-9518	166	25	.	.	PUNCT
bam-9518	167	1	a1	a1	NOUN
bam-9518	167	2	and	and	CCONJ
bam-9518	167	3	a2	a2	PROPN
bam-9518	167	4	illustrated	illustrate	VERB
bam-9518	167	5	a	a	DET
bam-9518	167	6	65	65	NUM
bam-9518	167	7	-	-	PUNCT
bam-9518	167	8	years	year	NOUN
bam-9518	167	9	old	old	ADJ
bam-9518	167	10	man	man	NOUN
bam-9518	167	11	with	with	ADP
bam-9518	167	12	dyspnea	dyspnea	NOUN
bam-9518	167	13	and	and	CCONJ
bam-9518	167	14	fever	fever	NOUN
bam-9518	167	15	with	with	ADP
bam-9518	167	16	the	the	DET
bam-9518	167	17	chest	chest	NOUN
bam-9518	167	18	ct	ct	NUM
bam-9518	167	19	severity	severity	NOUN
bam-9518	167	20	score	score	NOUN
bam-9518	167	21	of	of	ADP
bam-9518	167	22	12	12	NUM
bam-9518	167	23	initially	initially	ADV
bam-9518	167	24	,	,	PUNCT
bam-9518	167	25	which	which	PRON
bam-9518	167	26	improve	improve	VERB
bam-9518	167	27	to	to	ADP
bam-9518	167	28	4	4	NUM
bam-9518	167	29	after	after	ADP
bam-9518	167	30	treating	treat	VERB
bam-9518	167	31	with	with	ADP
bam-9518	167	32	allicin	allicin	NOUN
bam-9518	167	33	.	.	PUNCT
bam-9518	168	1	b1	b1	NOUN
bam-9518	168	2	and	and	CCONJ
bam-9518	168	3	b2	b2	NOUN
bam-9518	168	4	illustrated	illustrate	VERB
bam-9518	168	5	71	71	NUM
bam-9518	168	6	-	-	PUNCT
bam-9518	168	7	years	year	NOUN
bam-9518	168	8	old	old	ADJ
bam-9518	168	9	man	man	NOUN
bam-9518	168	10	with	with	ADP
bam-9518	168	11	shortness	shortness	NOUN
bam-9518	168	12	of	of	ADP
bam-9518	168	13	breath	breath	NOUN
bam-9518	168	14	and	and	CCONJ
bam-9518	168	15	fever	fever	NOUN
bam-9518	168	16	with	with	ADP
bam-9518	168	17	the	the	DET
bam-9518	168	18	chest	chest	NOUN
bam-9518	168	19	ct	ct	NUM
bam-9518	168	20	severity	severity	NOUN
bam-9518	168	21	score	score	NOUN
bam-9518	168	22	of	of	ADP
bam-9518	168	23	10	10	NUM
bam-9518	168	24	initially	initially	ADV
bam-9518	168	25	,	,	PUNCT
bam-9518	168	26	which	which	PRON
bam-9518	168	27	improve	improve	VERB
bam-9518	168	28	to	to	ADP
bam-9518	168	29	4	4	NUM
bam-9518	168	30	after	after	ADP
bam-9518	168	31	treating	treat	VERB
bam-9518	168	32	with	with	ADP
bam-9518	168	33	allicin	allicin	NOUN
bam-9518	168	34	effect	effect	NOUN
bam-9518	168	35	of	of	ADP
bam-9518	168	36	allicin	allicin	NOUN
bam-9518	168	37	(	(	PUNCT
bam-9518	168	38	l	l	NOUN
bam-9518	168	39	-	-	NOUN
bam-9518	168	40	cysteine	cysteine	NOUN
bam-9518	168	41	)	)	PUNCT
bam-9518	168	42	on	on	ADP
bam-9518	168	43	covid-19	covid-19	PROPN
bam-9518	168	44	eur	eur	PROPN
bam-9518	168	45	j	j	PROPN
bam-9518	168	46	transl	transl	PROPN
bam-9518	168	47	myol	myol	ADV
bam-9518	168	48	31	31	NUM
bam-9518	168	49	(	(	PUNCT
bam-9518	168	50	2	2	NUM
bam-9518	168	51	):	):	PUNCT
bam-9518	168	52	9518	9518	NUM
bam-9518	168	53	,	,	PUNCT
bam-9518	168	54	2021	2021	NUM
bam-9518	168	55	doi	doi	NOUN
bam-9518	168	56	:	:	PUNCT
bam-9518	168	57	10.4081	10.4081	NUM
bam-9518	168	58	/	/	SYM
bam-9518	168	59	ejtm.2021.9518	ejtm.2021.9518	ADJ
bam-9518	168	60	5	5	NUM
bam-9518	168	61	in	in	ADP
bam-9518	168	62	conclusion	conclusion	NOUN
bam-9518	168	63	,	,	PUNCT
bam-9518	168	64	we	we	PRON
bam-9518	168	65	showed	show	VERB
bam-9518	168	66	that	that	SCONJ
bam-9518	168	67	allicin	allicin	NOUN
bam-9518	168	68	(	(	PUNCT
bam-9518	168	69	l	l	NOUN
bam-9518	168	70	-	-	NOUN
bam-9518	168	71	cysteine	cysteine	NOUN
bam-9518	168	72	)	)	PUNCT
bam-9518	168	73	could	could	AUX
bam-9518	168	74	significantly	significantly	ADV
bam-9518	168	75	improve	improve	VERB
bam-9518	168	76	and	and	CCONJ
bam-9518	168	77	accelerate	accelerate	VERB
bam-9518	168	78	the	the	DET
bam-9518	168	79	healing	healing	NOUN
bam-9518	168	80	process	process	NOUN
bam-9518	168	81	within	within	ADP
bam-9518	168	82	two	two	NUM
bam-9518	168	83	weeks	week	NOUN
bam-9518	168	84	of	of	ADP
bam-9518	168	85	treatment	treatment	NOUN
bam-9518	168	86	.	.	PUNCT
bam-9518	169	1	allicin	allicin	NOUN
bam-9518	169	2	(	(	PUNCT
bam-9518	169	3	l	l	NOUN
bam-9518	169	4	-	-	NOUN
bam-9518	169	5	cysteine	cysteine	NOUN
bam-9518	169	6	)	)	PUNCT
bam-9518	169	7	not	not	PART
bam-9518	169	8	only	only	ADV
bam-9518	169	9	improve	improve	VERB
bam-9518	169	10	signs	sign	NOUN
bam-9518	169	11	and	and	CCONJ
bam-9518	169	12	symptoms	symptom	NOUN
bam-9518	169	13	of	of	ADP
bam-9518	169	14	covid-19	covid-19	PROPN
bam-9518	169	15	,	,	PUNCT
bam-9518	169	16	but	but	CCONJ
bam-9518	169	17	also	also	ADV
bam-9518	169	18	could	could	AUX
bam-9518	169	19	induce	induce	VERB
bam-9518	169	20	high	high	ADJ
bam-9518	169	21	impact	impact	NOUN
bam-9518	169	22	on	on	ADP
bam-9518	169	23	both	both	CCONJ
bam-9518	169	24	laboratory	laboratory	NOUN
bam-9518	169	25	and	and	CCONJ
bam-9518	169	26	radiological	radiological	ADJ
bam-9518	169	27	findings	finding	NOUN
bam-9518	169	28	.	.	PUNCT
bam-9518	170	1	list	list	NOUN
bam-9518	170	2	of	of	ADP
bam-9518	170	3	acronyms	acronym	NOUN
bam-9518	170	4	oa	oa	NOUN
bam-9518	170	5	–	–	PUNCT
bam-9518	170	6	osteoarthritis	osteoarthritis	NOUN
bam-9518	170	7	tka	tka	NOUN
bam-9518	170	8	–	–	PUNCT
bam-9518	170	9	total	total	ADJ
bam-9518	170	10	knee	knee	NOUN
bam-9518	170	11	arthroplasty	arthroplasty	NOUN
bam-9518	170	12	sppb	sppb	NOUN
bam-9518	170	13	–	–	PUNCT
bam-9518	170	14	short	short	ADJ
bam-9518	170	15	physical	physical	ADJ
bam-9518	170	16	performance	performance	NOUN
bam-9518	170	17	battery	battery	NOUN
bam-9518	170	18	6mwt	6mwt	NUM
bam-9518	170	19	–	–	PUNCT
bam-9518	170	20	six	six	NUM
bam-9518	170	21	-	-	PUNCT
bam-9518	170	22	minute	minute	NOUN
bam-9518	170	23	walk	walk	NOUN
bam-9518	170	24	test	test	NOUN
bam-9518	170	25	authors	author	NOUN
bam-9518	170	26	contributions	contribution	VERB
bam-9518	170	27	hy	hy	PROPN
bam-9518	170	28	,	,	PUNCT
bam-9518	170	29	se	se	X
bam-9518	170	30	,	,	PUNCT
bam-9518	170	31	hn	hn	PROPN
bam-9518	170	32	,	,	PUNCT
bam-9518	170	33	apy	apy	PROPN
bam-9518	170	34	,	,	PUNCT
bam-9518	170	35	vgh	vgh	PROPN
bam-9518	170	36	,	,	PUNCT
bam-9518	170	37	mmr	mmr	PROPN
bam-9518	170	38	,	,	PUNCT
bam-9518	170	39	and	and	CCONJ
bam-9518	170	40	amh	amh	PROPN
bam-9518	170	41	conceived	conceive	VERB
bam-9518	170	42	and	and	CCONJ
bam-9518	170	43	designed	design	VERB
bam-9518	170	44	the	the	DET
bam-9518	170	45	experiments	experiment	NOUN
bam-9518	170	46	,	,	PUNCT
bam-9518	170	47	performed	perform	VERB
bam-9518	170	48	the	the	DET
bam-9518	170	49	data	data	NOUN
bam-9518	170	50	analyses	analysis	NOUN
bam-9518	170	51	and	and	CCONJ
bam-9518	170	52	wrote	write	VERB
bam-9518	170	53	the	the	DET
bam-9518	170	54	paper	paper	NOUN
bam-9518	170	55	.	.	PUNCT
bam-9518	171	1	all	all	DET
bam-9518	171	2	authors	author	NOUN
bam-9518	171	3	have	have	AUX
bam-9518	171	4	read	read	VERB
bam-9518	171	5	and	and	CCONJ
bam-9518	171	6	approved	approve	VERB
bam-9518	171	7	the	the	DET
bam-9518	171	8	manuscript	manuscript	NOUN
bam-9518	171	9	.	.	PUNCT
bam-9518	172	1	availability	availability	NOUN
bam-9518	172	2	of	of	ADP
bam-9518	172	3	data	datum	NOUN
bam-9518	172	4	and	and	CCONJ
bam-9518	172	5	materials	material	NOUN
bam-9518	172	6	the	the	DET
bam-9518	172	7	datasets	dataset	NOUN
bam-9518	172	8	used	use	VERB
bam-9518	172	9	and/or	and/or	CCONJ
bam-9518	172	10	analysed	analyse	VERB
bam-9518	172	11	during	during	ADP
bam-9518	172	12	the	the	DET
bam-9518	172	13	current	current	ADJ
bam-9518	172	14	study	study	NOUN
bam-9518	172	15	are	be	AUX
bam-9518	172	16	available	available	ADJ
bam-9518	172	17	from	from	ADP
bam-9518	172	18	the	the	DET
bam-9518	172	19	corresponding	corresponding	ADJ
bam-9518	172	20	author	author	NOUN
bam-9518	172	21	on	on	ADP
bam-9518	172	22	reasonable	reasonable	ADJ
bam-9518	172	23	request	request	NOUN
bam-9518	172	24	.	.	PUNCT
bam-9518	173	1	acknowledgments	acknowledgment	NOUN
bam-9518	173	2	this	this	DET
bam-9518	173	3	research	research	NOUN
bam-9518	173	4	is	be	AUX
bam-9518	173	5	the	the	DET
bam-9518	173	6	result	result	NOUN
bam-9518	173	7	of	of	ADP
bam-9518	173	8	a	a	DET
bam-9518	173	9	student	student	NOUN
bam-9518	173	10	thesis	thesis	NOUN
bam-9518	173	11	of	of	ADP
bam-9518	173	12	mashhad	mashhad	PROPN
bam-9518	173	13	university	university	PROPN
bam-9518	173	14	of	of	ADP
bam-9518	173	15	medical	medical	ADJ
bam-9518	173	16	sciences	science	NOUN
bam-9518	173	17	.	.	PUNCT
bam-9518	174	1	authors	author	NOUN
bam-9518	174	2	thank	thank	AUX
bam-9518	174	3	saeideh	saeideh	VERB
bam-9518	174	4	ebrahimpour	ebrahimpour	ADV
bam-9518	174	5	for	for	ADP
bam-9518	174	6	her	her	PRON
bam-9518	174	7	help	help	NOUN
bam-9518	174	8	in	in	ADP
bam-9518	174	9	this	this	DET
bam-9518	174	10	study	study	NOUN
bam-9518	174	11	funding	fund	VERB
bam-9518	174	12	none	none	NOUN
bam-9518	174	13	.	.	PUNCT
bam-9518	175	1	conflict	conflict	NOUN
bam-9518	175	2	of	of	ADP
bam-9518	175	3	interest	interest	NOUN
bam-9518	175	4	the	the	DET
bam-9518	175	5	author	author	NOUN
bam-9518	175	6	declares	declare	VERB
bam-9518	175	7	no	no	DET
bam-9518	175	8	competing	compete	VERB
bam-9518	175	9	interests	interest	NOUN
bam-9518	175	10	.	.	PUNCT
bam-9518	176	1	ethical	ethical	ADJ
bam-9518	176	2	publication	publication	NOUN
bam-9518	176	3	statement	statement	NOUN
bam-9518	176	4	we	we	PRON
bam-9518	176	5	confirm	confirm	VERB
bam-9518	176	6	that	that	SCONJ
bam-9518	176	7	we	we	PRON
bam-9518	176	8	have	have	AUX
bam-9518	176	9	read	read	VERB
bam-9518	176	10	the	the	DET
bam-9518	176	11	journal	journal	NOUN
bam-9518	176	12	's	's	PART
bam-9518	176	13	position	position	NOUN
bam-9518	176	14	on	on	ADP
bam-9518	176	15	the	the	DET
bam-9518	176	16	issues	issue	NOUN
bam-9518	176	17	involved	involve	VERB
bam-9518	176	18	in	in	ADP
bam-9518	176	19	ethical	ethical	ADJ
bam-9518	176	20	publication	publication	NOUN
bam-9518	176	21	and	and	CCONJ
bam-9518	176	22	affirm	affirm	NOUN
bam-9518	176	23	that	that	SCONJ
bam-9518	176	24	this	this	DET
bam-9518	176	25	report	report	NOUN
bam-9518	176	26	is	be	AUX
bam-9518	176	27	consistent	consistent	ADJ
bam-9518	176	28	with	with	ADP
bam-9518	176	29	those	those	DET
bam-9518	176	30	guidelines	guideline	NOUN
bam-9518	176	31	.	.	PUNCT
bam-9518	177	1	corresponding	correspond	VERB
bam-9518	177	2	author	author	NOUN
bam-9518	177	3	amir	amir	PROPN
bam-9518	177	4	masoud	masoud	PROPN
bam-9518	177	5	hashemian	hashemian	PROPN
bam-9518	177	6	,	,	PUNCT
bam-9518	177	7	department	department	NOUN
bam-9518	177	8	of	of	ADP
bam-9518	177	9	emergency	emergency	NOUN
bam-9518	177	10	medicine	medicine	NOUN
bam-9518	177	11	,	,	PUNCT
bam-9518	177	12	faculty	faculty	NOUN
bam-9518	177	13	of	of	ADP
bam-9518	177	14	medicine	medicine	NOUN
bam-9518	177	15	,	,	PUNCT
bam-9518	177	16	mashhad	mashhad	PROPN
bam-9518	177	17	university	university	PROPN
bam-9518	177	18	of	of	ADP
bam-9518	177	19	medical	medical	ADJ
bam-9518	177	20	sciences	sciences	PROPN
bam-9518	177	21	,	,	PUNCT
bam-9518	177	22	mashhad	mashhad	PROPN
bam-9518	177	23	,	,	PUNCT
bam-9518	177	24	iran	iran	PROPN
bam-9518	177	25	.	.	PUNCT
bam-9518	178	1	phone	phone	NOUN
bam-9518	178	2	:	:	PUNCT
bam-9518	178	3	00989124244517	00989124244517	NUM
bam-9518	178	4	.	.	PUNCT
bam-9518	179	1	orcid	orcid	NOUN
bam-9518	180	1	i	i	PRON
bam-9518	180	2	d	d	NOUN
bam-9518	180	3	:	:	PUNCT
bam-9518	180	4	0000	0000	NUM
bam-9518	180	5	-	-	PUNCT
bam-9518	180	6	0001	0001	NUM
bam-9518	180	7	-	-	PUNCT
bam-9518	180	8	5668	5668	NUM
bam-9518	180	9	-	-	PUNCT
bam-9518	180	10	6599	6599	NUM
bam-9518	180	11	email	email	NOUN
bam-9518	180	12	:	:	PUNCT
bam-9518	180	13	hashemianam11@gmail.com	hashemianam11@gmail.com	X
bam-9518	180	14	e	e	NOUN
bam-9518	180	15	-	-	NOUN
bam-9518	180	16	mails	mail	NOUN
bam-9518	180	17	and	and	CCONJ
bam-9518	180	18	orcid	orcid	NOUN
bam-9518	181	1	i	i	INTJ
bam-9518	181	2	d	d	PROPN
bam-9518	181	3	of	of	ADP
bam-9518	181	4	coauthors	coauthor	NOUN
bam-9518	181	5	hosein	hosein	PROPN
bam-9518	181	6	yaghoubian	yaghoubian	PROPN
bam-9518	181	7	:	:	PUNCT
bam-9518	181	8	yaghoubianh1@mums.ac.ir	yaghoubianh1@mums.ac.ir	ADJ
bam-9518	181	9	orcid	orcid	NOUN
bam-9518	182	1	i	i	PRON
bam-9518	182	2	d	d	NOUN
bam-9518	182	3	:	:	PUNCT
bam-9518	182	4	0000	0000	NUM
bam-9518	182	5	-	-	PUNCT
bam-9518	182	6	0002	0002	NUM
bam-9518	182	7	-	-	PUNCT
bam-9518	182	8	1110	1110	NUM
bam-9518	182	9	-	-	PUNCT
bam-9518	182	10	9939	9939	NUM
bam-9518	182	11	hossein	hossein	PROPN
bam-9518	182	12	niktale	niktale	PROPN
bam-9518	182	13	:	:	PUNCT
bam-9518	182	14	hoseen.nikta@gmail.com	hoseen.nikta@gmail.com	X
bam-9518	182	15	orcid	orcid	NOUN
bam-9518	183	1	i	i	INTJ
bam-9518	183	2	d	d	NOUN
bam-9518	183	3	:	:	PUNCT
bam-9518	183	4	0000	0000	NUM
bam-9518	183	5	-	-	PUNCT
bam-9518	183	6	0002	0002	NUM
bam-9518	183	7	-	-	PUNCT
bam-9518	183	8	5345	5345	NUM
bam-9518	183	9	-	-	PUNCT
bam-9518	183	10	196x	196x	PROPN
bam-9518	183	11	arash	arash	PROPN
bam-9518	183	12	peivandi	peivandi	PROPN
bam-9518	183	13	yazdi	yazdi	NOUN
bam-9518	183	14	:	:	PUNCT
bam-9518	183	15	peivandia@mums.ac.ir	peivandia@mums.ac.ir	ADJ
bam-9518	183	16	orcid	orcid	NOUN
bam-9518	184	1	i	i	NOUN
bam-9518	184	2	d	d	NOUN
bam-9518	184	3	:	:	PUNCT
bam-9518	184	4	0000	0000	NUM
bam-9518	184	5	-	-	PUNCT
bam-9518	184	6	0002	0002	NUM
bam-9518	184	7	-	-	PUNCT
bam-9518	184	8	8274	8274	NUM
bam-9518	184	9	-	-	PUNCT
bam-9518	184	10	6783	6783	NUM
bam-9518	184	11	vahideh	vahideh	NOUN
bam-9518	184	12	ghorani	ghorani	NOUN
bam-9518	184	13	:	:	PUNCT
bam-9518	184	14	ghoranisv@mums.ac.ir	ghoranisv@mums.ac.ir	ADJ
bam-9518	184	15	orcid	orcid	NOUN
bam-9518	185	1	i	i	NOUN
bam-9518	185	2	d	d	NOUN
bam-9518	185	3	:	:	PUNCT
bam-9518	185	4	0000	0000	NUM
bam-9518	185	5	-	-	PUNCT
bam-9518	185	6	0001	0001	NUM
bam-9518	185	7	-	-	PUNCT
bam-9518	185	8	6883	6883	NUM
bam-9518	185	9	-	-	SYM
bam-9518	185	10	7972	7972	NUM
bam-9518	185	11	masoud	masoud	PROPN
bam-9518	185	12	mahdavi	mahdavi	PROPN
bam-9518	185	13	rashed	rashe	VERB
bam-9518	185	14	:	:	PUNCT
bam-9518	185	15	mahdavirm@mums.ac.ir	mahdavirm@mums.ac.ir	NOUN
bam-9518	185	16	orcid	orcid	NOUN
bam-9518	185	17	i	i	NOUN
bam-9518	185	18	d	d	NOUN
bam-9518	185	19	:	:	PUNCT
bam-9518	185	20	0000	0000	NUM
bam-9518	185	21	-	-	PUNCT
bam-9518	185	22	0003	0003	NUM
bam-9518	185	23	-	-	PUNCT
bam-9518	185	24	4594	4594	NUM
bam-9518	185	25	-	-	SYM
bam-9518	185	26	9095	9095	NUM
bam-9518	185	27	references	reference	NOUN
bam-9518	185	28	1	1	NUM
bam-9518	185	29	.	.	PUNCT
bam-9518	186	1	wang	wang	PROPN
bam-9518	186	2	c	c	PROPN
bam-9518	186	3	,	,	PUNCT
bam-9518	186	4	horby	horby	PROPN
bam-9518	186	5	pw	pw	PROPN
bam-9518	186	6	,	,	PUNCT
bam-9518	186	7	hayden	hayden	PROPN
bam-9518	186	8	fg	fg	PROPN
bam-9518	186	9	,	,	PUNCT
bam-9518	186	10	gao	gao	PROPN
bam-9518	186	11	gf	gf	PROPN
bam-9518	186	12	.	.	PUNCT
bam-9518	187	1	a	a	DET
bam-9518	187	2	novel	novel	ADJ
bam-9518	187	3	coronavirus	coronavirus	NOUN
bam-9518	187	4	outbreak	outbreak	NOUN
bam-9518	187	5	of	of	ADP
bam-9518	187	6	global	global	ADJ
bam-9518	187	7	health	health	NOUN
bam-9518	187	8	concern	concern	NOUN
bam-9518	187	9	.	.	PUNCT
bam-9518	188	1	lancet	lancet	PROPN
bam-9518	188	2	.	.	PUNCT
bam-9518	189	1	2020	2020	NUM
bam-9518	189	2	feb	feb	X
bam-9518	189	3	15;395(10223):470	15;395(10223):470	NUM
bam-9518	189	4	-	-	SYM
bam-9518	189	5	473	473	NUM
bam-9518	189	6	.	.	PUNCT
bam-9518	190	1	doi	doi	NOUN
bam-9518	190	2	:	:	PUNCT
bam-9518	190	3	10.1016	10.1016	NUM
bam-9518	190	4	/	/	SYM
bam-9518	190	5	s0140	s0140	PROPN
bam-9518	190	6	-	-	PUNCT
bam-9518	190	7	6736(20)30185	6736(20)30185	NUM
bam-9518	190	8	-	-	PUNCT
bam-9518	190	9	9	9	NUM
bam-9518	190	10	.	.	PUNCT
bam-9518	191	1	epub	epub	PROPN
bam-9518	191	2	2020	2020	NUM
bam-9518	191	3	jan	jan	PROPN
bam-9518	191	4	24	24	NUM
bam-9518	191	5	.	.	PUNCT
bam-9518	191	6	erratum	erratum	PROPN
bam-9518	191	7	in	in	ADP
bam-9518	191	8	:	:	PUNCT
bam-9518	191	9	lancet	lancet	PROPN
bam-9518	191	10	.	.	PUNCT
bam-9518	192	1	2020	2020	NUM
bam-9518	192	2	jan	jan	PROPN
bam-9518	192	3	29	29	NUM
bam-9518	192	4	.	.	PUNCT
bam-9518	193	1	2	2	NUM
bam-9518	193	2	.	.	X
bam-9518	193	3	bhimraj	bhimraj	PROPN
bam-9518	193	4	a	a	PRON
bam-9518	193	5	,	,	PUNCT
bam-9518	193	6	morgan	morgan	PROPN
bam-9518	193	7	rl	rl	PROPN
bam-9518	193	8	,	,	PUNCT
bam-9518	193	9	shumaker	shumaker	PROPN
bam-9518	193	10	ah	ah	INTJ
bam-9518	193	11	,	,	PUNCT
bam-9518	193	12	lavergne	lavergne	PROPN
bam-9518	193	13	v	v	PROPN
bam-9518	193	14	,	,	PUNCT
bam-9518	193	15	baden	baden	PROPN
bam-9518	193	16	l	l	PROPN
bam-9518	193	17	,	,	PUNCT
bam-9518	193	18	cheng	cheng	PROPN
bam-9518	193	19	vc	vc	PROPN
bam-9518	193	20	,	,	PUNCT
bam-9518	193	21	et	et	PROPN
bam-9518	193	22	al	al	PROPN
bam-9518	193	23	.	.	PROPN
bam-9518	194	1	infectious	infectious	ADJ
bam-9518	194	2	diseases	disease	NOUN
bam-9518	194	3	society	society	PROPN
bam-9518	194	4	of	of	ADP
bam-9518	194	5	america	america	PROPN
bam-9518	194	6	guidelines	guideline	NOUN
bam-9518	194	7	on	on	ADP
bam-9518	194	8	the	the	DET
bam-9518	194	9	treatment	treatment	NOUN
bam-9518	194	10	and	and	CCONJ
bam-9518	194	11	management	management	NOUN
bam-9518	194	12	of	of	ADP
bam-9518	194	13	patients	patient	NOUN
bam-9518	194	14	with	with	ADP
bam-9518	194	15	covid-19	covid-19	PROPN
bam-9518	194	16	.	.	PUNCT
bam-9518	195	1	clinical	clinical	ADJ
bam-9518	195	2	infectious	infectious	ADJ
bam-9518	195	3	diseases	disease	NOUN
bam-9518	195	4	:	:	PUNCT
bam-9518	195	5	an	an	DET
bam-9518	195	6	official	official	ADJ
bam-9518	195	7	publication	publication	NOUN
bam-9518	195	8	of	of	ADP
bam-9518	195	9	the	the	DET
bam-9518	195	10	infectious	infectious	ADJ
bam-9518	195	11	diseases	disease	NOUN
bam-9518	195	12	society	society	NOUN
bam-9518	195	13	of	of	ADP
bam-9518	195	14	america	america	PROPN
bam-9518	195	15	.	.	PUNCT
bam-9518	196	1	2020	2020	NUM
bam-9518	196	2	.	.	PUNCT
bam-9518	197	1	3	3	X
bam-9518	197	2	.	.	X
bam-9518	197	3	wang	wang	PROPN
bam-9518	197	4	d	d	PROPN
bam-9518	197	5	,	,	PUNCT
bam-9518	197	6	hu	hu	PROPN
bam-9518	197	7	b	b	PROPN
bam-9518	197	8	,	,	PUNCT
bam-9518	197	9	hu	hu	PROPN
bam-9518	197	10	c	c	PROPN
bam-9518	197	11	,	,	PUNCT
bam-9518	197	12	zhu	zhu	PROPN
bam-9518	197	13	f	f	X
bam-9518	197	14	,	,	PUNCT
bam-9518	197	15	liu	liu	PROPN
bam-9518	197	16	x	x	PROPN
bam-9518	197	17	,	,	PUNCT
bam-9518	197	18	zhang	zhang	PROPN
bam-9518	197	19	j	j	PROPN
bam-9518	197	20	,	,	PUNCT
bam-9518	197	21	wang	wang	PROPN
bam-9518	197	22	b	b	PROPN
bam-9518	197	23	,	,	PUNCT
bam-9518	197	24	xiang	xiang	PROPN
bam-9518	197	25	h	h	PROPN
bam-9518	197	26	,	,	PUNCT
bam-9518	197	27	cheng	cheng	PROPN
bam-9518	197	28	z	z	PROPN
bam-9518	197	29	,	,	PUNCT
bam-9518	197	30	xiong	xiong	PROPN
bam-9518	197	31	y	y	PROPN
bam-9518	197	32	,	,	PUNCT
bam-9518	197	33	zhao	zhao	PROPN
bam-9518	197	34	y	y	PROPN
bam-9518	197	35	,	,	PUNCT
bam-9518	197	36	li	li	PROPN
bam-9518	197	37	y	y	PROPN
bam-9518	197	38	,	,	PUNCT
bam-9518	197	39	wang	wang	PROPN
bam-9518	197	40	x	x	PROPN
bam-9518	197	41	,	,	PUNCT
bam-9518	197	42	peng	peng	PROPN
bam-9518	197	43	z.	z.	PROPN
bam-9518	197	44	clinical	clinical	PROPN
bam-9518	197	45	characteristics	characteristic	NOUN
bam-9518	197	46	of	of	ADP
bam-9518	197	47	138	138	NUM
bam-9518	197	48	hospitalized	hospitalize	VERB
bam-9518	197	49	patients	patient	NOUN
bam-9518	197	50	with	with	ADP
bam-9518	197	51	2019	2019	NUM
bam-9518	197	52	novel	novel	ADJ
bam-9518	197	53	coronavirus	coronavirus	NOUN
bam-9518	197	54	-	-	PUNCT
bam-9518	197	55	infected	infect	VERB
bam-9518	197	56	pneumonia	pneumonia	NOUN
bam-9518	197	57	in	in	ADP
bam-9518	197	58	wuhan	wuhan	PROPN
bam-9518	197	59	,	,	PUNCT
bam-9518	197	60	china	china	PROPN
bam-9518	197	61	.	.	PUNCT
bam-9518	198	1	jama	jama	PROPN
bam-9518	198	2	.	.	PUNCT
bam-9518	199	1	2020	2020	NUM
bam-9518	199	2	mar	mar	PROPN
bam-9518	199	3	17;323(11):1061	17;323(11):1061	NUM
bam-9518	199	4	-	-	SYM
bam-9518	199	5	1069	1069	NUM
bam-9518	199	6	.	.	PUNCT
bam-9518	200	1	doi	doi	NOUN
bam-9518	200	2	:	:	PUNCT
bam-9518	200	3	10.1001	10.1001	NUM
bam-9518	200	4	/	/	SYM
bam-9518	200	5	jama.2020.1585	jama.2020.1585	PROPN
bam-9518	200	6	.	.	PUNCT
bam-9518	201	1	erratum	erratum	PROPN
bam-9518	201	2	in	in	ADP
bam-9518	201	3	:	:	PUNCT
bam-9518	201	4	jama	jama	PROPN
bam-9518	201	5	.	.	PUNCT
bam-9518	202	1	2021	2021	NUM
bam-9518	202	2	mar	mar	PROPN
bam-9518	202	3	16;325(11):1113	16;325(11):1113	PROPN
bam-9518	202	4	.	.	PUNCT
bam-9518	203	1	4	4	NUM
bam-9518	203	2	.	.	X
bam-9518	203	3	oso	oso	NOUN
bam-9518	203	4	bj	bj	PROPN
bam-9518	203	5	,	,	PUNCT
bam-9518	203	6	adeoye	adeoye	VERB
bam-9518	203	7	ao	ao	PROPN
bam-9518	203	8	,	,	PUNCT
bam-9518	203	9	olaoye	olaoye	VERB
bam-9518	203	10	if	if	SCONJ
bam-9518	203	11	.	.	PUNCT
bam-9518	204	1	pharmacoinformatics	pharmacoinformatic	NOUN
bam-9518	204	2	and	and	CCONJ
bam-9518	204	3	hypothetical	hypothetical	ADJ
bam-9518	204	4	studies	study	NOUN
bam-9518	204	5	on	on	ADP
bam-9518	204	6	allicin	allicin	NOUN
bam-9518	204	7	,	,	PUNCT
bam-9518	204	8	curcumin	curcumin	NOUN
bam-9518	204	9	,	,	PUNCT
bam-9518	204	10	and	and	CCONJ
bam-9518	204	11	gingerol	gingerol	VERB
bam-9518	204	12	as	as	ADP
bam-9518	204	13	potential	potential	ADJ
bam-9518	204	14	candidates	candidate	NOUN
bam-9518	204	15	against	against	ADP
bam-9518	204	16	covid-19	covid-19	PROPN
bam-9518	204	17	-	-	PUNCT
bam-9518	204	18	associated	associate	VERB
bam-9518	204	19	proteases	protease	NOUN
bam-9518	204	20	.	.	PUNCT
bam-9518	205	1	j	j	PROPN
bam-9518	205	2	biomol	biomol	PROPN
bam-9518	205	3	struct	struct	NOUN
bam-9518	205	4	dyn	dyn	NOUN
bam-9518	205	5	.	.	PUNCT
bam-9518	206	1	2020	2020	NUM
bam-9518	206	2	sep	sep	NOUN
bam-9518	206	3	2:1	2:1	NUM
bam-9518	206	4	-	-	SYM
bam-9518	206	5	12	12	NUM
bam-9518	206	6	.	.	PUNCT
bam-9518	207	1	doi	doi	NOUN
bam-9518	207	2	:	:	PUNCT
bam-9518	207	3	10.1080/07391102.2020.1813630	10.1080/07391102.2020.1813630	NUM
bam-9518	207	4	.	.	PUNCT
bam-9518	208	1	epub	epub	NOUN
bam-9518	208	2	ahead	ahead	ADV
bam-9518	208	3	of	of	ADP
bam-9518	208	4	print	print	NOUN
bam-9518	208	5	.	.	PUNCT
bam-9518	209	1	5	5	X
bam-9518	209	2	.	.	X
bam-9518	209	3	cdc	cdc	PROPN
bam-9518	209	4	covid-19	covid-19	PROPN
bam-9518	209	5	response	response	NOUN
bam-9518	209	6	team	team	NOUN
bam-9518	209	7	.	.	PUNCT
bam-9518	210	1	severe	severe	ADJ
bam-9518	210	2	outcomes	outcome	NOUN
bam-9518	210	3	among	among	ADP
bam-9518	210	4	patients	patient	NOUN
bam-9518	210	5	with	with	ADP
bam-9518	210	6	coronavirus	coronavirus	NOUN
bam-9518	210	7	disease	disease	NOUN
bam-9518	210	8	2019	2019	NUM
bam-9518	210	9	(	(	PUNCT
bam-9518	210	10	covid-19	covid-19	PROPN
bam-9518	210	11	)	)	PUNCT
bam-9518	210	12	united	united	PROPN
bam-9518	210	13	states	states	PROPN
bam-9518	210	14	,	,	PUNCT
bam-9518	210	15	february	february	PROPN
bam-9518	210	16	12	12	NUM
bam-9518	210	17	-	-	PUNCT
bam-9518	210	18	march	march	NOUN
bam-9518	210	19	16	16	NUM
bam-9518	210	20	,	,	PUNCT
bam-9518	210	21	2020	2020	NUM
bam-9518	210	22	.	.	PUNCT
bam-9518	211	1	mmwr	mmwr	ADJ
bam-9518	211	2	morb	morb	NOUN
bam-9518	211	3	mortal	mortal	ADJ
bam-9518	211	4	wkly	wkly	PROPN
bam-9518	211	5	rep	rep	PROPN
bam-9518	211	6	.	.	PROPN
bam-9518	211	7	2020	2020	NUM
bam-9518	211	8	mar	mar	PROPN
bam-9518	211	9	27;69(12):343	27;69(12):343	NUM
bam-9518	211	10	-	-	SYM
bam-9518	211	11	346	346	NUM
bam-9518	211	12	.	.	PUNCT
bam-9518	212	1	doi	doi	NOUN
bam-9518	212	2	:	:	PUNCT
bam-9518	212	3	10.15585	10.15585	NUM
bam-9518	212	4	/	/	SYM
bam-9518	212	5	mmwr.mm6912e2	mmwr.mm6912e2	PROPN
bam-9518	212	6	.	.	PROPN
bam-9518	213	1	6	6	NUM
bam-9518	213	2	.	.	PUNCT
bam-9518	214	1	mehta	mehta	PROPN
bam-9518	214	2	p	p	PROPN
bam-9518	214	3	,	,	PUNCT
bam-9518	214	4	mcauley	mcauley	PROPN
bam-9518	214	5	df	df	PROPN
bam-9518	214	6	,	,	PUNCT
bam-9518	214	7	brown	brown	PROPN
bam-9518	214	8	m	m	PROPN
bam-9518	214	9	,	,	PUNCT
bam-9518	214	10	sanchez	sanchez	PROPN
bam-9518	214	11	e	e	NOUN
bam-9518	214	12	,	,	PUNCT
bam-9518	214	13	tattersall	tattersall	NOUN
bam-9518	214	14	rs	rs	NOUN
bam-9518	214	15	,	,	PUNCT
bam-9518	214	16	manson	manson	PROPN
bam-9518	214	17	jj	jj	PROPN
bam-9518	214	18	;	;	PUNCT
bam-9518	214	19	hlh	hlh	NOUN
bam-9518	214	20	across	across	ADP
bam-9518	214	21	speciality	speciality	NOUN
bam-9518	214	22	collaboration	collaboration	NOUN
bam-9518	214	23	,	,	PUNCT
bam-9518	214	24	uk	uk	PROPN
bam-9518	214	25	.	.	PUNCT
bam-9518	214	26	covid-19	covid-19	PROPN
bam-9518	214	27	:	:	PUNCT
bam-9518	214	28	consider	consider	VERB
bam-9518	214	29	cytokine	cytokine	ADJ
bam-9518	214	30	storm	storm	NOUN
bam-9518	214	31	syndromes	syndrome	NOUN
bam-9518	214	32	and	and	CCONJ
bam-9518	214	33	immunosuppression	immunosuppression	NOUN
bam-9518	214	34	.	.	PUNCT
bam-9518	215	1	lancet	lancet	NOUN
bam-9518	215	2	.	.	PUNCT
bam-9518	216	1	2020	2020	NUM
bam-9518	216	2	mar	mar	PROPN
bam-9518	216	3	28;395(10229):1033	28;395(10229):1033	PROPN
bam-9518	216	4	-	-	SYM
bam-9518	216	5	1034	1034	NUM
bam-9518	216	6	.	.	PUNCT
bam-9518	217	1	doi	doi	NOUN
bam-9518	217	2	:	:	PUNCT
bam-9518	217	3	10.1016	10.1016	NUM
bam-9518	217	4	/	/	SYM
bam-9518	217	5	s0140	s0140	PROPN
bam-9518	217	6	-	-	PUNCT
bam-9518	217	7	6736(20)30628	6736(20)30628	NUM
bam-9518	217	8	-	-	PUNCT
bam-9518	217	9	0	0	NUM
bam-9518	217	10	.	.	PUNCT
bam-9518	218	1	epub	epub	PROPN
bam-9518	218	2	2020	2020	NUM
bam-9518	218	3	mar	mar	PROPN
bam-9518	218	4	16	16	NUM
bam-9518	218	5	.	.	PUNCT
bam-9518	219	1	7	7	X
bam-9518	219	2	.	.	X
bam-9518	219	3	nishiura	nishiura	PROPN
bam-9518	219	4	h	h	PROPN
bam-9518	219	5	,	,	PUNCT
bam-9518	219	6	oshitani	oshitani	ADJ
bam-9518	219	7	h	h	NOUN
bam-9518	219	8	,	,	PUNCT
bam-9518	219	9	kobayashi	kobayashi	PROPN
bam-9518	219	10	t	t	PROPN
bam-9518	219	11	,	,	PUNCT
bam-9518	219	12	saito	saito	PROPN
bam-9518	219	13	t	t	PROPN
bam-9518	219	14	,	,	PUNCT
bam-9518	219	15	sunagawa	sunagawa	PROPN
bam-9518	219	16	t	t	PROPN
bam-9518	219	17	,	,	PUNCT
bam-9518	219	18	matsui	matsui	PROPN
bam-9518	219	19	t	t	PROPN
bam-9518	219	20	,	,	PUNCT
bam-9518	219	21	wakita	wakita	PROPN
bam-9518	219	22	t	t	PROPN
bam-9518	219	23	,	,	PUNCT
bam-9518	219	24	covid	covid	PROPN
bam-9518	219	25	m	m	PROPN
bam-9518	219	26	,	,	PUNCT
bam-9518	219	27	suzuki	suzuki	PROPN
bam-9518	219	28	m.	m.	PROPN
bam-9518	219	29	closed	close	VERB
bam-9518	219	30	environments	environment	NOUN
bam-9518	219	31	facilitate	facilitate	VERB
bam-9518	219	32	secondary	secondary	ADJ
bam-9518	219	33	transmission	transmission	NOUN
bam-9518	219	34	of	of	ADP
bam-9518	219	35	coronavirus	coronavirus	NOUN
bam-9518	219	36	disease	disease	NOUN
bam-9518	219	37	2019	2019	NUM
bam-9518	219	38	(	(	PUNCT
bam-9518	219	39	covid-19	covid-19	PROPN
bam-9518	219	40	)	)	PUNCT
bam-9518	219	41	.	.	PUNCT
bam-9518	220	1	medrxiv	medrxiv	PROPN
bam-9518	220	2	.	.	PUNCT
bam-9518	220	3	2020	2020	NUM
bam-9518	220	4	jan	jan	PROPN
bam-9518	220	5	1	1	NUM
bam-9518	220	6	.	.	NOUN
bam-9518	220	7	8	8	NUM
bam-9518	220	8	.	.	PUNCT
bam-9518	221	1	bai	bai	PROPN
bam-9518	221	2	y	y	PROPN
bam-9518	221	3	,	,	PUNCT
bam-9518	221	4	yao	yao	PROPN
bam-9518	221	5	l	l	PROPN
bam-9518	221	6	,	,	PUNCT
bam-9518	221	7	wei	wei	PROPN
bam-9518	221	8	t	t	PROPN
bam-9518	221	9	,	,	PUNCT
bam-9518	221	10	tian	tian	PROPN
bam-9518	221	11	f	f	PROPN
bam-9518	221	12	,	,	PUNCT
bam-9518	221	13	jin	jin	PROPN
bam-9518	221	14	dy	dy	PROPN
bam-9518	221	15	,	,	PUNCT
bam-9518	221	16	chen	chen	PROPN
bam-9518	221	17	l	l	PROPN
bam-9518	221	18	,	,	PUNCT
bam-9518	221	19	wang	wang	PROPN
bam-9518	221	20	m.	m.	PROPN
bam-9518	221	21	presumed	presume	VERB
bam-9518	221	22	asymptomatic	asymptomatic	ADJ
bam-9518	221	23	carrier	carrier	NOUN
bam-9518	221	24	transmission	transmission	NOUN
bam-9518	221	25	of	of	ADP
bam-9518	221	26	covid-19	covid-19	PROPN
bam-9518	221	27	.	.	PUNCT
bam-9518	221	28	jama	jama	PROPN
bam-9518	221	29	.	.	PUNCT
bam-9518	222	1	2020	2020	NUM
bam-9518	222	2	apr	apr	NOUN
bam-9518	222	3	14;323(14):14061407	14;323(14):14061407	NUM
bam-9518	222	4	.	.	PUNCT
bam-9518	223	1	doi	doi	NOUN
bam-9518	223	2	:	:	PUNCT
bam-9518	223	3	10.1001	10.1001	NUM
bam-9518	223	4	/	/	SYM
bam-9518	223	5	jama.2020.2565	jama.2020.2565	NOUN
bam-9518	223	6	.	.	PUNCT
bam-9518	224	1	9	9	X
bam-9518	224	2	.	.	X
bam-9518	224	3	cucinotta	cucinotta	PROPN
bam-9518	224	4	d	d	PROPN
bam-9518	224	5	,	,	PUNCT
bam-9518	224	6	vanelli	vanelli	PROPN
bam-9518	224	7	m.	m.	NOUN
bam-9518	224	8	who	who	PRON
bam-9518	224	9	declares	declare	VERB
bam-9518	224	10	covid-19	covid-19	PROPN
bam-9518	224	11	a	a	DET
bam-9518	224	12	pandemic	pandemic	NOUN
bam-9518	224	13	.	.	PUNCT
bam-9518	225	1	acta	acta	PROPN
bam-9518	225	2	biomed	biome	VERB
bam-9518	225	3	.	.	PUNCT
bam-9518	226	1	2020	2020	NUM
bam-9518	226	2	mar	mar	PROPN
bam-9518	226	3	19;91(1):157160	19;91(1):157160	NUM
bam-9518	226	4	.	.	PUNCT
bam-9518	227	1	doi	doi	NOUN
bam-9518	227	2	:	:	PUNCT
bam-9518	227	3	10.23750	10.23750	NUM
bam-9518	227	4	/	/	SYM
bam-9518	227	5	abm.v91i1.9397	abm.v91i1.9397	PROPN
bam-9518	227	6	.	.	PROPN
bam-9518	228	1	10	10	NUM
bam-9518	228	2	.	.	PUNCT
bam-9518	229	1	tahir	tahir	PROPN
bam-9518	229	2	ul	ul	PROPN
bam-9518	229	3	qamar	qamar	PROPN
bam-9518	229	4	m	m	PROPN
bam-9518	229	5	,	,	PUNCT
bam-9518	229	6	alqahtani	alqahtani	PROPN
bam-9518	229	7	sm	sm	PROPN
bam-9518	229	8	,	,	PUNCT
bam-9518	229	9	alamri	alamri	PROPN
bam-9518	229	10	ma	ma	PROPN
bam-9518	229	11	,	,	PUNCT
bam-9518	229	12	chen	chen	PROPN
bam-9518	229	13	ll	ll	PROPN
bam-9518	229	14	.	.	PUNCT
bam-9518	230	1	structural	structural	ADJ
bam-9518	230	2	basis	basis	NOUN
bam-9518	230	3	of	of	ADP
bam-9518	230	4	sars	sar	NOUN
bam-9518	230	5	-	-	PUNCT
bam-9518	230	6	cov-2	cov-2	NUM
bam-9518	230	7	3clpro	3clpro	NUM
bam-9518	230	8	and	and	CCONJ
bam-9518	230	9	anti	anti	ADJ
bam-9518	230	10	-	-	ADJ
bam-9518	230	11	covid-19	covid-19	ADJ
bam-9518	230	12	drug	drug	NOUN
bam-9518	230	13	discovery	discovery	NOUN
bam-9518	230	14	from	from	ADP
bam-9518	230	15	medicinal	medicinal	ADJ
bam-9518	230	16	plants	plant	NOUN
bam-9518	230	17	.	.	PUNCT
bam-9518	231	1	j	j	PROPN
bam-9518	231	2	pharm	pharm	PROPN
bam-9518	231	3	anal	anal	PROPN
bam-9518	231	4	.	.	PUNCT
bam-9518	232	1	2020	2020	NUM
bam-9518	232	2	aug;10(4):313	aug;10(4):313	PROPN
bam-9518	232	3	-	-	PUNCT
bam-9518	232	4	319	319	NUM
bam-9518	232	5	.	.	PUNCT
bam-9518	233	1	doi	doi	NOUN
bam-9518	233	2	:	:	PUNCT
bam-9518	233	3	10.1016	10.1016	NUM
bam-9518	233	4	/	/	SYM
bam-9518	233	5	j.jpha.2020.03.009	j.jpha.2020.03.009	PROPN
bam-9518	233	6	.	.	PUNCT
bam-9518	234	1	epub	epub	PROPN
bam-9518	234	2	2020	2020	NUM
bam-9518	234	3	mar	mar	PROPN
bam-9518	234	4	26	26	NUM
bam-9518	234	5	.	.	PUNCT
bam-9518	235	1	mailto:hashemianam11@gmail.com	mailto:hashemianam11@gmail.com	PROPN
bam-9518	236	1	mailto:yaghoubianh1@mums.ac.ir	mailto:yaghoubianh1@mums.ac.ir	VERB
bam-9518	236	2	mailto:hoseen.nikta@gmail.com	mailto:hoseen.nikta@gmail.com	X
bam-9518	237	1	mailto:peivandia@mums.ac.ir	mailto:peivandia@mums.ac.ir	ADJ
bam-9518	237	2	mailto:ghoranisv@mums.ac.ir	mailto:ghoranisv@mums.ac.ir	NOUN
bam-9518	237	3	mailto:mahdavirm@mums.ac.ir	mailto:mahdavirm@mums.ac.ir	ADJ
bam-9518	237	4	effect	effect	NOUN
bam-9518	237	5	of	of	ADP
bam-9518	237	6	allicin	allicin	NOUN
bam-9518	237	7	(	(	PUNCT
bam-9518	237	8	l	l	NOUN
bam-9518	237	9	-	-	NOUN
bam-9518	237	10	cysteine	cysteine	NOUN
bam-9518	237	11	)	)	PUNCT
bam-9518	237	12	on	on	ADP
bam-9518	237	13	covid-19	covid-19	PROPN
bam-9518	237	14	eur	eur	PROPN
bam-9518	237	15	j	j	PROPN
bam-9518	237	16	transl	transl	PROPN
bam-9518	237	17	myol	myol	ADV
bam-9518	237	18	31	31	NUM
bam-9518	237	19	(	(	PUNCT
bam-9518	237	20	2	2	NUM
bam-9518	237	21	):	):	PUNCT
bam-9518	237	22	9518	9518	NUM
bam-9518	237	23	,	,	PUNCT
bam-9518	237	24	2021	2021	NUM
bam-9518	237	25	doi	doi	NOUN
bam-9518	237	26	:	:	PUNCT
bam-9518	237	27	10.4081	10.4081	NUM
bam-9518	237	28	/	/	SYM
bam-9518	237	29	ejtm.2021.9518	ejtm.2021.9518	ADJ
bam-9518	237	30	6	6	NUM
bam-9518	237	31	11	11	NUM
bam-9518	237	32	.	.	PUNCT
bam-9518	238	1	middleton	middleton	PROPN
bam-9518	238	2	j	j	PROPN
bam-9518	238	3	,	,	PUNCT
bam-9518	238	4	reintjes	reintjes	ADV
bam-9518	238	5	r	r	PROPN
bam-9518	238	6	,	,	PUNCT
bam-9518	238	7	lopes	lopes	PROPN
bam-9518	238	8	h.	h.	PROPN
bam-9518	238	9	meat	meat	PROPN
bam-9518	238	10	plants	plant	NOUN
bam-9518	238	11	-	-	PUNCT
bam-9518	238	12	a	a	DET
bam-9518	238	13	new	new	ADJ
bam-9518	238	14	front	front	ADJ
bam-9518	238	15	line	line	NOUN
bam-9518	238	16	in	in	ADP
bam-9518	238	17	the	the	DET
bam-9518	238	18	covid-19	covid-19	PROPN
bam-9518	238	19	pandemic	pandemic	NOUN
bam-9518	238	20	.	.	PUNCT
bam-9518	239	1	bmj	bmj	PROPN
bam-9518	239	2	.	.	PUNCT
bam-9518	239	3	2020	2020	NUM
bam-9518	239	4	jul	jul	PROPN
bam-9518	239	5	9;370	9;370	NUM
bam-9518	239	6	:	:	PUNCT
bam-9518	239	7	m2716	m2716	NOUN
bam-9518	239	8	.	.	PUNCT
bam-9518	240	1	doi	doi	NOUN
bam-9518	240	2	:	:	PUNCT
bam-9518	240	3	10.1136	10.1136	NUM
bam-9518	240	4	/	/	SYM
bam-9518	240	5	bmj.m2716	bmj.m2716	NOUN
bam-9518	240	6	.	.	PUNCT
bam-9518	241	1	12	12	NUM
bam-9518	241	2	.	.	PUNCT
bam-9518	242	1	shree	shree	PROPN
bam-9518	242	2	p	p	PROPN
bam-9518	242	3	,	,	PUNCT
bam-9518	242	4	mishra	mishra	PROPN
bam-9518	242	5	p	p	PROPN
bam-9518	242	6	,	,	PUNCT
bam-9518	242	7	selvaraj	selvaraj	ADJ
bam-9518	242	8	c	c	X
bam-9518	242	9	,	,	PUNCT
bam-9518	242	10	singh	singh	PROPN
bam-9518	242	11	sk	sk	NOUN
bam-9518	242	12	,	,	PUNCT
bam-9518	242	13	chaube	chaube	NOUN
bam-9518	242	14	r	r	NOUN
bam-9518	242	15	,	,	PUNCT
bam-9518	242	16	garg	garg	NOUN
bam-9518	242	17	n	n	CCONJ
bam-9518	242	18	,	,	PUNCT
bam-9518	242	19	tripathi	tripathi	PROPN
bam-9518	242	20	yb	yb	PROPN
bam-9518	242	21	.	.	PUNCT
bam-9518	243	1	targeting	target	VERB
bam-9518	243	2	covid-19	covid-19	PROPN
bam-9518	243	3	(	(	PUNCT
bam-9518	243	4	sars	sar	NOUN
bam-9518	243	5	-	-	PUNCT
bam-9518	243	6	cov-2	cov-2	NOUN
bam-9518	243	7	)	)	PUNCT
bam-9518	243	8	main	main	ADJ
bam-9518	243	9	protease	protease	NOUN
bam-9518	243	10	through	through	ADP
bam-9518	243	11	active	active	ADJ
bam-9518	243	12	phytochemicals	phytochemical	NOUN
bam-9518	243	13	of	of	ADP
bam-9518	243	14	ayurvedic	ayurvedic	ADJ
bam-9518	243	15	medicinal	medicinal	ADJ
bam-9518	243	16	plants	plant	NOUN
bam-9518	243	17	withania	withania	PROPN
bam-9518	243	18	somnifera	somnifera	PROPN
bam-9518	243	19	(	(	PUNCT
bam-9518	243	20	ashwagandha	ashwagandha	NOUN
bam-9518	243	21	)	)	PUNCT
bam-9518	243	22	,	,	PUNCT
bam-9518	243	23	tinospora	tinospora	PROPN
bam-9518	243	24	cordifolia	cordifolia	PROPN
bam-9518	243	25	(	(	PUNCT
bam-9518	243	26	giloy	giloy	PROPN
bam-9518	243	27	)	)	PUNCT
bam-9518	243	28	and	and	CCONJ
bam-9518	243	29	ocimum	ocimum	ADJ
bam-9518	243	30	sanctum	sanctum	NOUN
bam-9518	243	31	(	(	PUNCT
bam-9518	243	32	tulsi	tulsi	NOUN
bam-9518	243	33	)	)	PUNCT
bam-9518	243	34	a	a	DET
bam-9518	243	35	molecular	molecular	ADJ
bam-9518	243	36	docking	docking	NOUN
bam-9518	243	37	study	study	NOUN
bam-9518	243	38	.	.	PUNCT
bam-9518	244	1	j	j	PROPN
bam-9518	244	2	biomol	biomol	PROPN
bam-9518	244	3	struct	struct	NOUN
bam-9518	244	4	dyn	dyn	NOUN
bam-9518	244	5	.	.	PUNCT
bam-9518	245	1	2020	2020	NUM
bam-9518	245	2	aug	aug	PROPN
bam-9518	245	3	27:1	27:1	NUM
bam-9518	245	4	-	-	SYM
bam-9518	245	5	14	14	NUM
bam-9518	245	6	.	.	PUNCT
bam-9518	246	1	doi	doi	NOUN
bam-9518	246	2	:	:	PUNCT
bam-9518	246	3	10.1080/07391102.2020.1810778	10.1080/07391102.2020.1810778	NUM
bam-9518	246	4	.	.	PUNCT
bam-9518	247	1	epub	epub	NOUN
bam-9518	247	2	ahead	ahead	ADV
bam-9518	247	3	of	of	ADP
bam-9518	247	4	print	print	NOUN
bam-9518	247	5	.	.	PUNCT
bam-9518	248	1	13	13	NUM
bam-9518	248	2	.	.	PUNCT
bam-9518	248	3	khanal	khanal	PROPN
bam-9518	248	4	p	p	NOUN
bam-9518	248	5	,	,	PUNCT
bam-9518	248	6	duyu	duyu	PROPN
bam-9518	248	7	t	t	PROPN
bam-9518	248	8	,	,	PUNCT
bam-9518	248	9	patil	patil	PROPN
bam-9518	248	10	bm	bm	PROPN
bam-9518	248	11	,	,	PUNCT
bam-9518	248	12	dey	dey	PROPN
bam-9518	248	13	yn	yn	PROPN
bam-9518	248	14	,	,	PUNCT
bam-9518	248	15	pasha	pasha	PROPN
bam-9518	248	16	i	i	PROPN
bam-9518	248	17	,	,	PUNCT
bam-9518	248	18	wanjari	wanjari	PROPN
bam-9518	248	19	m	m	PROPN
bam-9518	248	20	,	,	PUNCT
bam-9518	248	21	gurav	gurav	PROPN
bam-9518	248	22	ss	ss	PROPN
bam-9518	248	23	,	,	PUNCT
bam-9518	248	24	maity	maity	NOUN
bam-9518	248	25	a.	a.	NOUN
bam-9518	248	26	network	network	PROPN
bam-9518	248	27	pharmacology	pharmacology	NOUN
bam-9518	248	28	of	of	ADP
bam-9518	248	29	ayush	ayush	ADJ
bam-9518	248	30	recommended	recommend	VERB
bam-9518	248	31	immuneboosting	immunebooste	VERB
bam-9518	248	32	medicinal	medicinal	ADJ
bam-9518	248	33	plants	plant	NOUN
bam-9518	248	34	against	against	ADP
bam-9518	248	35	covid-19	covid-19	PROPN
bam-9518	248	36	.	.	PUNCT
bam-9518	249	1	j	j	PROPN
bam-9518	249	2	ayurveda	ayurveda	PROPN
bam-9518	249	3	integr	integr	PROPN
bam-9518	249	4	med	me	VERB
bam-9518	249	5	.	.	PUNCT
bam-9518	250	1	2020	2020	NUM
bam-9518	250	2	nov	nov	PROPN
bam-9518	250	3	25	25	NUM
bam-9518	250	4	.	.	PUNCT
bam-9518	251	1	doi	doi	NOUN
bam-9518	251	2	:	:	PUNCT
bam-9518	251	3	10.1016	10.1016	NUM
bam-9518	251	4	/	/	SYM
bam-9518	251	5	j.jaim.2020.11.004	j.jaim.2020.11.004	PROPN
bam-9518	251	6	.	.	PUNCT
bam-9518	252	1	epub	epub	NOUN
bam-9518	252	2	ahead	ahead	ADV
bam-9518	252	3	of	of	ADP
bam-9518	252	4	print	print	NOUN
bam-9518	252	5	.	.	PUNCT
bam-9518	253	1	14	14	NUM
bam-9518	253	2	.	.	PUNCT
bam-9518	254	1	d'adamo	d'adamo	PROPN
bam-9518	254	2	i	i	PRON
bam-9518	254	3	,	,	PUNCT
bam-9518	254	4	gastaldi	gastaldi	PROPN
bam-9518	254	5	m	m	PROPN
bam-9518	254	6	,	,	PUNCT
bam-9518	254	7	morone	morone	NOUN
bam-9518	254	8	p.	p.	NOUN
bam-9518	254	9	the	the	DET
bam-9518	254	10	post	post	NOUN
bam-9518	254	11	covid-19	covid-19	PROPN
bam-9518	254	12	green	green	ADJ
bam-9518	254	13	recovery	recovery	NOUN
bam-9518	254	14	in	in	ADP
bam-9518	254	15	practice	practice	NOUN
bam-9518	254	16	:	:	PUNCT
bam-9518	254	17	assessing	assess	VERB
bam-9518	254	18	the	the	DET
bam-9518	254	19	profitability	profitability	NOUN
bam-9518	254	20	of	of	ADP
bam-9518	254	21	a	a	DET
bam-9518	254	22	policy	policy	NOUN
bam-9518	254	23	proposal	proposal	NOUN
bam-9518	254	24	on	on	ADP
bam-9518	254	25	residential	residential	ADJ
bam-9518	254	26	photovoltaic	photovoltaic	NOUN
bam-9518	254	27	plants	plant	NOUN
bam-9518	254	28	.	.	PUNCT
bam-9518	255	1	energy	energy	NOUN
bam-9518	255	2	policy	policy	NOUN
bam-9518	255	3	.	.	PUNCT
bam-9518	256	1	2020	2020	NUM
bam-9518	256	2	dec;147:111910	dec;147:111910	NOUN
bam-9518	256	3	.	.	PUNCT
bam-9518	257	1	doi	doi	NOUN
bam-9518	257	2	:	:	PUNCT
bam-9518	257	3	10.1016	10.1016	NUM
bam-9518	257	4	/	/	SYM
bam-9518	257	5	j.enpol.2020.111910	j.enpol.2020.111910	NOUN
bam-9518	257	6	.	.	PUNCT
bam-9518	258	1	epub	epub	NOUN
bam-9518	258	2	2020	2020	NUM
bam-9518	258	3	sep	sep	PROPN
bam-9518	258	4	23	23	NUM
bam-9518	258	5	.	.	PUNCT
bam-9518	259	1	15	15	NUM
bam-9518	259	2	.	.	PUNCT
bam-9518	259	3	monajjemi	monajjemi	PROPN
bam-9518	259	4	m	m	PROPN
bam-9518	259	5	,	,	PUNCT
bam-9518	259	6	mollaamin	mollaamin	PROPN
bam-9518	259	7	f	f	PROPN
bam-9518	259	8	,	,	PUNCT
bam-9518	259	9	shojaei	shojaei	VERB
bam-9518	259	10	s.	s.	PROPN
bam-9518	259	11	an	an	DET
bam-9518	259	12	overview	overview	NOUN
bam-9518	259	13	on	on	ADP
bam-9518	259	14	coronaviruses	coronaviruse	NOUN
bam-9518	259	15	family	family	NOUN
bam-9518	259	16	from	from	ADP
bam-9518	259	17	past	past	NOUN
bam-9518	259	18	to	to	ADP
bam-9518	259	19	covid-19	covid-19	PROPN
bam-9518	259	20	:	:	PUNCT
bam-9518	259	21	introduce	introduce	VERB
bam-9518	259	22	some	some	DET
bam-9518	259	23	inhibitors	inhibitor	NOUN
bam-9518	259	24	as	as	ADP
bam-9518	259	25	antiviruses	antiviruse	NOUN
bam-9518	259	26	from	from	ADP
bam-9518	259	27	gillan	gillan	PROPN
bam-9518	259	28	’s	’s	PART
bam-9518	259	29	plants	plant	NOUN
bam-9518	259	30	.	.	PUNCT
bam-9518	260	1	biointerface	biointerface	NOUN
bam-9518	260	2	research	research	NOUN
bam-9518	260	3	in	in	ADP
bam-9518	260	4	applied	applied	ADJ
bam-9518	260	5	chemistry	chemistry	NOUN
bam-9518	260	6	.	.	PUNCT
bam-9518	261	1	2020	2020	NUM
bam-9518	261	2	jan	jan	NOUN
bam-9518	261	3	1;10(3	1;10(3	NUM
bam-9518	261	4	)	)	PUNCT
bam-9518	261	5	.	.	PUNCT
bam-9518	262	1	16	16	NUM
bam-9518	262	2	.	.	PUNCT
bam-9518	263	1	khaerunnisa	khaerunnisa	NOUN
bam-9518	263	2	s	s	PROPN
bam-9518	263	3	,	,	PUNCT
bam-9518	263	4	kurniawan	kurniawan	PROPN
bam-9518	263	5	h	h	PROPN
bam-9518	263	6	,	,	PUNCT
bam-9518	263	7	awaluddin	awaluddin	ADV
bam-9518	263	8	r	r	NOUN
bam-9518	263	9	,	,	PUNCT
bam-9518	263	10	suhartati	suhartati	NOUN
bam-9518	263	11	s	s	PART
bam-9518	263	12	,	,	PUNCT
bam-9518	263	13	soetjipto	soetjipto	PROPN
bam-9518	263	14	s.	s.	PROPN
bam-9518	263	15	potential	potential	ADJ
bam-9518	263	16	inhibitor	inhibitor	NOUN
bam-9518	263	17	of	of	ADP
bam-9518	263	18	covid-19	covid-19	PROPN
bam-9518	263	19	main	main	ADJ
bam-9518	263	20	protease	protease	NOUN
bam-9518	263	21	(	(	PUNCT
bam-9518	263	22	mpro	mpro	ADJ
bam-9518	263	23	)	)	PUNCT
bam-9518	263	24	from	from	ADP
bam-9518	263	25	several	several	ADJ
bam-9518	263	26	medicinal	medicinal	ADJ
bam-9518	263	27	plant	plant	NOUN
bam-9518	263	28	compounds	compound	NOUN
bam-9518	263	29	by	by	ADP
bam-9518	263	30	molecular	molecular	ADJ
bam-9518	263	31	docking	docking	NOUN
bam-9518	263	32	study	study	NOUN
bam-9518	263	33	.	.	PUNCT
bam-9518	264	1	prepr	prepr	ADJ
bam-9518	264	2	.	.	PUNCT
bam-9518	265	1	doi10	doi10	ADJ
bam-9518	265	2	.	.	PROPN
bam-9518	265	3	2020	2020	NUM
bam-9518	265	4	mar	mar	PROPN
bam-9518	265	5	13;20944:1	13;20944:1	PROPN
bam-9518	265	6	-	-	PUNCT
bam-9518	265	7	4	4	NUM
bam-9518	265	8	.	.	NUM
bam-9518	265	9	17	17	NUM
bam-9518	265	10	.	.	PUNCT
bam-9518	266	1	khaerunnisa	khaerunnisa	PROPN
bam-9518	266	2	s	s	PROPN
bam-9518	266	3	,	,	PUNCT
bam-9518	266	4	kurniawan	kurniawan	PROPN
bam-9518	266	5	h	h	PROPN
bam-9518	266	6	,	,	PUNCT
bam-9518	266	7	awaluddin	awaluddin	ADV
bam-9518	266	8	r	r	NOUN
bam-9518	266	9	,	,	PUNCT
bam-9518	266	10	suhartati	suhartati	NOUN
bam-9518	266	11	s	s	PART
bam-9518	266	12	,	,	PUNCT
bam-9518	266	13	soetjipto	soetjipto	PROPN
bam-9518	266	14	s.	s.	PROPN
bam-9518	266	15	potential	potential	ADJ
bam-9518	266	16	inhibitor	inhibitor	NOUN
bam-9518	266	17	of	of	ADP
bam-9518	266	18	covid-19	covid-19	PROPN
bam-9518	266	19	main	main	ADJ
bam-9518	266	20	protease	protease	NOUN
bam-9518	266	21	(	(	PUNCT
bam-9518	266	22	mpro	mpro	ADJ
bam-9518	266	23	)	)	PUNCT
bam-9518	266	24	from	from	ADP
bam-9518	266	25	several	several	ADJ
bam-9518	266	26	medicinal	medicinal	ADJ
bam-9518	266	27	plant	plant	NOUN
bam-9518	266	28	compounds	compound	NOUN
bam-9518	266	29	by	by	ADP
bam-9518	266	30	molecular	molecular	ADJ
bam-9518	266	31	docking	docking	NOUN
bam-9518	266	32	study	study	NOUN
bam-9518	266	33	.	.	PUNCT
bam-9518	267	1	prepr	prepr	ADJ
bam-9518	267	2	.	.	PUNCT
bam-9518	268	1	doi10	doi10	ADJ
bam-9518	268	2	.	.	PROPN
bam-9518	268	3	2020	2020	NUM
bam-9518	268	4	mar	mar	PROPN
bam-9518	268	5	13;20944:1	13;20944:1	PROPN
bam-9518	268	6	-	-	PUNCT
bam-9518	268	7	4	4	NUM
bam-9518	268	8	.	.	NOUN
bam-9518	268	9	18	18	NUM
bam-9518	268	10	.	.	PUNCT
bam-9518	268	11	shekh	shekh	PROPN
bam-9518	268	12	s	s	PROPN
bam-9518	268	13	,	,	PUNCT
bam-9518	268	14	reddy	reddy	PROPN
bam-9518	268	15	kk	kk	PROPN
bam-9518	268	16	,	,	PUNCT
bam-9518	268	17	gowd	gowd	PROPN
bam-9518	268	18	kh	kh	PROPN
bam-9518	268	19	.	.	PUNCT
bam-9518	269	1	in	in	ADP
bam-9518	269	2	silico	silico	NOUN
bam-9518	269	3	allicin	allicin	NOUN
bam-9518	269	4	(	(	PUNCT
bam-9518	269	5	lcysteine	lcysteine	NOUN
bam-9518	269	6	)	)	PUNCT
bam-9518	269	7	induced	induce	VERB
bam-9518	269	8	s	s	NOUN
bam-9518	269	9	-	-	PUNCT
bam-9518	269	10	thioallylation	thioallylation	NOUN
bam-9518	269	11	of	of	ADP
bam-9518	269	12	sars	sar	NOUN
bam-9518	269	13	-	-	PUNCT
bam-9518	269	14	cov-2	cov-2	NOUN
bam-9518	269	15	main	main	ADJ
bam-9518	269	16	protease	protease	NOUN
bam-9518	269	17	.	.	PUNCT
bam-9518	270	1	journal	journal	NOUN
bam-9518	270	2	of	of	ADP
bam-9518	270	3	sulfur	sulfur	NOUN
bam-9518	270	4	chemistry	chemistry	NOUN
bam-9518	270	5	.	.	PUNCT
bam-9518	271	1	2020	2020	NUM
bam-9518	271	2	sep	sep	PROPN
bam-9518	271	3	16:1	16:1	PROPN
bam-9518	271	4	-	-	PROPN
bam-9518	271	5	2	2	NUM
bam-9518	271	6	.	.	NOUN
bam-9518	271	7	19	19	NUM
bam-9518	271	8	.	.	PUNCT
bam-9518	272	1	khaerunnisa	khaerunnisa	PROPN
bam-9518	272	2	s	s	PROPN
bam-9518	272	3	,	,	PUNCT
bam-9518	272	4	kurniawan	kurniawan	PROPN
bam-9518	272	5	h	h	PROPN
bam-9518	272	6	,	,	PUNCT
bam-9518	272	7	awaluddin	awaluddin	ADV
bam-9518	272	8	r	r	NOUN
bam-9518	272	9	,	,	PUNCT
bam-9518	272	10	suhartati	suhartati	NOUN
bam-9518	272	11	s	s	PART
bam-9518	272	12	,	,	PUNCT
bam-9518	272	13	soetjipto	soetjipto	PROPN
bam-9518	272	14	s.	s.	PROPN
bam-9518	272	15	potential	potential	ADJ
bam-9518	272	16	inhibitor	inhibitor	NOUN
bam-9518	272	17	of	of	ADP
bam-9518	272	18	covid-19	covid-19	PROPN
bam-9518	272	19	main	main	ADJ
bam-9518	272	20	protease	protease	NOUN
bam-9518	272	21	(	(	PUNCT
bam-9518	272	22	mpro	mpro	ADJ
bam-9518	272	23	)	)	PUNCT
bam-9518	272	24	from	from	ADP
bam-9518	272	25	several	several	ADJ
bam-9518	272	26	medicinal	medicinal	ADJ
bam-9518	272	27	plant	plant	NOUN
bam-9518	272	28	compounds	compound	NOUN
bam-9518	272	29	by	by	ADP
bam-9518	272	30	molecular	molecular	ADJ
bam-9518	272	31	docking	docking	NOUN
bam-9518	272	32	study	study	NOUN
bam-9518	272	33	.	.	PUNCT
bam-9518	273	1	prepr	prepr	ADJ
bam-9518	273	2	.	.	PUNCT
bam-9518	274	1	doi10	doi10	ADJ
bam-9518	274	2	.	.	PROPN
bam-9518	274	3	2020	2020	NUM
bam-9518	274	4	mar	mar	PROPN
bam-9518	274	5	13;20944:1	13;20944:1	PROPN
bam-9518	274	6	-	-	PUNCT
bam-9518	274	7	4	4	NUM
bam-9518	274	8	.	.	NOUN
bam-9518	274	9	20	20	NUM
bam-9518	274	10	.	.	PUNCT
bam-9518	275	1	boone	boone	PROPN
bam-9518	275	2	ha	ha	INTJ
bam-9518	275	3	,	,	PUNCT
bam-9518	275	4	medunjanin	medunjanin	PROPN
bam-9518	275	5	d	d	PROPN
bam-9518	275	6	,	,	PUNCT
bam-9518	275	7	sijerčić	sijerčić	ADJ
bam-9518	275	8	a.	a.	NOUN
bam-9518	275	9	review	review	NOUN
bam-9518	275	10	on	on	ADP
bam-9518	275	11	potential	potential	NOUN
bam-9518	275	12	of	of	ADP
bam-9518	275	13	phytotherapeutics	phytotherapeutic	NOUN
bam-9518	275	14	in	in	ADP
bam-9518	275	15	fight	fight	NOUN
bam-9518	275	16	against	against	ADP
bam-9518	275	17	covid-19	covid-19	PROPN
bam-9518	275	18	.	.	PUNCT
bam-9518	276	1	int	int	PROPN
bam-9518	277	1	j	j	PROPN
bam-9518	277	2	innov	innov	PROPN
bam-9518	277	3	sci	sci	PROPN
bam-9518	277	4	res	res	PROPN
bam-9518	277	5	technol	technol	NOUN
bam-9518	277	6	.	.	PUNCT
bam-9518	278	1	2020;5:481	2020;5:481	NUM
bam-9518	278	2	-	-	SYM
bam-9518	278	3	91	91	NUM
bam-9518	278	4	.	.	PUNCT
bam-9518	279	1	21	21	NUM
bam-9518	279	2	.	.	PUNCT
bam-9518	279	3	fasogbon	fasogbon	PROPN
bam-9518	279	4	bm	bm	PROPN
bam-9518	279	5	,	,	PUNCT
bam-9518	279	6	ademuyiwa	ademuyiwa	ADJ
bam-9518	279	7	oh	oh	INTJ
bam-9518	279	8	,	,	PUNCT
bam-9518	279	9	bamidele	bamidele	PROPN
bam-9518	279	10	op	op	PROPN
bam-9518	279	11	,	,	PUNCT
bam-9518	279	12	wahab	wahab	PROPN
bam-9518	279	13	ie	ie	X
bam-9518	279	14	,	,	PUNCT
bam-9518	279	15	ola	ola	PROPN
bam-9518	279	16	-	-	PUNCT
bam-9518	279	17	adedoyin	adedoyin	PROPN
bam-9518	279	18	at	at	ADP
bam-9518	279	19	,	,	PUNCT
bam-9518	279	20	alakija	alakija	VERB
bam-9518	279	21	o.	o.	PROPN
bam-9518	279	22	positive	positive	ADJ
bam-9518	279	23	therapeutic	therapeutic	ADJ
bam-9518	279	24	role	role	NOUN
bam-9518	279	25	of	of	ADP
bam-9518	279	26	selected	select	VERB
bam-9518	279	27	foods	food	NOUN
bam-9518	279	28	and	and	CCONJ
bam-9518	279	29	plant	plant	NOUN
bam-9518	279	30	on	on	ADP
bam-9518	279	31	ailments	ailment	NOUN
bam-9518	279	32	with	with	ADP
bam-9518	279	33	a	a	DET
bam-9518	279	34	trend	trend	NOUN
bam-9518	279	35	towards	towards	ADP
bam-9518	279	36	covid-19	covid-19	PROPN
bam-9518	279	37	:	:	PUNCT
bam-9518	279	38	a	a	DET
bam-9518	279	39	review	review	NOUN
bam-9518	279	40	.	.	PUNCT
bam-9518	280	1	prev	prev	PROPN
bam-9518	280	2	nutr	nutr	PROPN
bam-9518	280	3	food	food	PROPN
bam-9518	280	4	sci	sci	PROPN
bam-9518	280	5	.	.	PROPN
bam-9518	280	6	2021	2021	NUM
bam-9518	280	7	mar	mar	PROPN
bam-9518	280	8	31;26(1):111	31;26(1):111	PROPN
bam-9518	280	9	.	.	PUNCT
bam-9518	281	1	doi	doi	PROPN
bam-9518	281	2	:	:	PUNCT
bam-9518	281	3	10.3746	10.3746	NUM
bam-9518	281	4	/	/	SYM
bam-9518	281	5	pnf.2021.26.1.1	pnf.2021.26.1.1	NOUN
bam-9518	281	6	.	.	PUNCT
bam-9518	282	1	submitted	submit	VERB
bam-9518	282	2	:	:	PUNCT
bam-9518	282	3	november	november	PROPN
bam-9518	282	4	19	19	NUM
bam-9518	282	5	,	,	PUNCT
bam-9518	282	6	2021	2021	NUM
bam-9518	282	7	revision	revision	NOUN
bam-9518	282	8	received	receive	VERB
bam-9518	282	9	:	:	PUNCT
bam-9518	282	10	april	april	PROPN
bam-9518	282	11	18	18	NUM
bam-9518	282	12	,	,	PUNCT
bam-9518	282	13	2021	2021	NUM
bam-9518	282	14	accepted	accept	VERB
bam-9518	282	15	for	for	ADP
bam-9518	282	16	publication	publication	NOUN
bam-9518	282	17	:	:	PUNCT
bam-9518	282	18	april	april	PROPN
bam-9518	282	19	18	18	NUM
bam-9518	282	20	,	,	PUNCT
bam-9518	282	21	2021	2021	NUM